0001033905-16-000192.txt : 20161101 0001033905-16-000192.hdr.sgml : 20161101 20161101113109 ACCESSION NUMBER: 0001033905-16-000192 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161101 DATE AS OF CHANGE: 20161101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LUMINEX CORP CENTRAL INDEX KEY: 0001033905 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 742747608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-30109 FILM NUMBER: 161963739 BUSINESS ADDRESS: STREET 1: 12212 TECHNOLOGY BLVD STREET 2: 512-219-8020 CITY: AUSTIN STATE: TX ZIP: 78727 MAIL ADDRESS: STREET 1: 12212 TECHNOLOGY BLVD CITY: AUSTIN STATE: TX ZIP: 78727 10-Q 1 lmnx-09302016x10q.htm FORM 10-Q Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q
þ
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2016.
or
o
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from __________ to __________.

Commission File Number: 000-30109
lmnxlogoa01a01a02a05.jpg 
LUMINEX CORPORATION
(Exact name of registrant as specified in its charter)
 
 
DELAWARE
74-2747608
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)
 
 
12212 TECHNOLOGY BLVD., AUSTIN, TEXAS
78727
(Address of principal executive offices)
(Zip Code)
(512) 219-8020
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ
 
Accelerated filer o
Non-accelerated filer o (Do not check if smaller reporting company)
 
Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o   No þ

There were 43,584,558 shares of the Company’s Common Stock, par value $0.001 per share, outstanding on October 31, 2016.


TABLE OF CONTENTS
 
Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EX-101 INSTANCE DOCUMENT
 
EX-101 SCHEMA DOCUMENT
 
EX-101 CALCULATION LINKBASE DOCUMENT
 
EX-101 DEFINITION LINKBASE DOCUMENT
 
EX-101 LABELS LINKBASE DOCUMENT
 
EX-101 PRESENTATION LINKBASE DOCUMENT
 


PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS
 
LUMINEX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts)
 
September 30, 2016
 
December 31, 2015
 
(unaudited)
 
 
ASSETS

 
 
Current assets:
 
 
 
Cash and cash equivalents
$
84,145

 
$
128,546

Short-term investments
—

 
11,988

Accounts receivable, net
29,962

 
28,853

Inventories, net
41,455

 
31,252

Prepaids and other
9,294

 
8,887

Total current assets
164,856

 
209,526

Property and equipment, net
55,461

 
47,796

Intangible assets, net
88,370

 
52,482

Deferred income taxes
42,208

 
31,821

Long-term investments
—

 
7,459

Goodwill
83,898

 
49,619

Other
6,335

 
3,853

Total assets
$
441,128

 
$
402,556

LIABILITIES AND STOCKHOLDERS' EQUITY
 

 
 

Current liabilities:
 

 
 

Accounts payable
$
9,881

 
$
7,868

Accrued liabilities
16,115

 
15,152

Deferred revenue
5,601

 
4,212

Total current liabilities
31,597

 
27,232

Deferred revenue
1,864

 
2,064

Other
4,902

 
4,724

Total liabilities
38,363

 
34,020

Stockholders' equity:
 

 
 

Common stock, $.001 par value, 200,000,000 shares authorized; issued and outstanding: 42,708,733 shares at September 30, 2016; 42,314,581 shares at December 31, 2015
43

 
42

Preferred stock, $.001 par value, 5,000,000 shares authorized; no shares issued and outstanding
—

 
—

Additional paid-in capital
331,474

 
321,657

Accumulated other comprehensive loss
(966
)
 
(1,296
)
Retained earnings
72,214

 
48,133

Total stockholders' equity
402,765

 
368,536

Total liabilities and stockholders' equity
$
441,128

 
$
402,556

 
 
 
 
See the accompanying notes which are an integral part of these
Condensed Consolidated Financial Statements.

1

LUMINEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands, except per share amounts)
 
 
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
 
(unaudited)
 
(unaudited)
Revenue
$
71,221

 
$
60,601

 
$
198,368

 
$
177,259

Cost of revenue
25,556

 
18,789

 
62,976

 
51,958

Gross profit
45,665

 
41,812

 
135,392

 
125,301

Operating expenses:
 

 
 

 
 

 
 

Research and development
12,762

 
10,093

 
35,324

 
31,748

Selling, general and administrative
26,393

 
21,236

 
70,942

 
61,740

Amortization of acquired intangible assets
2,482

 
777

 
5,797

 
2,455

Total operating expenses
41,637

 
32,106

 
112,063

 
95,943

Income from operations
4,028

 
9,706

 
23,329

 
29,358

Other income (expense), net
30

 
13

 
(1,395
)
 
964

Settlement of litigation
—

 
—

 
—

 
(7,300
)
Income before income taxes
4,058

 
9,719

 
21,934

 
23,022

Income taxes
(1,307
)
 
(3,317
)
 
(4,760
)
 
(6,538
)
Net income
$
2,751

 
$
6,402

 
$
17,174

 
$
16,484

 
 
 
 
 
 
 
 
Other comprehensive income:
 

 
 

 
 

 
 

Foreign currency translation adjustments
113

 
(20
)
 
292

 
(375
)
Unrealized gain on available-for-sale securities, net of tax
—

 
2

 
38

 
24

Other comprehensive income (loss)
113

 
(18
)
 
330

 
(351
)
Comprehensive income
$
2,864

 
$
6,384

 
$
17,504

 
$
16,133

 
 
 
 
 
 
 
 
Net income per share, basic
$
0.06

 
$
0.15

 
$
0.40

 
$
0.39

Shares used in computing net income per share, basic
42,683

 
42,152

 
42,522

 
42,041

 
 
 
 
 
 
 
 
Net income per share, diluted
$
0.06

 
$
0.15

 
$
0.40

 
$
0.39

Shares used in computing net income per share, diluted
43,136

 
42,556

 
42,929

 
42,354

 
 
 
 
 
 
 
 
See the accompanying notes which are an integral part of these
Condensed Consolidated Financial Statements.

2

LUMINEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
 
(unaudited)
 
(unaudited)
Cash flows from operating activities:
 
 
 
 
 
 
 
Net income
$
2,751

 
$
6,402

 
$
17,174

 
$
16,484

Adjustments to reconcile net income to net cash provided by operating activities:
 

 
 

 
 

 
 

Depreciation and amortization
5,913

 
3,411

 
14,401

 
9,733

Stock-based compensation
3,526

 
3,099

 
8,181

 
7,768

Deferred income tax expense
1,540

 
176

 
4,471

 
6,207

Excess income tax expense from employee stock-based awards
—

 
14

 
—

 
1,005

Loss (gain) on sale or disposal of assets
87

 
(62
)
 
128

 
(743
)
Other
(799
)
 
(25
)
 
(870
)
 
(128
)
Changes in operating assets and liabilities:
 

 
 

 
 

 
 

Accounts receivable, net
(3,118
)
 
(3,985
)
 
3,555

 
2,101

Inventories, net
(2,125
)
 
3,364

 
(6,165
)
 
7,414

Other assets
(902
)
 
764

 
(230
)
 
(1,629
)
Accounts payable
(1,674
)
 
1,238

 
1,050

 
(2,536
)
Accrued liabilities
(428
)
 
(3,452
)
 
(6,602
)
 
(1,485
)
Deferred revenue
112

 
(36
)
 
733

 
(212
)
Net cash provided by operating activities
4,883

 
10,908

 
35,826

 
43,979

Cash flows from investing activities:
 

 
 

 
 

 
 

Sales and maturities of available-for-sale securities
—

 
—

 
19,491

 
—

Purchase of property and equipment
(2,675
)
 
(2,731
)
 
(8,394
)
 
(15,299
)
Proceeds from sale of assets
42

 
—

 
45

 
893

Business acquisition consideration, net of cash acquired
(1,196
)
 
—

 
(68,098
)
 
—

Purchase of cost method investment
(500
)
 
—

 
(500
)
 
—

Acquired technology rights
—

 
(650
)
 
(200
)
 
(852
)
Net cash used in investing activities
(4,329
)
 
(3,381
)
 
(57,656
)
 
(15,258
)
Cash flows from financing activities:
 

 
 

 
 

 
 

Payments on debt
—

 
—

 
(25,000
)
 
—

Proceeds from issuance of common stock
1,799

 
977

 
3,561

 
1,690

Shares surrendered for tax withholding
(13
)
 
(14
)
 
(1,497
)
 
(1,593
)
Excess income tax expense from employee stock-based awards
—

 
(14
)
 
—

 
(1,005
)
Net cash provided by (used in) financing activities
1,786

 
949

 
(22,936
)
 
(908
)
Effect of foreign currency exchange rate on cash
87

 
13

 
365

 
46

Change in cash and cash equivalents
2,427

 
8,489

 
(44,401
)
 
27,859

Cash and cash equivalents, beginning of period
81,718

 
111,064

 
128,546

 
91,694

Cash and cash equivalents, end of period
$
84,145

 
$
119,553

 
$
84,145

 
$
119,553

 
 
 
 
 
 
 
 
See the accompanying notes which are an integral part of these
Condensed Consolidated Financial Statements.

3

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared by Luminex Corporation (the Company or Luminex) in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, all adjustments (consisting of normal recurring entries) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 (the 2015 10-K).

NOTE 2 — BUSINESS COMBINATIONS

On June 30, 2016, the Company completed its acquisition (the Acquisition) of 100% of the outstanding shares of Nanosphere, Inc. (Nanosphere), which was a publicly-held molecular diagnostic company that was founded in 1999 and based in Northbrook, Illinois. On May 15, 2016, the Company, Nanosphere and Commodore Acquisition, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (Purchaser) entered into an Agreement and Plan of Merger (as amended, the Merger Agreement). In accordance with the terms of the Merger Agreement, on June 2, 2016, Purchaser commenced a cash tender offer (the Tender Offer) for all of the outstanding shares of Nanosphere’s common stock, par value $0.01 per share (the Shares), for $1.70 per share, net to the seller in cash, without interest and less any required withholding taxes, upon the terms and conditions set forth in the Offer to Purchase dated June 2, 2016, as amended or supplemented from time to time, and in the related Letter of Transmittal. The Tender Offer expired at 12:00 midnight Eastern Daylight Time, at the end of June 29, 2016, and was not extended. Upon the completion of the Tender Offer, the Company, through Purchaser, paid $1.70 for each Share validly tendered and not withdrawn. Following the consummation of the Tender Offer, the Company completed the Acquisition by consummating the merger of Purchaser with and into Nanosphere, pursuant to which, any Shares not purchased in the Tender Offer were automatically converted into the right to receive $1.70 per Share. The aggregate consideration paid to Nanosphere stockholders required to acquire all outstanding Shares pursuant to the Tender Offer and the merger was approximately $88.5 million, which was funded from cash on hand. Pursuant to the terms of the Merger Agreement, Nanosphere agreed to cancel all outstanding and exercisable Nanosphere stock options and replace each such stock option with the right to receive a cash payment equal to the number of shares subject to such option multiplied by the difference between $1.70 and the applicable exercise price of the respective options. Nanosphere also agreed to cancel all of its outstanding restricted stock and convert such restricted stock into the right to receive a cash payment equal to the number of shares of restricted stock multiplied by $1.70.  The Company paid $1.4 million in aggregate consideration of the cancelled Nanosphere options and outstanding restricted stock. Additionally, for each Nanosphere warrant holder, the Company agreed to issue replacement warrants that are exercisable for an amount in cash equal to the product of the number of shares of stock represented by the replacement warrant and the difference between $1.70 and the per share price of the replacement warrant. The Company purchased 1.5 million Nanosphere warrants outstanding for an additional $2.5 million in consideration to the Nanosphere warrant holders.

The Acquisition was undertaken to expand the Company's access to the high-growth molecular microbiology market and to Nanosphere's portfolio of molecular testing solutions. Nanosphere delivers proprietary diagnostic tools that enable detection of respiratory, gastroenteric and bloodstream infections. Nanosphere shares ceased trading on the Nasdaq Capital Market as of the close of business on June 30, 2016. The results of operations for Nanosphere have been included in the Company’s consolidated financial statements beginning July 1, 2016.  

Immediately subsequent to the Acquisition, on June 30, 2016, the Company retired approximately $25.4 million of Nanosphere's debt, including approximately $391,000 of accrued interest, by using the Company's existing cash reserves, including $25.6 million of cash acquired in the Acquisition. As part of this debt retirement, we incurred $1.5 million of related fees which were expensed as part of the Company's second quarter 2016 results.

4


The Acquisition has been accounted for as a business combination in accordance with U.S. GAAP and, as such, the assets acquired and liabilities assumed have been recorded at their respective fair values. The determination of fair value for the identifiable tangible and intangible assets acquired and liabilities assumed requires extensive use of estimates and judgments. Significant estimates and assumptions include, but are not limited to, Level 3 measurements estimating future cash flows and determining the appropriate discount rate. The following table summarizes the estimated fair values of Nanosphere’s assets acquired and liabilities assumed at June 30, 2016 (in thousands):
 
 
Net tangible assets assumed as of June 30, 2016
$
34,387

Intangible assets subject to amortization
41,685

Long-term debt and accrued interest
(25,391
)
Deferred tax assets, net of deferred tax liabilities
7,449

Goodwill
34,279

Total purchase price
92,409

Less cash and cash equivalents acquired
(24,311
)
Net cash paid for business acquisition
$
68,098


The Company is in the process of finalizing third-party valuations of certain intangible assets and finalizing the calculations of the deferred tax liabilities related to Nanosphere; thus the provisional measurement of intangible assets, deferred tax liabilities and goodwill are subject to change.  If information that existed prior to June 30, 2016 becomes available which would indicate adjustments are required to the purchase price allocation, such adjustments will be included in the purchase price allocations through revisions to the net tangible assets assumed, fair values of the intangible assets, deferred tax assets and liabilities and resulting goodwill recorded.

Acquired finished goods and work-in-process inventory was valued at its estimated selling price less the sum of the costs of sales efforts and a reasonable profit allowance for the Company's selling effort and, with respect to work-in-process inventory, estimated costs to complete. This resulted in a fair value adjustment that increased finished goods inventory by approximately $0.5 million, which increased cost of goods sold in the quarter ending September 30, 2016 as these inventory items were sold.

The Acquisition contributed $7.4 million of revenue and net losses of $6.2 million, during the three months ended September 30, 2016.

Unaudited Pro forma Financial Information
Nanosphere's results of operations have been included in the Company's financial statements for the three months ended September 30, 2016, following the Acquisition on June 30, 2016. The unaudited pro forma financial information set forth below assumes that Nanosphere had been acquired at the beginning of January 1, 2015, and includes the effect of estimated amortization of acquired identifiable intangible assets, removal of interest expense on Nanosphere’s debt extinguished at the date of the Acquisition, and removal of Acquisition costs and the impact of purchase accounting adjustments, tax and inventory valuation adjustments. This unaudited pro forma financial information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have resulted had the Acquisition been in effect at the beginning of the periods presented. In addition, the unaudited pro forma financial information is not intended to be a projection of future results and does not reflect any operating efficiencies or cost savings that might be achievable.


5

 
Nine Months Ended September 30,
 
2016
 
2015
 
(unaudited)
(in thousands)
Revenue
$
212,320

 
$
191,483

Income from operations
12,814

 
4,060

Net income (loss)
10,557

 
(2,792
)
Net income (loss) per share, basic
0.25

 
(0.07
)
Shares used in computing net income (loss) per share, basic
42,522

 
42,041

Net income (loss) per share, diluted
0.25

 
(0.07
)
Shares used in computing net income (loss) per share, diluted
42,929

 
42,354


NOTE 3 — INVESTMENTS

Marketable Securities

The Company determines the appropriate classification of its investments in debt and equity securities at the time of purchase and re-evaluates such determinations at each balance sheet date. Marketable securities that are bought and held principally for the purpose of selling them in the near term are classified as trading securities and are reported at fair value, with unrealized gains and losses recognized in earnings. Debt securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are stated at amortized cost, which approximates the fair value of these investments. Debt securities for which the Company does not have the intent or ability to hold to maturity are classified as available-for-sale. Debt and marketable equity securities not classified as held-to-maturity or as trading are classified as available-for-sale, and are carried at fair market value, with the unrealized gains and losses included in the determination of comprehensive income and reported in stockholders’ equity. As of September 30, 2016 and December 31, 2015, all of the Company’s marketable securities were classified as available-for-sale. Marketable securities are recorded as either short-term or long-term on the balance sheet based on the contractual maturity date. The fair value of all securities is determined by quoted market prices, market interest rate inputs, or other than quoted prices that are observable either directly or indirectly (as of the end of the reporting period). Declines in fair value below the Company’s carrying value deemed to be other than temporary are charged against net earnings. As of September 30, 2016, the Company had no short or long term investments, since those funds were used to pay for the Acquisition.

Available-for-sale securities consisted of the following as of September 30, 2016 (in thousands):
 
Amortized Cost
 
Gains in Accumulated Other Comprehensive Income
 
Losses in Accumulated Other Comprehensive Income
 
Estimated Fair Value
Current:
 
 
 
 
 
 
 
Cash equivalents
$
701

 


 
$
—

 
$
701

Government sponsored debt securities
—

 
—

 
—

 
—

Non-government sponsored debt securities
—

 
—

 
—

 
—

Total current securities
701

 
—

 
—

 
701

Noncurrent:
 

 
 

 
 

 
 

Government sponsored debt securities
—

 
—

 
—

 
—

Non-government sponsored debt securities
—

 
—

 
—

 
—

Total noncurrent securities
—

 
—

 
—

 
—

Total available-for-sale securities
$
701

 
$
—

 
$
—

 
$
701

 

6

Available-for-sale securities consisted of the following as of December 31, 2015 (in thousands):
 
Amortized Cost
 
Gains in Accumulated Other Comprehensive Income
 
Losses in Accumulated Other Comprehensive Income
 
Estimated Fair Value
Current:
 
 
 
 
 
 
 
Cash equivalents
$
144

 
$
—

 
$
—

 
$
144

Government sponsored debt securities
10,000

 
—

 
(10
)
 
9,990

Non-government sponsored debt securities
2,001

 
—

 
(3
)
 
1,998

Total current securities
12,145

 
—

 
(13
)
 
12,132

Noncurrent:
 

 
 

 
 

 
 

Government sponsored debt securities
1,998

 
—

 
(6
)
 
1,992

Non-government sponsored debt securities
5,491

 
—

 
(24
)
 
5,467

Total noncurrent securities
7,489

 
—

 
(30
)
 
7,459

Total available-for-sale securities
$
19,634

 
$
—

 
$
(43
)
 
$
19,591


Proceeds from the sales of available-for-sale securities during the three and nine months ended September 30, 2016 totaled zero and $19.5 million, respectively, and these proceeds were used to partially fund the Acquisition. There were no proceeds from the sales of available-for-sale securities for the three and nine ended September 30, 2015. Realized gains and losses on sales of investments are determined using the specific identification method. Realized gains and losses are included in Other income, net in the Consolidated Statements of Comprehensive Income. All of the Company's available-for-sale securities with gross unrealized holding losses as of September 30, 2016 and December 31, 2015 had been in a loss position for less than 12 months.

The estimated fair value of available-for-sale debt securities as of September 30, 2016 and December 31, 2015, by contractual maturity, was as follows (in thousands):
 
Estimated Fair Value
 
September 30, 2016
 
December 31, 2015
Due in one year or less
$
—

 
$
11,988

Due after one year through two years
—

 
7,459

 
$
—

 
$
19,447


Expected maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.

Non-Marketable Securities and Other-Than-Temporary Impairment

In the third quarter of 2016, the Company made a $0.5 million minority interest investment in a private company based in the U.S. that is focused on development of next generation technologies. This minority interest is included at cost in other long-term assets on the Company’s Consolidated Balance Sheets as the Company does not have significant influence over the investee since the Company owns less than 20% of the voting equity in the investee and the investee is not publicly traded. Although we may invest further in this entity over the course of the next several quarters, we do not anticipate our ownership interest to exceed 20% in the short term.

The Company owns a minority interest in a private company based in the U.S. through its investment of $1.0 million in the third quarter of 2012.  This minority interest is included at cost in other long-term assets on the Company’s Consolidated Balance Sheets as the Company does not have significant influence over the investee since the Company owns less than 20% of the voting equity in the investee and the investee is not publicly traded.

The Company's other minority interest in a private company was acquired by a third party in July 2013. The Company realized a gain of $5.4 million on the sale of this minority interest investment in the third quarter of 2013 and an additional gain of $0.9 million in the first quarter of 2015 related to the settlement of escrowed funds.


7

The Company regularly evaluates the carrying value of its cost-method investment for impairment and whether any events or circumstances are identified that would significantly harm the fair value of the investment. The primary indicators the Company utilizes to identify these events and circumstances are the investee's ability to remain in business, such as the investee's liquidity and rate of cash use, and the investee’s ability to secure additional funding and the value of that additional funding. In the event a decline in fair value is judged to be other-than-temporary, the Company will record an other-than-temporary impairment charge in Other income, net in the Consolidated Statements of Comprehensive Income. As the inputs utilized for the Company's periodic impairment assessment are not based on observable market data, the determination of fair value of this cost-method investment is classified within Level 3 of the fair value hierarchy. See Note 5 - Fair Value Measurement to our condensed consolidated financial statements for further discussion. To determine the fair value of this investment, the Company uses all available financial information related to the entities, including information based on recent or pending third-party equity investments in these entities. In certain instances, a cost-method investment's fair value is not estimated as there are no identified events or changes in the circumstances that may have a significant adverse effect on the fair value of the investment and to do so would be impractical.

NOTE 4 — INVENTORIES, NET

Inventories are stated at the lower of cost or market, with cost determined according to the standard cost method, which approximates the first-in, first-out method. The Company routinely assesses its on-hand inventory for timely identification and measurement of obsolete, slow-moving or otherwise impaired inventory. Inventories consisted of the following (in thousands):
 
September 30, 2016
 
December 31, 2015
Parts and supplies
$
23,792

 
$
15,296

Work-in-progress
6,704

 
8,797

Finished goods
10,959

 
7,159

 
$
41,455

 
$
31,252


NOTE 5 — FAIR VALUE MEASUREMENT

The Fair Value Measurements and Disclosures Topic of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) defines fair value, establishes a framework for measuring fair value under U.S. GAAP and enhances disclosures about fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The ASC describes a fair value hierarchy based on the following three levels of inputs that may be used to measure fair value, of which the first two are considered observable and the last unobservable:
 
Level 1 –
Quoted prices in active markets for identical assets or liabilities.
 
Level 2 –
Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
 
Level 3 –
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company determines the fair value of its investment portfolio assets by obtaining non-binding market prices from its third-party portfolio managers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. There were no transfers between Level 1, Level 2, or Level 3 measurements for the three month period ended September 30, 2016.


8

The following table represents the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2016 and December 31, 2015 (in thousands):
 
Fair Value Measurements as of September 30, 2016 Using
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Money Market funds
$
701

 
$
—

 
$
—

 
$
701

Government sponsored debt securities
—

 
—

 
—

 
—

Non-government sponsored debt securities
—

 
—

 
—

 
—


 
Fair Value Measurements as of December 31, 2015 Using
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Money Market funds
$
144

 
$
—

 
$
—

 
$
144

Government sponsored debt securities
—

 
11,988

 
—

 
$
11,988

Non-government sponsored debt securities
—

 
7,459

 
—

 
$
7,459


NOTE 6 — GOODWILL AND OTHER INTANGIBLE ASSETS

On June 30, 2016, the Company completed the Acquisition. As a result of the Acquisition, the Company recorded approximately $34.3 million of goodwill and $41.7 million of other identifiable intangible assets. The goodwill is derived from expected synergies from combining operations of the Company and Nanosphere. The purchase price allocation is preliminary as the Company’s determination of the fair values of the assets acquired and liabilities assumed is still in process.

Goodwill is reviewed for impairment at least annually at the beginning of the fourth quarter, or more frequently if impairment indicators arise. The Company's goodwill is not expected to be deductible for tax purposes.

The changes in the carrying amount of the Company’s goodwill during the period are as follows (in thousands):
 
September 30, 2016
 
December 31, 2015
Balance at beginning of year
$
49,619

 
$
49,619

Acquisition of Nanosphere
34,279

 
—

Balance at end of period
$
83,898

 
$
49,619



9

The Company’s intangible assets are reflected in the table below (in thousands, except weighted average lives):
 
Finite-lived
 
Indefinite-lived
 
 
 
Technology, trade secrets and know-how
 
Customer lists and contracts
 
Other identifiable intangible assets
 
IP R&D
 
Total
2015
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2014
$
29,704

 
$
7,958

 
$
1,890

 
$
40,100

 
$
79,652

Completion of IP R&D project
40,100

 
—

 
—

 
(40,100
)
 
—

Removal of fully amortized assets
(702
)
 
(161
)
 
(238
)
 
—

 
(1,101
)
Balance as of December 31, 2015
69,102

 
7,797

 
1,652

 
—

 
78,551

Less: accumulated amortization:
 

 
 

 
 

 
 

 
 

Accumulated amortization balance as of December 31, 2014
(19,325
)
 
(3,085
)
 
(860
)
 
—

 
(23,270
)
Amortization expense
(3,023
)
 
(743
)
 
(134
)
 
—

 
(3,900
)
Removal of fully amortized assets
702

 
161

 
238

 
—

 
1,101

Accumulated amortization balance as of December 31, 2015
(21,646
)
 
(3,667
)
 
(756
)
 
—

 
(26,069
)
Net balance as of December 31, 2015
$
47,456

 
$
4,130

 
$
896

 
$
—

 
$
52,482

Weighted average life (in years)
10

 
11

 
11

 
 

 
 

 
 
 
 
 
 
 
 
 
 
2016
 

 
 

 
 

 
 

 
 

Balance as of December 31, 2015
$
69,102

 
$
7,797

 
$
1,652

 
$
—

 
$
78,551

Additions due to acquisition of Nanosphere
12,282

 
12,409

 
4,012

 
12,982

 
41,685

Balance as of September 30, 2016
81,384

 
20,206

 
5,664

 
12,982

 
120,236

Less: accumulated amortization:
 

 
 

 
 

 
 

 
 

Accumulated amortization balance as of December 31, 2015
(21,646
)
 
(3,667
)
 
(756
)
 
—

 
(26,069
)
Amortization expense
(4,683
)
 
(902
)
 
(212
)
 
—

 
(5,797
)
Accumulated amortization balance as of September 30, 2016
(26,329
)
 
(4,569
)
 
(968
)
 
—

 
(31,866
)
Net balance as of September 30, 2016
$
55,055

 
$
15,637

 
$
4,696

 
$
12,982

 
$
88,370

Weighted average life (in years)
10

 
10

 
10

 
 

 
 


The estimated aggregate amortization expense for the next five fiscal years and thereafter is as follows (in thousands):
2016 (three months)
$
2,482

2017
8,979

2018
8,789

2019
8,789

2020
8,789

Thereafter
37,560

 
$
75,388

IPR&D
12,982

 
$
88,370




10

NOTE 7 — OTHER COMPREHENSIVE INCOME (LOSS)

Other comprehensive income (loss) represents a measure of all changes in equity that result from recognized transactions and other economic events other than those resulting from investments by and distributions to shareholders. Other comprehensive income (loss) for the Company includes foreign currency translation adjustments and net unrealized holding gains and losses on available-for-sale investments.

The following table presents the changes in each component of accumulated other comprehensive income (loss), net of tax (in thousands):
 
Foreign Currency Items
 
Available-for-Sale Investments
 
Accumulated Other Comprehensive Income (Loss) Items
Balance as of December 31, 2015
$
(1,258
)
 
$
(38
)
 
$
(1,296
)
Other comprehensive income before reclassifications
292

 
38

 
330

Net current-period other comprehensive income
292

 
38

 
330

Balance as of September 30, 2016
$
(966
)
 
$
—

 
$
(966
)

The following table presents the tax (expense) benefit allocated to each component of other comprehensive income (loss) (in thousands):
 
Three Months Ended September 30, 2016
 
Nine Months Ended September 30, 2016
 
Before Tax
 
Tax Benefit
 
Net of Tax
 
Before Tax
 
Tax Benefit
 
Net of Tax
Foreign currency translation adjustments
$
113

 
$
—

 
$
113

 
$
292

 
$
—

 
$
292

Unrealized gains on available-for-sale investments
—

 
—

 
—

 
44

 
(6
)
 
38

Other comprehensive income (loss)
$
113

 
$
—

 
$
113

 
$
336

 
$
(6
)
 
$
330



11

NOTE 8 — EARNINGS PER SHARE

A reconciliation of the denominators used in computing per share net income, or EPS, is as follows (in thousands, except per share amounts):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Numerator:
 
 
 
 
 
 
 
Net income
$
2,751

 
$
6,402

 
$
17,174

 
$
16,484

Denominator:
 

 
 

 
 

 
 

Denominator for basic net income per share - weighted average common stock outstanding
42,683

 
42,152

 
42,522

 
42,041

Effect of dilutive securities: stock options and awards
453

 
404

 
407

 
313

Denominator for diluted net income per share - weighted average shares outstanding - diluted
43,136

 
42,556

 
42,929

 
42,354

Basic net income per share
$
0.06

 
$
0.15

 
$
0.40

 
$
0.39

Diluted net income per share
$
0.06

 
$
0.15

 
$
0.40

 
$
0.39

 

Basic net income per share is computed by dividing the net income for the period by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed by dividing the net income for the period by the weighted average number of common and common equivalent shares outstanding during the period. Stock options to acquire approximately zero and 0.6 million shares for the three months ended September 30, 2016 and 2015, and zero and 0.6 million shares for the nine months ended September 30, 2016 and 2015, respectively, were excluded from the computations of diluted EPS because the effect of including those stock options would have been anti-dilutive.


NOTE 9 — STOCK-BASED COMPENSATION

The Company’s stock option activity for the nine months ended September 30, 2016 was as follows:
Stock Options (shares in thousands)
Shares
 
Weighted Average Exercise Price
Outstanding as of December 31, 2015
1,692

 
$
17.47

Granted
886

 
19.21

Exercised
(143
)
 
17.51

Cancelled or expired
(92
)
 
18.58

Outstanding as of September 30, 2016
2,343

 
$
18.08

 
The Company had $11.7 million of total unrecognized compensation costs related to stock options as of September 30, 2016, which costs are expected to be recognized over a weighted average period of 2.86 years years.


12

The Company’s restricted share activity for the nine months ended September 30, 2016 was as follows:
Restricted Stock Awards (shares in thousands)
Shares
 
Weighted Average Grant Price
Non-vested as of December 31, 2015
836

 
$
18.66

Granted
300

 
19.74

Vested
(205
)
 
19.59

Cancelled or expired
(53
)
 
18.36

Non-vested as of September 30, 2016
878

 
$
18.83

 
 
 
 
Restricted Stock Units (in thousands)
Shares
 
 

Non-vested as of December 31, 2015
501

 
 

Granted
99

 
 

Vested
(83
)
 
 

Cancelled or expired
(46
)
 
 

Non-vested as of September 30, 2016
471

 
 

 
As of September 30, 2016, there was $15.0 million and $3.3 million of total unrecognized compensation costs related to Restricted Stock Awards (RSAs) and Restricted Stock Units (RSUs), respectively. This cost is expected to be recognized over a weighted average period of 2.36 years years for the RSAs and 1.95 years years for the RSUs. The Company issues a small number of cash settled RSUs pursuant to the Company's equity incentive plan in certain foreign countries. These grants do not result in the issuance of common stock and are considered immaterial by the Company.

The following are the stock-based compensation costs recognized in the Company’s condensed consolidated statements of comprehensive income (in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Cost of revenue
$
334

 
$
238

 
$
903

 
$
742

Research and development
754

 
725

 
1,896

 
1,705

Selling, general and administrative
2,438

 
2,136

 
5,382

 
5,321

Stock-based compensation costs reflected in net income
$
3,526

 
$
3,099

 
$
8,181

 
$
7,768


NOTE 10 — ACCRUED LIABILITIES

Accrued liabilities consisted of the following (in thousands):
 
September 30, 2016
 
December 31, 2015
Compensation and employee benefits
$
11,515

 
$
10,946

Income and other taxes
734

 
1,261

Warranty costs
667

 
553

Other
3,199

 
2,392

 
$
16,115

 
$
15,152


Sales of certain of the Company's systems are subject to a warranty. System warranties typically extend for a period of 12 months from the date of installation not to exceed 24 months from the date of shipment. The Company estimates the amount of warranty claims on sold products that may be incurred based on current and historical data. The actual warranty expense could differ from the estimates made by the Company based on product performance. Warranty expenses are evaluated and adjusted periodically.


13

The following table summarizes the changes in the warranty accrual (in thousands):
Accrued warranty costs as of December 31, 2015
$
553

Warranty adjustments/settlements
(582
)
Accrual for warranty costs
696

Accrued warranty costs as of September 30, 2016
$
667


NOTE 11 — INCOME TAXES
 
At the end of each interim reporting period, an estimate is made of the effective tax rate expected to be applicable for the full year. The estimated full year’s effective tax rate is used to determine the income tax rate for each applicable interim reporting period. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period of the enactment date. The effective tax rate for the nine months ended September 30, 2016 was 21.70%, including amounts recorded for discrete events. This differs from the statutory rate of 35% primarily because of the worldwide mix of consolidated earnings and losses before taxes and an assessment regarding the realizability of the Company’s deferred tax assets. The Company’s tax expense reflects the full federal, various state, and foreign blended statutory rates. The Company is utilizing its net operating losses and tax credits in the U.S., Canada and the Netherlands and currently expects a full year effective tax rate of less than 30%. Therefore, cash taxes to be paid are expected to continue to be less than 15% of book tax expense.
 
The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, Australia, Canada, China, Hong Kong, Japan, the Netherlands, and various states. Due to net operating losses, the U.S., Canadian and Australian tax returns dating back to 2011 can still be reviewed by the taxing authorities. No material changes to this liability are expected within the next 12 months. For the nine months ended September 30, 2016, there were no material changes to the total amount of unrecognized tax benefits. The Company recognizes interest and penalties related to uncertain tax positions in the provision for income taxes.

NOTE 12 - COMMITMENTS AND CONTINGENCIES

On August 30, 2012, Abbott Laboratories, Inc. (Abbott) was named as a defendant in a complaint filed by ENZO Life Sciences, Inc. (ENZO) in U.S. District Court in Delaware for alleged infringement of U.S. Patent 7,064,197 as a result of Abbott's distribution of Luminex's xTAG Respiratory Viral Panel.  Luminex and Abbott entered into an agreement requiring Luminex to defend and indemnify Abbott for any alleged patent infringement resulting from its distribution of Luminex's xTAG Respiratory Viral Panel. The complaint sought unspecified monetary damages and injunctive relief.  Abbott filed an answer to the complaint on October 15, 2012.  On November 30, 2012, Luminex intervened in the lawsuit. On January 2, 2013, ENZO filed additional claims against Luminex, alleging infringement of U.S. Patent 7,064,197 resulting from Luminex's sale of its xTAG, FlexScript LDA, SelecTAG, and xMAP Salmonella Serotyping Assay products and alleging infringement of U.S. Patent 8,097,405 resulting from Luminex's sale of MultiCode® products. Luminex filed an answer to ENZO's additional claims on January 28, 2013.  On October 2, 2013, ENZO filed additional claims against Luminex, alleging infringement of U.S. Patent 6,992,180 resulting from Luminex’s sale of MultiCode® products. Luminex filed an answer to ENZO’s additional claims on October 21, 2013.

Effective July 2, 2015, Luminex agreed to pay ENZO $7.1 million to settle the litigation. This settlement resulted in the entry of orders dismissing (i) with prejudice all claims, counterclaims and causes of action asserted by ENZO against Luminex, (ii) without prejudice all claims, counterclaims and causes of action asserted by Luminex against ENZO, (iii) with prejudice all claims, counterclaims and causes of action solely under U.S. Patent 7,064,197 asserted in the litigation by ENZO against Abbott and (iv) without prejudice all claims, counterclaims and causes of action relating solely to U.S. Patent 7,064,197 asserted by Abbott against ENZO; and resulted in the grant to the Company and its affiliates of a fully paid, non-exclusive, worldwide license under the patents asserted in the complaint. In addition, the Company and ENZO released each other from certain claims related to the above-referenced patents, including the claims and counterclaims asserted in the complaint. ENZO further released Abbott from certain claims, including those asserted in the complaint, related solely to U.S. Patent 7,064,197. The settlement was entered into solely by way of compromise and does not constitute an admission or concession by Luminex of any liability or wrongdoing.

14


Because Luminex (i) never paid any royalties to ENZO in the past, (ii) will not be required to pay any future or ongoing royalties to ENZO as a result of the settlement, (iii) has never recorded any revenue or expense related to ENZO in operating revenue or in operating expenses in the past, outside of legal fees, and (iv) believes that it does not infringe on any valid and enforceable claim with respect to the asserted patents, Luminex determined that this settlement of litigation expense was outside of operations. Luminex accordingly recorded the settlement as a separate, non-operating line item in the second quarter of 2015. Luminex made the $7.1 million payment to ENZO in July 2015.

When and if it appears probable in management's judgment, and based upon consultation with outside counsel, that we will incur monetary damages or other costs in connection with any claims or proceedings, and such costs can be reasonably estimated, we record the estimated liability in the financial statements.  If only a range of estimated losses can be estimated, we record an amount within the range that, in management's judgment, reflects the most likely outcome; if none of the estimates within that range is a better estimate than any other amount, we record the liability at the low end of the range of estimates. Any such accrual would be charged to expense in the appropriate period.   We disclose significant contingencies when the loss is not probable and/or the amount of the loss is not estimable, when we believe there is at least a reasonable possibility that a loss has been incurred.  We recognize costs associated with legal proceedings in the period in which the services were provided.

NOTE 13 — RECENT ACCOUNTING PRONOUNCEMENTS

Recently adopted accounting guidance

In March 2016, the FASB issued guidance that simplifies some provisions in stock compensation accounting related to accounting for a stock payment’s tax consequences. The guidance also amends how excess tax benefits and a company's payments to cover the tax bills for the shares’ recipients should be classified. The amendments allow companies to estimate the number of stock awards they expect to vest, and the amendments also revise the withholding requirements for classifying stock awards as equity. This guidance is effective for annual periods beginning after December 15, 2016. Early adoption is permitted.

This new standard requires that an entity recognize excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement when the awards vest or are settled. Under the previous standard, excess tax benefits and tax deficiencies were recognized in additional paid-in capital. Cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows. In addition, related cash payments made on an employee's behalf for shares withheld are presented as a financing activity on the statement of cash flows.

The Company early adopted this standard in the quarter ended June 30, 2016. The adoption of this standard resulted in the recognition of $6.9 million of previously unrecognized excess tax benefits in deferred income taxes, net and an increase to retained earnings on our Consolidated Balance Sheet and the recognition of $211,000 of income tax expense in our income tax provision for the nine months ended September 30, 2016. We have elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost to be recognized in each period.

In September 2015, the FASB issued additional guidance on business combinations. This guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period with a corresponding adjustment to goodwill in the reporting period in which the adjustment amounts are determined. The effect on earnings from changes in depreciation, amortization or other income effects, if any, as a result of the change to the provisional amounts will be recorded in the same period's financial statements, calculated as if the accounting had been completed at the acquisition date. The Company adopted this standard during the quarter ended June 30, 2016, and its adoption did not have any impact on its consolidated financial statements.

Recent accounting guidance not yet adopted

In August 2016, the FASB issued specific guidance on eight cash flow classification issues that are not currently addressed by current U.S. GAAP and thereby reduce the current diversity in practice.  This guidance is effective for annual periods beginning after December 15, 2017. Early adoption is permitted. The Company does not anticipate that this guidance will have a material impact on its consolidated financial statements.

15


In February 2016, the FASB issued guidance requiring lessees to recognize a right-of-use asset and a lease liability on the balance sheet for all leases with the exception of short-term leases. The effective date of the new guidance is for the Company's first quarter of fiscal 2019 and early adoption is permitted. The new standard must be adopted using a modified retrospective transition and requires application of the new guidance at the beginning of the earliest comparative period presented. The Company is currently evaluating the impact of the adoption of this requirement on its consolidated financial statements, but does not anticipate that adoption of this guidance will have a material impact on its consolidated financial statements except for the addition of the right-of-use asset and a lease liability to the balance sheet.

In January 2016, the FASB issued guidance that changes how entities measure equity investments that do not result in consolidation and are not accounted for under the equity method. Entities will be required to measure these investments at fair value at the end of each reporting period and recognize changes in fair value in net income. This guidance also changes certain disclosure requirements and other aspects of current U.S. GAAP. This guidance is effective for annual periods beginning after December 15, 2017. Early adoption is permitted. The Company does not anticipate that adoption of this guidance will have a material impact on its consolidated financial statements as the only potential impact would be related to the Company's one cost-method investment discussed in Note 3 - Investments.

In July 2015, the FASB issued guidance regarding the measurement of inventory. The new guidance requires inventory to be measured at the lower of cost and net realizable value, which is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. This new guidance is effective for the Company's first quarter of fiscal 2018 and early adoption is permitted. The guidance must be applied prospectively. The Company is currently evaluating the impact of the adoption of this requirement on its consolidated financial statements, but does not anticipate that adoption of this guidance will have a material impact on its consolidated financial statements.

In May 2014, the FASB issued a new standard on revenue recognition which outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the revenue model is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In doing so, companies will need to use their judgment and make estimates more extensively than under current U.S. GAAP. These judgments may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The standard is designed to create greater comparability for financial statement users across industries and jurisdictions and also requires enhanced disclosures. On July 9, 2015, the FASB voted in favor of delaying the effective date of the new standard by one year, with early adoption permitted as of the original effective date. The guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements.

16


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following information should be read in conjunction with the condensed consolidated financial statements and the accompanying notes included in Part I, Item 1 of this Report, and the “Risk Factors” included in Part I, Item 1A of the 2015 10-K.

SAFE HARBOR CAUTIONARY STATEMENT

This quarterly report on Form 10-Q contains statements that are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide our current expectations of forecasts of future events. All statements other than statements of current or historical fact contained in this quarterly report, including statements regarding our future financial position, business strategy, impact of the reimbursement landscape, the acquisition impact and integration of Nanosphere, new products including ARIES® and NxTAG®, assay sales, consumables sales patterns and bulk purchases, budgets, system sales, anticipated gross margins, liquidity, cash flows, projected costs and expenses, taxes, deferred tax assets, litigation costs, including the costs or impact of any litigation settlements or orders, regulatory approvals or the impact of any laws or regulations applicable to us, plans and objectives of management for future operations, and acquisition impact and integration and the expected benefit of our future acquisitions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “should,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “will” and similar expressions as they relate to us, are intended to identify forward-looking statements. These statements are based on our current plans and actual future activities, and our financial condition and results of operations may be materially different from those set forth in the forward-looking statements as a result of known or unknown risks and uncertainties, including, among other things:
 
•
risks and uncertainties associated with the integration of Nanosphere and implementing our acquisition strategy, our ability to identify suitable acquisition targets including our ability to obtain financing on acceptable terms, our ability to integrate acquired companies, or selected assets into our consolidated business operations, and the ability to fully realize the benefits of our acquisitions;

•
concentration of our revenue in a limited number of direct customers and strategic partners, some of which may experience decreased demand for their products utilizing or incorporating our technology, budget or finance constraints in the current economic environment, or periodic variability in their purchasing patterns or practices as a result of material resource planning challenges;

•
risks and uncertainties relating to market demand and acceptance of our products and technology, including ARIES®, MultiCode®, NxTAG®, xMAP® and Verigene®;

•
our ability to successfully launch new products in a timely manner;

•
the uncertainty relating to increased focus on direct sales to the end user;

•
dependence on strategic partners for development, commercialization and distribution of products;

•
the timing of and process for regulatory approvals;

•
competition and competitive technologies utilized by our competitors;

•
fluctuations in quarterly results due to a lengthy and unpredictable sales cycle, fluctuations in bulk purchases of consumables, fluctuations in product mix, and the seasonal nature of some of our assay products;

•
our ability to obtain and enforce intellectual property protections on our products and technologies;

•
our ability to scale manufacturing operations and manage operating expenses, gross margins and inventory levels;

•
the impact of the ongoing uncertainty in global finance markets and changes in government and government agency funding, including its effects on the capital spending policies of our partners and end users and their ability to finance purchases of our products;

•
changes in principal members of our management staff;

17


•
potential shortages, or increases in costs, of components or other disruptions to our manufacturing operations;

•
our increasing dependency on information technology to enable us to improve the effectiveness of our operations and to monitor financial accuracy and efficiency;

•
the implementation, including any modification, of our strategic operating plans;

•
the uncertainty regarding the outcome or expense of any litigation brought against or initiated by us; and

•
risks relating to our foreign operations, including fluctuations in exchange rates, tariffs, customs and other barriers to importing/exporting materials and products in a cost effective and timely manner; difficulties in accounts receivable collections; the burden of monitoring and complying with foreign and international laws and treaties; and the burden of complying with and change in international taxation policies.

Many of these risks, uncertainties and other factors are beyond our control and are difficult to predict. Any or all of our forward-looking statements in this quarterly report may turn out to be inaccurate. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. New factors could also emerge from time to time that could adversely affect our business. The forward-looking statements herein can be affected by inaccurate assumptions we might make or by known or unknown risks, uncertainties and assumptions, including the risks, uncertainties and assumptions outlined above and described in the 2015 10-K. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this quarterly report may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. When you consider these forward-looking statements, you should keep in mind these risk factors and other cautionary statements in this quarterly report, including in this "Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in our other annual and periodic reports.
 
Our forward-looking statements speak only as of the date made. We undertake no obligation to publicly update or revise forward-looking statements whether as a result of new information, future events or otherwise. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in this quarterly report.

Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q to “Luminex,” the “Company,” “we,” “us” and “our” refer to Luminex Corporation and its subsidiaries.

OVERVIEW

We develop, manufacture and sell proprietary biological testing technologies and products with applications throughout the diagnostics, pharmaceutical and life sciences industries. These industries depend on a broad range of tests, called assays, to perform diagnostic testing and conduct life science research.

We have established a position in several segments of the life sciences industry by developing and delivering products that meet a variety of customer needs in specific market segments, including multiplexing, accuracy, precision, sensitivity, specificity, reduction of labor and ability to test for proteins and nucleic acids. These needs are addressed by our proprietary technology, which allows the end user in a laboratory to perform biological testing in a multiplexed format. Multiplexing allows for many different laboratory results to be generated from one sample with a single assay. This is important because our end user customers, which include laboratory professionals performing research and clinical laboratories performing tests on patients as ordered by physicians and other laboratories, have a fundamental need to perform high quality testing as efficiently as possible. Until the availability of multiplexing technology such as our xMAP® (Multi-Analyte-Profiling) technology, the laboratory professional had to perform one assay at a time in a sequential manner, and if additional testing was required on a sample, a second assay would be performed to generate the second result, and so on until all the necessary tests were performed.

We have a full range of instruments using our xMAP technology: our LUMINEX 100/200™ systems offer 100-plex testing; our FLEXMAP 3D® system is our high-throughput, 500-plex testing system; and our MAGPIX® system provides 50-plex testing at a lower cost using imaging rather than flow cytometry. By using our xMAP technology, the end users are able to be more efficient by generating multiple simultaneous results per sample. We believe that this technology may also offer advantages in other industries, such as in food safety/animal health and bio-defense/bio-threat markets. Using the products Luminex has available today, up to 500 simultaneous analyte results can be determined from a single sample.


18

We primarily serve the diagnostics, pharmaceutical and life sciences industries by marketing products, including our testing equipment and assays, to various types of testing laboratories. We have a large installed base of systems that has grown primarily from the following:
•
placements made by partners who either:
•
license our xMAP technology and develop products that incorporate our xMAP technology into products that they then sell to end users, or
•
purchase our proprietary xMAP laboratory instrumentation and our proprietary xMAP microspheres and sell xMAP-based assay products and/or xMAP-based testing services, which run on the xMAP instrumentation, and pay a royalty to us; and
•
our direct sales force that focuses on the sale of molecular diagnostic assays that run on our systems.

As of September 30, 2016, Luminex had 73 strategic partners, of which 52 have released commercialized reagent-based products utilizing our technology. Our remaining partners are in various stages of development and commercialization of products that incorporate our technology.

Our acquisition of Nanosphere on June 30, 2016 expands our offering in the molecular diagnostic market segment with Nanosphere's proprietary diagnostic tools that enable rapid and accurate detection of respiratory, gastrointestinal and bloodstream infections. Nanosphere is a leader in the high-growth bloodstream infection testing segment with its U.S. Food and Drug Administration (FDA) cleared Verigene Gram-Positive and Gram-Negative Blood Culture test panels, for the early detection of pathogens associated with bloodstream infections. In addition to detecting bacteria, these panels also detect yeast and identify antibiotic resistance markers. In contrast to traditional methodologies, which can take several days, these assays enable physicians to identify the pathogen, including associated resistance markers, and thus prescribe the most appropriate antibiotic regimen within 2.5 hours after positive blood culture. The ability for clinicians to make earlier, better informed therapeutic decisions results in improved patient outcomes and lower healthcare costs. In addition, Nanosphere has FDA-cleared products for the detection of gastrointestinal and respiratory infections. These include a targeted product for the detection of  C. difficile, as well as highly multiplexed molecular enteric and respiratory pathogen panels which tests for a wide spectrum of microorganisms often associated with these types of infections. With the addition of the Verigene platform, Luminex offers customers automated molecular platforms for both syndromic and targeted molecular diagnostic testing.

In addition to our menu of infectious disease tests, we are currently developing a next generation Verigene system that will deliver improved user experience. This system is designed to provide reduced time to result, improved user interface, including a room temperature cartridge all in a fully automated sample to result system with an optimized footprint.

A primary focus for our growth is the development and sale of molecular diagnostic assays utilizing our proprietary MultiCode® and Verigene technologies for use on our installed base of systems. We utilize a direct sales model for sales of these products, which is intended to take advantage of our increasing installed base of instruments. Our assays are primarily focused on multiplexed applications for the human molecular clinical diagnostics market. Our assay products are currently focused on three segments of the molecular diagnostic testing market: human genetics, personalized medicine and infectious disease.

In addition to the sales to this installed base, in the fourth quarter of 2015 we received FDA clearance for our ARIES® system. The ARIES® system is a sample to answer clinical test system that automates and integrates extraction of nucleic acid from a clinical sample, performs real-time polymerase chain reaction, and detects multiple signals generated by target specific probes. The ARIES® system is used with specific assays to measure multiple analytes indicative of infectious disease. The ARIES® system uses internal barcode scanning and other advanced features to minimize operator errors. Two independent modules each support from one to six cassettes, allowing both STAT and Batch testing. The ARIES® system can run both In Vitro Diagnostics (IVD) and MultiCode® Analyte Specific Reagents simultaneously with a common Universal Assay Protocol. The ARIES® system was commercially launched in the fourth quarter of 2015. We also received FDA clearance for the ARIES® HSV (herpes simplex virus) 1&2 Assay in the fourth quarter of 2015; CE-IVD Mark in Europe for the ARIES® System and ARIES® HSV 1&2 Assay in the first quarter of 2016; CE-IVD Mark in Europe for the ARIES® Flu A/B & RSV Assay in the second quarter of 2016; and FDA Clearance and CE-IVD Mark for the ARIES® M1 System and FDA clearance for the ARIES® Flu A/B & RSV Assay in the third quarter of 2016.

19


Third Quarter 2016 Highlights

•
Consolidated revenue was $71.2 million for the quarter ended September 30, 2016, representing an 18% increase over revenue for the third quarter of 2015.

•
System revenue was $10.5 million for the quarter ended September 30, 2016, representing a 9% increase over system revenue for the third quarter of 2015.

•
Consumable revenue was $12.3 million for the quarter ended September 30, 2016, representing a 12% increase over consumable revenue for the third quarter of 2015.

•
Assay revenue was $32.4 million for the quarter ended September 30, 2016, representing a 32% increase over assay revenue for the third quarter of 2015.

•
Royalty revenue was $11.1 million for the quarter ended September 30, 2016, representing an 8% increase over royalty revenue for the third quarter of 2015.

•
Received U.S. FDA clearance for the ARIES® Flu A/B & RSV Assay.

•
Received U.S. FDA clearance and CE-IVD Mark for the Company's ARIES M1 System.

•
Received FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay.

•
Shipments of 294 multiplexing analyzers, which include Luminex® 100/200TM systems, MAGPIX® systems and FLEXMAP 3D® systems.

Recent Acquisition of Nanosphere

As previously discussed in Note 2 - Business Combinations, on June 30, 2016, we completed our acquisition of Nanosphere, Inc. (Nanosphere), a publicly-held molecular diagnostic company based in Northbrook, Illinois. The Acquisition was an all cash transaction that was undertaken to expand the Company's access to the high-growth molecular microbiology market and to Nanosphere's portfolio of molecular testing solutions. In connection with closing the Acquisition, we retired Nanosphere's $25.4 million of debt and paid transaction and debt prepayment expenses of approximately $4.0 million. As a result of the Acquisition and the debt payoff, our cash, cash equivalents and investments were reduced by approximately $93.1 million during the nine months ended September 30, 2016, partially offset by operating cash flows of $35.8 million. The results of operations for Nanosphere are included in the Company’s consolidated financial statements beginning July 1, 2016.  

As a result of the dilutive nature of the Acquisition, we believe both profitability and operating cash flows over the next eighteen months, approximately, will be lower than our recent historical results; however, we expect to maintain profitability and positive operating cash flows. We currently anticipate that the Acquisition and its related integration will be accretive to the Company's consolidated revenue, profitability, and cash flow by the end of 2017.

Growth in Inventory

Our inventory has increased from $31.3 million as of December 31, 2015 to $41.5 million as of September 30, 2016 primarily due to increases in systems inventory and the inclusion of the acquired Nanosphere inventory. Based upon the increased demand for our systems that we have experienced over the past twelve months, we are building both our finished good system inventory and parts and supplies inventory related to our systems to be able to meet both expected and unanticipated demand.

20


Material Partner Activity

As previously disclosed, the cystic fibrosis (CF) assay revenue from the Company's largest customer, LabCorp, will wind down in 2017 while LabCorp transfers its CF business to an alternative technology. Also, LabCorp recently informed us following a request for proposal process that they have elected to develop the next iteration of one of their women's health products with another party. The transition time is significant and, as a result, the parties have negotiated significant minimum women's health purchases for 2017 and the first half of 2018, pursuant to an amendment to the Party’s existing supply agreement. LabCorp historically had the right to terminate the supply agreement with Luminex on 90 days’ notice. Going forward, through June 30, 2018, LabCorp will acquire no less than $63.1 million in additional women's health products during 2017 and the first six months of 2018. This is in comparison to anticipated 2016 purchases of approximately $36.0 million.

Consumables Sales and Royalty Revenue Trends

We have experienced significant fluctuations in consumable revenue over the past three years. Overall, the fluctuations manifested themselves through periodic changes in volume from our largest purchasing customers. On a quarterly basis, our largest customers account for approximately 70% of our total consumable sales volume. We expect these fluctuations to continue as the ordering patterns and inventory levels of our largest bulk purchasing partners remain variable. Additionally, even though we experience variability in consumable revenue, the key indicator of the success of our partners’ commercialization efforts is the rising level of royalties and reported royalty bearing sales.

Future Operations

We expect our areas of focus over the next twelve months to be:

•
accelerating development and commercialization of the assays on our automated diagnostics systems;

•
increasing the growth of our partner business through enrichment of our existing partner relationships and the addition of new partners;

•
developing and commercializing the next generation system for Verigene;

•
placement of our ARIES® system, our sample to answer platform for our MultiCode®-RTx technology, including IVD assays;

•
realizing the anticipated synergies of the Nanosphere acquisition and associated integration, including the effective incorporation of our combined salesforce in the marketplace;

•
development and commercialization of a pipeline of assays for the ARIES® system;

•
market acceptance of our recently launched Respiratory Viral Panel line of IVD assays;

•
continued execution of our direct sales strategy, including developing the infrastructure necessary to support our sales force and decreasing reliance on our distributors;

•
commercialization, regulatory clearance and market adoption of products, including commercialization of MultiCode® assays outside of the United States;

•
maintenance and improvement of our existing products and the timely development, completion and successful commercial launch of our pipeline products;

•
adoption and use of our platforms and consumables by our customers for their testing services;

•
expansion and enhancement of our installed base of systems and our market position within our identified target market segments;

•
monitoring and mitigating the effect of the ongoing uncertainty in global finance markets and changes in government funding on planned purchases by end users; and


21

•
continued adoption and development of partner products incorporating Luminex technology through effective partner management.

We anticipate continued revenue concentration in our higher margin items (assays, consumables and royalties) contributing to favorable, but variable, gross margin percentages. Additionally, we believe that a sustained investment in research and development is necessary in order to meet the needs of our marketplace and provide a sustainable new product pipeline. We may experience volatility in research and development expenses as a percentage of revenue on a quarterly basis as a result of the timing of development expenses, clinical validation and clinical trials in advance of the commercial launch of our new products.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP for interim financial statements. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates and assumptions are reviewed periodically. Actual results may differ from these estimates under different assumptions or conditions.

Management believes there have been no significant changes during the quarter ended September 30, 2016 to the items that we disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the 2015 10-K.

RESULTS OF OPERATIONS

THREE MONTHS ENDED SEPTEMBER 30, 2016 COMPARED TO THREE MONTHS ENDED SEPTEMBER 30, 2015

Selected consolidated financial data for the three months ended September 30, 2016 and 2015 is as follows (dollars in thousands):
 
Three Months Ended September 30,
 
 
 
 
 
2016
 
2015
 
Variance
 
Variance (%)
Revenue
$
71,221

 
$
60,601

 
$
10,620

 
18
 %
Gross profit
$
45,665

 
$
41,812

 
3,853

 
9
 %
Gross margin percentage
64
%
 
69
%
 
(5
)%
 
N/A

Operating expenses
$
41,637

 
$
32,106

 
9,531

 
30
 %
Income from operations
$
4,028

 
$
9,706

 
(5,678
)
 
(58
)%
 
Total revenue increased by 18% to $71.2 million for the three months ended September 30, 2016 from $60.6 million for the comparable period in 2015, driven primarily by the Acquisition on June 30, 2016, which contributed approximately 13% of the 18% increase. Nanosphere's most notable impact is expected to be in the assay revenue component of our business.

A breakdown of revenue for the three months ended September 30, 2016 and 2015 is as follows (dollars in thousands):
 
Three Months Ended September 30,
 
 
 
 
 
2016
 
2015
 
Variance
 
Variance (%)
System sales
$
10,494

 
$
9,622

 
$
872

 
9
 %
Consumable sales
12,305

 
10,940

 
1,365

 
12
 %
Royalty revenue
11,068

 
10,249

 
819

 
8
 %
Assay revenue
32,443

 
24,639

 
7,804

 
32
 %
Service revenue
2,934

 
2,386

 
548

 
23
 %
Other revenue
1,977

 
2,765

 
(788
)
 
(28
)%
 
$
71,221

 
$
60,601

 
$
10,620

 
18
 %


22

We continue to experience revenue concentration in a limited number of customers. Five customers accounted for 47% (20%, 11%, 7%, 5% and 4%, respectively) of consolidated total revenue in the third quarter of 2016. For comparative purposes, these top five customers accounted for 52% (23%, 13%, 9%, 5% and 2%, respectively) of total revenue in the third quarter of 2015. No other customer accounted for more than 10% of consolidated total revenue during those periods.

Revenue from the sale of systems and peripheral components increased 9% to $10.5 million for the three months ended September 30, 2016 from $9.6 million for the three months ended September 30, 2015, resulting in part to the Acquisition, placement of additional ARIES® systems, as well as favorable mix in sales of multiplexing analyzers with lower sales of MAGPIX systems, partially offset by more sales of LX and FLEXMAP 3D systems. We sold 294 multiplexing analyzers in the third quarter of 2016, as compared to 307 multiplexing analyzers sold for the corresponding prior year period. For the three months ended September 30, 2016, five of our partners accounted for 211 multiplexing analyzers, or 72%, of total multiplexing analyzers sold, as compared to five of our partners accounting for 229 multiplexing analyzers, or 75%, of total multiplexing analyzers sold for the three months ended September 30, 2015.

Consumable sales, comprised of microspheres and sheath fluid, increased 12% to $12.3 million for the three months ended September 30, 2016 from $10.9 million for the three months ended September 30, 2015. During the three months ended September 30, 2016, we had 22 bulk purchases of consumables totaling approximately $9.6 million (78% of total consumable revenue), ranging from $0.1 million to $1.8 million, as compared with 21 bulk purchases totaling approximately $8.3 million (75% of total consumable revenue), ranging from $0.1 million to $1.8 million, for the three months ended September 30, 2015. The increase in revenue from bulk purchases in the third quarter of 2016 is the primary driver to the increase in consumable revenue from the prior year quarter. We expect fluctuations in consumable sales on an ongoing basis. Partners who reported royalty bearing sales accounted for $9.0 million, or 73%, of consumable sales for the three months ended September 30, 2016 compared to $7.7 million, or 70%, of the total consumable sales for the three months ended September 30, 2015.

Royalty revenue, which results when our partners sell products or testing services incorporating our technology, increased by 8% to $11.1 million for the three months ended September 30, 2016 from $10.2 million for the three months ended September 30, 2015. This increase is the result of an increase in base royalties of $0.5 million and an increase in minimum royalty payments and royalty audit findings and other adjustments of approximately $0.3 million. We expect modest fluctuations in the royalties submitted quarter to quarter based upon the varying contractual terms, differing reporting and payment requirements, and the addition of new partners. Our partners’ end user sales may reflect volatility from quarter to quarter and therefore, that same volatility is reflected in our reported royalty revenues on a quarterly basis. 

23


Assay revenue increased 32% to $32.4 million for the three months ended September 30, 2016 from $24.6 million for the three months ended September 30, 2015, driven primarily by the Acquisition, which accounted for 26% of the 32% increase, in addition to increased sales of infectious disease testing assays. Revenue for our primary assay portfolios increased in infectious disease testing products by 53% while our genetic testing assay products decreased by 13% for the three months ended September 30, 2016 from the third quarter of 2015. This decrease was attributable to pricing and reimbursement challenges within the pharmacogenetic market segment, causing us to shift some focus away from these opportunities. Additionally, infectious disease testing assay products and genetic testing assay products represented 78% and 22%, respectively, of total assay revenue in the third quarter of 2016, compared to 68% and 32%, respectively, in the third quarter of 2015. The acquired assay revenue for Nanosphere represents approximately 20% of total assay revenue for the three months ended September 30, 2016, and consisted primarily of infectious disease testing assay products. Our largest customer, by revenue, accounted for 41% of total assay revenue for the three months ended September 30, 2016 compared to 53% for the three months ended September 30, 2015. No other customer accounted for more than 10% of total assay revenue during those periods. As disclosed previously, cystic fibrosis revenue from our largest assay customer is expected to transition to a competing technology and, although timing is uncertain, the loss of a significant portion of that revenue is expected by the first half of 2017. As discussed in the Overview section above, the same assay customer has recently informed us that they plan on developing the next iteration of their women's health portfolio with another party, which could negatively impact assay revenue in 2018.

Service revenue, comprised of extended warranty contracts earned ratably over the term of a contract and time and materials for billable service work not under an extended warranty contract, increased $0.5 million, or 23%, to $2.9 million for the third quarter of 2016 compared to the third quarter of 2015. As of September 30, 2016, we had 1,981 Luminex systems covered under extended service agreements and $4.8 million in deferred revenue related to those contracts. As of September 30, 2015, we had 1,682 Luminex systems covered under extended service agreements and $4.3 million in deferred revenue related to those contracts.

Other revenue, which includes training revenue, shipping revenue, miscellaneous part sales, amortized license fees, 2015 milestone payments from our development agreement with Merck and revenue from agreements with U.S. government agencies, decreased 28% to $2.0 million for the three months ended September 30, 2016 compared to $2.8 million for the three months ended September 30, 2015, primarily driven by a reduction in government contract revenue. We expect this trend to continue in the near term as our focus has shifted away from these government contract opportunities.

Gross Profit. Gross profit increased to $45.7 million for the three months ended September 30, 2016, as compared to $41.8 million for the three months ended September 30, 2015. However, gross margin (gross profit as a percentage of total revenue) was 64% for the three months ended September 30, 2016, lower than the prior year quarter of 69%. The decrease in gross margin percentage is attributable to the Acquisition. The acquired Nanosphere portfolio has meaningfully lower gross margins than the pre-existing Luminex business, including the impact of a $0.5 million incremental expense resulting from recording Nanosphere's inventory acquired at fair value on the date of the Acquisition. We expect the gross margins on the acquired portfolio to continue to negatively impact our consolidated gross margins in the near term; however, we expect synergies realized from the acquisition, increased sales volumes and the commercialization of the next generation Verigene system to increase these gross margins in the longer term. We anticipate continued fluctuation in gross margin and related gross profit primarily as a result of variability in consumable and system purchases and seasonality effects inherent in our assay revenue.

Research and Development Expense. Research and development expense increased to $12.8 million, or 18% of total revenue, for the three months ended September 30, 2016 from $10.1 million, or 17% of total revenue, for the three months ended September 30, 2015. The increase in research and development expense was primarily a result of the addition of Nanosphere's expenses, as well as higher costs for clinical trials of ARIES assays. Research and development headcount as of September 30, 2016 was 229, including 33 Nanosphere employees, as compared to 199 as of September 30, 2015. The focus of our research and development activities is the development and commercialization of a pipeline of assays for the ARIES® system and the development of the next generation Verigene system and assays.

Selling, General and Administrative Expense. Selling, general and administrative expenses, excluding the amortization of acquired intangible assets, increased to $26.4 million for the three months ended September 30, 2016 from $21.2 million for the three months ended September 30, 2015. The increase was primarily attributable to the addition of Nanosphere's expenses and transaction costs of $0.5 million incurred during the quarter. Selling, general and administrative headcount as of September 30, 2016 was 371, including 47 Nanosphere employees, as compared to 312 as of September 30, 2015. As a percentage of revenue, selling, general and administrative expense, excluding the amortization of acquired intangible assets, was 37% in the third quarter of 2016, up from 35% in the third quarter of 2015.

24


Amortization of Acquired Intangible Assets. Amortization of acquired intangible assets increased to $2.5 million for the three months ended September 30, 2016 from $0.8 million for the three months ended September 30, 2015. The increase was primarily driven by the completion of the in-process research and development project related to our ARIES® System which began amortizing in November 2015, as well as due to acquired intangible assets from the Acquisition which began amortizing in July 2016.

Income taxes. Our effective tax rate for the three months ended September 30, 2016 was 32%, reflecting a $1.3 million expense, as compared to 34%, or a $3.3 million expense, for the three months ended September 30, 2015 primarily resulting from the impact of projected income tax benefits related to Nanosphere in our provisional tax rates. We expect our consolidated effective tax rate to be in the 25% to 35% range over the next several years, absent any other significant discrete items. We continue to assess our business model and its impact in various tax jurisdictions.

NINE MONTHS ENDED SEPTEMBER 30, 2016 COMPARED TO NINE MONTHS ENDED SEPTEMBER 30, 2015

Selected consolidated financial data for the nine months ended September 30, 2016 and 2015 is as follows (dollars in thousands):
 
Nine Months Ended September 30,
 
 
 
 
 
2016
 
2015
 
Variance
 
Variance (%)
Revenue
$
198,368

 
$
177,259

 
$
21,109

 
12
 %
Gross profit
$
135,392

 
$
125,301

 
10,091

 
8
 %
Gross margin percentage
68
%
 
71
%
 
(3
)%
 
N/A

Operating expenses
$
112,063

 
$
95,943

 
16,120

 
17
 %
Income from operations
$
23,329

 
$
29,358

 
(6,029
)
 
(21
)%
 
Total revenue increased by 12% to $198.4 million for the nine months ended September 30, 2016 from $177.3 million for the comparable period in 2015. The increase was primarily attributable to increases in assay, system, and consumable sales, driven in part by the Acquisition on June 30, 2016 which contributed approximately 4% of the 12% growth in total revenue.

A breakdown of revenue for the nine months ended September 30, 2016 and 2015 is as follows (dollars in thousands):
 
Nine Months Ended September 30,
 
 
 
 
 
2016
 
2015
 
Variance
 
Variance (%)
System sales
$
27,805

 
$
22,129

 
$
5,676

 
26
 %
Consumable sales
37,489

 
32,714

 
4,775

 
15
 %
Royalty revenue
33,888

 
32,024

 
1,864

 
6
 %
Assay revenue
85,367

 
74,323

 
11,044

 
15
 %
Service revenue
7,892

 
7,108

 
784

 
11
 %
Other revenue
5,927

 
8,961

 
(3,034
)
 
(34
)%
 
$
198,368

 
$
177,259

 
$
21,109

 
12
 %

We continue to experience revenue concentration in a limited number of customers. Five customers accounted for 50% (21%, 13%, 7%, 6% and 3%, respectively) of consolidated total revenue in the nine months ended September 30, 2016. For comparative purposes, these top five customers accounted for 53% (23%, 13%, 8%, 6% and 3%, respectively) of total revenue in the nine months ended September 30, 2015. No other customer accounted for more than 10% of consolidated total revenue during those periods.

Revenue from the sale of systems and peripheral components increased 26% to $27.8 million for the nine months ended September 30, 2016 from $22.1 million for the nine months ended September 30, 2015, primarily due to the increase in the total multiplexing analyzer placements. We sold 826 multiplexing analyzers in the nine months ended September 30, 2016, as compared to 734 multiplexing analyzers sold for the corresponding prior year period. For the nine months ended September 30, 2016, five of our partners accounted for 592, or 72%, of total multiplexing analyzers sold.  Five of our partners accounted for 559, or 76%, of total multiplexing analyzers sold for the nine months ended September 30, 2015.


25

Consumable sales increased 15% to $37.5 million for the nine months ended September 30, 2016 compared to $32.7 million for the nine months ended September 30, 2015. We had 64 bulk purchases of consumables totaling approximately $29.4 million (78% of total consumable revenue), ranging from $0.1 million to $3.4 million, during the nine months ended September 30, 2016, as compared with 52 bulk purchases totaling approximately $24.4 million (75% of total consumable revenue), ranging from $0.1 million to $6.9 million, for the nine months ended September 30, 2015.  The increase in revenue from bulk purchases in the nine months ended September 30, 2016 is the main driver to the increase in consumable revenue from the prior year period and is primarily due to overall growth across our partners. We anticipate a modest decline in our consumable sales in the fourth quarter of 2016 primarily attributable to the timing of purchases by our largest purchaser of consumables. However, excluding purchases from our largest purchaser of consumables for the nine months ended September 30, 2016 and 2015, consumables from our remaining customers grew by 16% for the nine months ended September 30, 2016 as compared to the prior year period. We expect fluctuations in consumable sales on an ongoing basis. Partners who reported royalty bearing sales accounted for $25.0 million, or 67%, of consumable sales for the nine months ended September 30, 2016 compared to $22.4 million, or 69%, of the total consumable sales for the nine months ended September 30, 2015.

Royalty revenue increased 6% to $33.9 million for the nine months ended September 30, 2016 from $32.0 million for the nine months ended September 30, 2015.  This increase is primarily attributable to an increase in base royalties of approximately $1.4 million as a result of continued menu expansion and increased utilization of our partners’ assays on our technology. We expect modest fluctuations in the royalties submitted quarter to quarter based upon the varying contractual terms, differing reporting and payment requirements, and the addition of new partners. Our partners’ end user sales may reflect volatility from quarter to quarter and therefore, that same volatility is reflected in our reported royalty revenues on a quarterly basis.

Assay revenue increased 15% to $85.4 million for the nine months ended September 30, 2016 from $74.3 million for the nine months ended September 30, 2015, driven primarily by the Acquisition, which contributed 9% of the 15% increase. The remaining 6% of growth is attributable to increased sales in infectious disease testing assays. Our infectious disease testing assay portfolio increased 27% from the first nine months of 2015 while our genetic testing assay portfolio decreased 9% over the comparable time period.  Additionally, infectious disease testing and genetic testing assay products represented 73% and 27%, respectively, of total assay revenue in the nine months ended September 30, 2016, compared to 66% and 34%, respectively, in the nine months ended September 30, 2015. Our largest customer, by revenue, accounted for 45% of total assay revenue for the nine months ended September 30, 2016 compared to 51% for the nine months ended September 30, 2015. No other customer accounted for more than 10% of total assay revenue during those periods. As disclosed previously, cystic fibrosis revenue from our largest assay customer is expected to transition to a competing technology and, although timing is uncertain, the loss of a significant portion of that revenue is expected by the first half of 2017.

Service revenue, comprised of extended warranty contracts earned ratably over the term of a contract and time and materials for billable service work not under an extended warranty contract, increased 11% to $7.9 million for the nine months ended September 30, 2016 compared to $7.1 million for the nine months ended September 30, 2015.

Other revenue, which includes training revenue, shipping revenue, miscellaneous part sales, amortized license fees, 2015 milestone payments from our development agreement with Merck and revenue from agreements with U.S. government agencies, decreased to $5.9 million for the nine months ended September 30, 2016 compared to $9.0 million for the nine months ended September 30, 2015, primarily driven by a decrease in revenue from U.S. government contracts, in addition to a Merck milestone payment in 2015, which did not recur in 2016.

Gross Profit. Gross profit increased to $135.4 million for the nine months ended September 30, 2016, as compared to $125.3 million for the nine months ended September 30, 2015. Gross margin (gross profit as a percentage of total revenue) was 68% for the nine months ended September 30, 2016, a decrease from 71% for the nine months ended September 30, 2015, was attributable to the Acquisition. The acquired Nanosphere portfolio currently has meaningfully lower gross margins than the pre-existing Luminex business, including the impact of a $0.5 million incremental expense resulting from recording Nanosphere's inventory acquired at fair value on the date of the Acquisition. The acquired Nanosphere portfolio has significantly lower gross margins than the pre-existing Luminex business. We expect the gross margins on the acquired portfolio to continue to negatively impact our consolidated gross margins in the near term; however, we expect synergies realized from the acquisition, increased sales volumes and the commercialization of the next generation Verigene system to increase these gross margins in the longer term. We anticipate continued fluctuation in gross margin and related gross profit primarily as a result of variability in consumable and system purchases and seasonality effects inherent in our assay revenue.

26


Research and Development Expense. Research and development expense increased to $35.3 million, or 18% of total revenue, for the nine months ended September 30, 2016 from $31.7 million, or 18% of total revenue, for the nine months ended September 30, 2015. The $3.6 million increase in research and development expense was primarily the result of the addition of Nanosphere's expenses and higher material and expenses driven by the expansion of assay research and clinical trials. Research and development headcount as of September 30, 2016 was 229, including 33 Nanosphere employees, as compared to 199 as of September 30, 2015. The focus of our research and development activities has been the development and clinical validation of our next generation sample to answer platform for our ARIES® system.

Selling, General and Administrative Expense. Selling, general and administrative expenses, excluding the amortization of acquired intangible assets, increased to $70.9 million for the nine months ended September 30, 2016 from $61.7 million for the nine months ended September 30, 2015, primarily resulting from the addition of Nanosphere and the Acquisition transaction costs of $2.5 million, in addition to higher sales and marketing expenses driven by increased headcount and marketing activities. Selling, general and administrative headcount as of September 30, 2016 was 371, including 47 Nanosphere employees, as compared to 312 as of September 30, 2015. As a percentage of revenue, selling, general and administrative expense, excluding the amortization of acquired intangible assets, was 36% in the first nine months of 2016, compared to 35% in the first nine months of 2015.

Amortization of Acquired Intangible Assets. Amortization of acquired intangible assets increased to $5.8 million for the nine months ended September 30, 2016 from $2.5 million for the nine months ended September 30, 2015. The increase was primarily driven by the completion of the in-process research and development project related to our ARIES® System which began amortizing in November 2015, as well as due to acquired intangible assets from the acquisition of Nanosphere which began amortizing in July 2016.

Other Income, net. Other income, net decreased to a loss of $1.4 million for the nine months ended September 30, 2016 from income of $1.0 million for the nine months ended September 30, 2015. The decrease was primarily the result of the $1.5 million debt retirement fees in connection with the payoff of Nanosphere's debt.

Settlement of litigation. An expense of $7.1 million was recorded in the second quarter of 2015 related to the settlement of litigation with ENZO. The expense associated with the settlement was for partial consideration of a license, dismissal of litigation, releases, and covenants granted by ENZO. See Note 12 - Commitments and Contingencies to our condensed consolidated financial statements for further discussion.

Income taxes. Our effective tax rate for the nine months ended September 30, 2016 was 22%, reflecting a $4.8 million expense, as compared to 28%, or a $6.5 million expense, for the nine months ended September 30, 2015 primarily the result of the impact of the Acquisition and the inclusion of projected income tax benefits related to Nanosphere in our provisional tax rates in 2016. We expect our consolidated effective tax rate to be in the 25% to 35% range over the next several years, absent any other significant discrete items. We continue to assess our business model and its impact in various tax jurisdictions.

27


LIQUIDITY AND CAPITAL RESOURCES
 
September 30, 2016
 
December 31, 2015
 
(in thousands)
Cash and cash equivalents
$
84,145

 
$
128,546

Short-term investments
—

 
11,988

Long-term investments
—

 
7,459

 
$
84,145

 
$
147,993


As of September 30, 2016, we held cash and cash equivalents, short-term investments and long-term investments of $84.1 million and had working capital of $133.3 million. At December 31, 2015, we held cash and cash equivalents, short-term investments and long-term investments of $148.0 million and had working capital of $182.3 million. The $63.8 million decrease in cash, cash equivalents and investments is primarily attributable to the cash payment of approximately $92.4 million in connection with the acquisition of Nanosphere, and the subsequent retirement of approximately $25.4 million of Nanosphere's debt. These payments were partially offset by the cash acquired from Nanosphere of $24.3 million and operating cash flows of the Company in the amount of $35.8 million for the nine months ended September 30, 2016. Our capital expenditures were $8.4 million during the first nine months of 2016, which were partially funded by $3.6 million in proceeds from our employee stock purchase plan.

As a result of the dilutive nature of the Acquisition, we believe both profitability and operating cash flows over the next eighteen months, approximately, will be lower than our recent historical results; however, we expect to maintain profitability and positive operating cash flows. We currently anticipate that the Acquisition and its related integration will be accretive to the Company's consolidated revenue, profitability, and cash flow by the end of 2017.

We have funded our operations to date primarily through the issuance of equity securities (in conjunction with an initial public offering in 2000, subsequent option exercises, and our secondary public offering in 2008) and cash generated from operations. Our cash reserves are typically held directly or indirectly in a variety of short-term, interest-bearing instruments, including non-government sponsored debt securities. We do not have any investments in asset-backed commercial paper, auction rate securities, or mortgage backed or sub-prime style investments.

Our future capital requirements will depend on a number of factors, including our success in developing and expanding markets for our products, payments under possible future strategic arrangements, continued progress of our research and development of potential products, the timing and outcome of regulatory approvals, the need to acquire licenses to new technology, costs associated with strategic acquisitions including integration costs and assumed liabilities, the status of competitive products and potential cost associated with both protecting and defending our intellectual property. We believe that our existing cash and cash equivalents are sufficient to fund our operating expenses, capital equipment requirements and other expected liquidity requirements for the coming twelve months. Factors that could affect our capital requirements, in addition to those listed above, include, without limitation: (i) continued collections of accounts receivable consistent with our historical experience; (ii) our ability to manage our inventory levels consistent with past practices; (iii) volatility in our key partners' consumable purchasing patterns; (iv) execution of partnership agreements that include significant up front license fees; (v) our stock repurchase programs from time to time and (vi) executing strategic investment or acquisition agreements requiring significant cash consideration. See also the "Safe Harbor Cautionary Statement" of this report and the risk factors in the 2015 10-K and our other filings with the SEC.

To the extent our capital resources are insufficient to meet future capital requirements we will have to raise additional funds to continue the development and deployment of our technologies, or to supplement our position through strategic acquisitions. There can be no assurance that debt or equity funds will be available on favorable terms, if at all. Any downgrade in our credit rating could adversely affect our ability to raise debt capital on favorable terms, or at all. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of those securities could result in dilution to our stockholders. Moreover, incurring debt financing could result in a substantial portion of our operating cash flow being dedicated to the payment of principal and interest on such indebtedness, could render us more vulnerable to competitive pressures and economic downturns and could impose restrictions on our operations. If adequate funds are not available, we may be required to curtail operations significantly or to obtain funds through entering into agreements on unattractive terms.


28

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk. Our interest income is sensitive to changes in the general level of domestic interest rates, particularly since our investments are in short-term instruments available-for-sale. A 50 basis point fluctuation from average investment returns as of September 30, 2016 would yield a less than 0.5% variance in overall investment return, which would not have a material effect on our financial condition.

Foreign Currency Risk. Our international business is subject to risks, including, but not limited to: foreign exchange rate volatility, differing tax structures, unique economic conditions, other regulations and restrictions, and changes in political climate. Accordingly, our future results could be materially adversely impacted by changes in these and other factors.

As of September 30, 2016, as a result of our foreign operations, we have costs, assets and liabilities that are denominated in foreign currencies, primarily Canadian dollars and to a lesser extent the Euro, Renminbi, Hong Kong dollar and Yen. For example, some fixed asset purchases and certain expenses in our Canadian subsidiary are denominated in Canadian dollars while sales of products are primarily denominated in U.S. dollars. Transactions in our Netherlands, Japanese and Hong Kong subsidiaries are primarily denominated in Euros, Yen and Hong Kong dollars, respectively. The majority of transactions, with the exception of our initial capital investment, in our Chinese subsidiary are denominated in Renminbi. As a consequence, movements in exchange rates could cause our foreign currency denominated expenses to fluctuate as a percentage of net revenue, affecting our profitability and cash flows. A significant majority of our revenues are denominated in U.S. dollars. The impact of foreign exchange rates on foreign denominated balances will vary in relation to changes between the U.S. dollar, Canadian dollar, Euro, Yen, Renminbi and Hong Kong dollar exchange rates. A 10% change in these exchange rates in relation to the U.S. dollar would result in an income statement impact of approximately $0.9 million on foreign currency denominated asset and liability balances as of September 30, 2016. As a result of our efforts to expand globally, in the future we will be exposed to additional foreign currency risk in multiple currencies; however, at this time, our exposure to foreign currency fluctuations is not material. We regularly assess the market to determine if additional strategies are appropriate to mitigate future risks.

In addition, the indirect effect of fluctuations in interest rates and foreign currency exchange rates could have a material adverse effect on our business financial condition and results of operations. For example, currency exchange rate fluctuations could affect international demand for our products. In addition, interest rate fluctuations could affect our customers’ buying patterns. Furthermore, interest rate and currency exchange rate fluctuations may broadly influence the United States and foreign economies resulting in a material adverse effect on our business, financial condition and results of operations. As a result, we cannot give any assurance as to the effect that future changes in foreign currency rates will have on our consolidated financial position, results of operations or cash flows. Our aggregate foreign currency transaction loss of approximately $55,000 was included in determining our consolidated results for the quarter ended September 30, 2016.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (Exchange Act), which are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as of the end of the period covered by this quarterly report. Based on the evaluation and criteria of these disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective.
 
Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Exchange Act Rule 13a-15(d) during the quarter ended September 30, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


29

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

When and if it appears probable in management's judgment, and based upon consultation with outside counsel, that we will incur monetary damages or other costs in connection with any claims or proceedings, and such costs can be reasonably estimated, we record the estimated liability in the financial statements.  If only a range of estimated losses can be estimated, we record an amount within the range that, in management's judgment, reflects the most likely outcome; if none of the estimates within that range is a better estimate than any other amount, we record the liability at the low end of the range of estimates. Any such accrual would be charged to expense in the appropriate period.   We disclose significant contingencies when the loss is not probable and/or the amount of the loss is not estimable, when we believe there is at least a reasonable possibility that a loss has been incurred.  We recognize costs associated with legal proceedings in the period in which the services were provided.

ITEM 1A. RISK FACTORS

Reference is made to the factors set forth under the caption “Safe Harbor Cautionary Statement” in Part I, Item 2 of this report and other risk factors described in Part I, Item 1A of the 2015 10-K, which are incorporated herein by reference. There have been no material changes from the risk factors previously disclosed in the 2015 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The stock repurchase activity for the third quarter of 2016 was as follows:
ISSUER PURCHASES OF EQUITY SECURITIES
Period
Total Number of Shares Purchased (1)
 
Average Price Paid per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
 
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
7/1/16 - 7/31/16
116

 
$
22.39

 
—

 
$
—

8/1/16 - 8/31/16
301

 
21.65

 
—

 
—

9/1/16 - 9/30/16
129

 
21.12

 
—

 
—

Total Third Quarter
546

 
$
21.68

 
—

 
$
—

(1) Total shares purchased are attributable to the withholding of shares by Luminex to satisfy the payment of tax obligations related to the vesting of restricted shares.


30

ITEM 6. EXHIBITS

The following exhibits are filed herewith:
Exhibit
Number
 
 
Description of Documents
 
 
 
31.1
 
Certification by CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
31.2
 
Certification by CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.1
 
Certification by CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.2
 
Certification by CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
101
 
The following materials from Luminex Corporation's Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2016, formatted in XBRL: (i) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Comprehensive Income; (iii) Condensed Consolidated Statement of Cash Flows; and (iv) Notes to Condensed Consolidated Financial Statements. 




31

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.


Date: October 31, 2016

LUMINEX CORPORATION

By: /s/ Harriss T. Currie   
Harriss T. Currie
Chief Financial Officer, Senior Vice President of Finance
(Principal Financial Officer)



EXHIBIT INDEX
Exhibit
Number
 
 
Description of Documents
 
 
 
31.1
 
Certification by CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
31.2
 
Certification by CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.1
 
Certification by CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.2
 
Certification by CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
101
 
The following materials from Luminex Corporation's Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2016, formatted in XBRL: (i) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Comprehensive Income; (iii) Condensed Consolidated Statement of Cash Flows; and (iv) Notes to Condensed Consolidated Financial Statements. 


 EX-31.1 2 lmnx-09302016xexhibit311.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1
 
CERTIFICATION

I, Nachum Shamir, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Luminex Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
Date: October 31, 2016

By:  /s/ Nachum Shamir   
Nachum Shamir
President and Chief Executive Officer


 EX-31.2 3 lmnx-09302016xexhibit312.htm EXHIBIT 31.2 Exhibit


Exhibit 31.2
 
CERTIFICATION

I, Harriss T. Currie, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Luminex Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: October 31, 2016
 
By: /s/ Harriss T. Currie   
Harriss T. Currie
Chief Financial Officer, Senior Vice President of Finance


 EX-32.1 4 lmnx-09302016xexhibit321.htm EXHIBIT 32.1 Exhibit


Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Luminex Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Nachum Shamir, President and Chief Executive Officer of the Company, certify, pursuant to Title 18, Chapter 63, Section 1350 of the United States Code, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

/s/ Nachum Shamir   
Nachum Shamir
President and Chief Executive Officer
October 31, 2016

A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO LUMINEX CORPORATION AND WILL BE RETAINED BY LUMINEX CORPORATION AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.


 EX-32.2 5 lmnx-09302016xexhibit322.htm EXHIBIT 32.2 Exhibit


Exhibit 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Luminex Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Harriss T. Currie, Chief Financial Officer and Senior Vice President of Finance of the Company, certify, pursuant to Title 18, Chapter 63, Section 1350 of the United States Code, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

/s/ Harriss T. Currie   
Harriss T. Currie
Chief Financial Officer, Senior Vice President of Finance
October 31, 2016


A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO LUMINEX CORPORATION AND WILL BE RETAINED BY LUMINEX CORPORATION AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.



 EX-101.INS 6 lmnx-20160930.xml XBRL INSTANCE DOCUMENT 0001033905 2016-01-01 2016-09-30 0001033905 2016-10-31 0001033905 2016-09-30 0001033905 2015-12-31 0001033905 2015-01-01 2015-09-30 0001033905 2016-07-01 2016-09-30 0001033905 2015-07-01 2015-09-30 0001033905 2015-09-30 0001033905 2016-06-30 0001033905 2014-12-31 0001033905 2015-06-30 0001033905 lmnx:NanosphereMember 2015-01-01 2015-09-30 0001033905 lmnx:NanosphereMember 2016-01-01 2016-09-30 0001033905 lmnx:NanosphereMember 2016-07-01 2016-09-30 0001033905 lmnx:NanosphereMember 2016-06-30 0001033905 lmnx:NanosphereMember 2016-01-01 2016-06-30 0001033905 lmnx:InvestmentInPrivateCompany1Member 2016-07-01 2016-09-30 0001033905 lmnx:InvestmentInPrivateCompany1Member 2013-07-01 2013-09-30 0001033905 lmnx:InvestmentInPrivateCompany2Member 2016-09-30 0001033905 us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2015-12-31 0001033905 lmnx:CurrentgovernmentsponsoreddebtsecuritiesMemberMember 2015-12-31 0001033905 lmnx:TotalNonCurrentAvailableForSaleSecuritiesMember 2015-12-31 0001033905 us-gaap:MoneyMarketFundsMember 2015-12-31 0001033905 lmnx:TotalCurrentAvailableForSaleSecuritiesMember 2015-12-31 0001033905 lmnx:NonCurrentNonGovernmentSponsoredDebtSecuritiesMember 2015-12-31 0001033905 lmnx:CurrentNonGovernmentSponsoredDebtSecuritiesMember 2015-12-31 0001033905 lmnx:NonCurrentNonGovernmentSponsoredDebtSecuritiesMember 2016-09-30 0001033905 lmnx:TotalCurrentAvailableForSaleSecuritiesMember 2016-09-30 0001033905 lmnx:TotalNonCurrentAvailableForSaleSecuritiesMember 2016-09-30 0001033905 lmnx:CurrentNonGovernmentSponsoredDebtSecuritiesMember 2016-09-30 0001033905 lmnx:CurrentgovernmentsponsoreddebtsecuritiesMemberMember 2016-09-30 0001033905 us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember 2016-09-30 0001033905 us-gaap:MoneyMarketFundsMember 2016-09-30 0001033905 us-gaap:FairValueInputsLevel2Member 2015-12-31 0001033905 us-gaap:FairValueInputsLevel1Member 2015-12-31 0001033905 us-gaap:FairValueInputsLevel3Member 2015-12-31 0001033905 us-gaap:FairValueInputsLevel2Member 2016-09-30 0001033905 us-gaap:FairValueInputsLevel1Member 2016-09-30 0001033905 us-gaap:FairValueInputsLevel3Member 2016-09-30 0001033905 us-gaap:OtherIntangibleAssetsMember 2015-12-31 0001033905 us-gaap:OtherIntangibleAssetsMember 2015-01-01 2015-12-31 0001033905 us-gaap:CustomerListsMember 2016-09-30 0001033905 us-gaap:CustomerListsMember 2015-01-01 2015-12-31 0001033905 lmnx:TechnologyTradeSecretsAndKnowHowMember 2015-12-31 0001033905 us-gaap:InProcessResearchAndDevelopmentMember 2015-12-31 0001033905 lmnx:TechnologyTradeSecretsAndKnowHowMember 2015-01-01 2015-12-31 0001033905 us-gaap:InProcessResearchAndDevelopmentMember 2014-12-31 0001033905 2015-01-01 2015-12-31 0001033905 us-gaap:InProcessResearchAndDevelopmentMember 2015-01-01 2015-12-31 0001033905 lmnx:TechnologyTradeSecretsAndKnowHowMember 2016-09-30 0001033905 us-gaap:CustomerListsMember 2016-01-01 2016-09-30 0001033905 us-gaap:InProcessResearchAndDevelopmentMember 2016-09-30 0001033905 us-gaap:CustomerListsMember 2015-12-31 0001033905 us-gaap:OtherIntangibleAssetsMember 2016-09-30 0001033905 lmnx:TechnologyTradeSecretsAndKnowHowMember 2016-01-01 2016-09-30 0001033905 lmnx:TechnologyTradeSecretsAndKnowHowMember 2014-12-31 0001033905 us-gaap:InProcessResearchAndDevelopmentMember 2016-01-01 2016-09-30 0001033905 us-gaap:OtherIntangibleAssetsMember 2016-01-01 2016-09-30 0001033905 us-gaap:OtherIntangibleAssetsMember 2014-12-31 0001033905 us-gaap:CustomerListsMember 2014-12-31 0001033905 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-01-01 2016-09-30 0001033905 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-12-31 0001033905 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-09-30 0001033905 us-gaap:AccumulatedTranslationAdjustmentMember 2016-09-30 0001033905 us-gaap:AccumulatedTranslationAdjustmentMember 2015-12-31 0001033905 us-gaap:AccumulatedTranslationAdjustmentMember 2016-01-01 2016-09-30 0001033905 us-gaap:RestrictedStockMember 2016-01-01 2016-09-30 0001033905 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-09-30 0001033905 us-gaap:RestrictedStockMember 2016-09-30 0001033905 us-gaap:RestrictedStockUnitsRSUMember 2016-09-30 0001033905 us-gaap:RestrictedStockUnitsRSUMember 2015-12-31 0001033905 us-gaap:RestrictedStockMember 2015-12-31 0001033905 us-gaap:ResearchAndDevelopmentExpenseMember 2015-07-01 2015-09-30 0001033905 lmnx:ReflectedInNetIncomeLossMember 2016-07-01 2016-09-30 0001033905 us-gaap:CostOfSalesMember 2016-01-01 2016-09-30 0001033905 us-gaap:GeneralAndAdministrativeExpenseMember 2015-07-01 2015-09-30 0001033905 lmnx:ReflectedInNetIncomeLossMember 2015-01-01 2015-09-30 0001033905 lmnx:ReflectedInNetIncomeLossMember 2016-01-01 2016-09-30 0001033905 us-gaap:CostOfSalesMember 2015-07-01 2015-09-30 0001033905 us-gaap:CostOfSalesMember 2016-07-01 2016-09-30 0001033905 us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-01 2016-09-30 0001033905 us-gaap:ResearchAndDevelopmentExpenseMember 2016-07-01 2016-09-30 0001033905 us-gaap:ResearchAndDevelopmentExpenseMember 2015-01-01 2015-09-30 0001033905 lmnx:ReflectedInNetIncomeLossMember 2015-07-01 2015-09-30 0001033905 us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-01 2016-09-30 0001033905 us-gaap:GeneralAndAdministrativeExpenseMember 2016-07-01 2016-09-30 0001033905 us-gaap:CostOfSalesMember 2015-01-01 2015-09-30 0001033905 us-gaap:GeneralAndAdministrativeExpenseMember 2015-01-01 2015-09-30 0001033905 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-09-30 0001033905 us-gaap:EmployeeStockOptionMember 2016-09-30 0001033905 us-gaap:EmployeeStockOptionMember 2015-12-31 0001033905 us-gaap:ScenarioForecastMember 2016-01-01 2016-12-31 0001033905 2015-04-01 2015-06-30 0001033905 us-gaap:NewAccountingPronouncementEarlyAdoptionEffectMember 2016-09-30 0001033905 us-gaap:NewAccountingPronouncementEarlyAdoptionEffectMember 2016-01-01 2016-09-30 iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares false --12-31 Q3 2016 2016-09-30 10-Q 0001033905 43584558 Large Accelerated Filer Luminex Corp 1261000 734000 1000000 7459000 0 88500000 92409000 68098000 41685000 12282000 12409000 4012000 12982000 391000 1400000 2500000 34387000 1500000 0 40100000 0 0 40100000 19447000 0 75388000 12982000 11988000 0 11988000 0 0 0 0 0 0 79652000 29704000 7958000 1890000 40100000 78551000 69102000 7797000 1652000 0 120236000 81384000 20206000 5664000 12982000 0.15 144000 144000 0 0 701000 701000 0 0 7459000 0 7459000 0 0 0 0 0 0 0.20 1101000 702000 161000 238000 0 1101000 702000 161000 238000 0 7868000 9881000 10946000 11515000 15152000 16115000 -1296000 -38000 -1258000 -966000 0 -966000 321657000 331474000 3099000 238000 2136000 725000 7768000 742000 5321000 1705000 3526000 334000 2438000 754000 8181000 903000 5382000 1896000 777000 2455000 3900000 3023000 743000 134000 0 2482000 5797000 4683000 902000 212000 0 579256 579256 0 0 402556000 441128000 209526000 164856000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 43000 3000 10000 24000 13000 30000 0 6000 0 0 0 0 0 0 0 0 19591000 1998000 9990000 5467000 12132000 7459000 144000 1992000 701000 0 0 701000 0 701000 19634000 2001000 10000000 5491000 12145000 7489000 144000 1998000 701000 0 0 0 701000 0 701000 0 11988000 0 1500000 1.00 -0.07 0.25 -0.07 0.25 1.70 4060000 12814000 -2792000 10557000 191483000 212320000 500000 24311000 7449000 41685000 25391000 25600000 91694000 111064000 119553000 128546000 81718000 84145000 8489000 27859000 2427000 -44401000 0.001 0.01 0.001 200000000 200000000 42314581 42708733 42314581 42708733 42000 43000 6384000 16133000 2864000 17504000 5400000 900000 18789000 51958000 25556000 62976000 176000 6207000 1540000 4471000 4212000 5601000 2064000 1864000 31821000 42208000 3411000 9733000 5913000 14401000 0.15 0.39 0.06 0.40 0.15 0.39 0.06 0.40 13000 46000 87000 365000 0.2170 0.30 0.35 11700000 15000000 3300000 P2Y10M10D P2Y4M10D P1Y11M12D -14000 -1005000 0 0 P10Y P11Y P11Y P10Y P10Y P10Y 23270000 19325000 3085000 860000 0 26069000 21646000 3667000 756000 0 31866000 26329000 4569000 968000 0 37560000 2482000 8789000 8789000 8789000 8979000 88370000 62000 743000 -87000 -128000 -7100000 0 -7300000 0 0 49619000 49619000 83898000 0 34279000 34279000 41812000 125301000 45665000 135392000 9719000 23022000 4058000 21934000 3317000 6538000 1307000 4760000 211000 1238000 -2536000 -1674000 1050000 -3452000 -1485000 -428000 -6602000 -36000 -212000 112000 733000 -3364000 -7414000 2125000 6165000 -764000 1629000 902000 230000 3985000 -2101000 3118000 -3555000 52482000 47456000 4130000 896000 0 88370000 55055000 15637000 4696000 12982000 7159000 10959000 31252000 41455000 15296000 23792000 8797000 6704000 34020000 38363000 402556000 441128000 27232000 31597000 7459000 0 949000 -908000 1786000 -22936000 -3381000 -15258000 -4329000 -57656000 10908000 43979000 4883000 35826000 6402000 16484000 2751000 6200000 17174000 32106000 95943000 41637000 112063000 9706000 29358000 4028000 23329000 2392000 3199000 3853000 6335000 113000 292000 113000 292000 0 0 2000 24000 0 38000 330000 38000 292000 113000 336000 -20000 -375000 113000 292000 -18000 -351000 113000 330000 38000 292000 0 -6000 0 44000 0 38000 0 -6000 4724000 4902000 25000 128000 799000 870000 13000 964000 30000 -1395000 14000 1593000 13000 1497000 0 0 1196000 68098000 650000 852000 0 200000 0 0 500000 500000 2731000 15299000 2675000 8394000 0.001 0.001 5000000 5000000 0 0 0 0 0 0 8887000 9294000 14000 1005000 0 0 977000 1690000 1799000 3561000 0 0 0 19491000 0 0 0 19500000 0 893000 42000 45000 47796000 55461000 28853000 29962000 0 0 0 25000000 10093000 31748000 12762000 35324000 48133000 72214000 6900000 60601000 177259000 71221000 7400000 198368000 21236000 61740000 26393000 70942000 3099000 7768000 3526000 8181000 53000 46000 18.36 300000 99000 19.74 836000 501000 878000 471000 18.66 18.83 205000 83000 19.59 92000 18.58 886000 1692000 2343000 17.47 18.08 17.51 19.21 11988000 0 553000 667000 582000 696000 143000 368536000 402765000 404000 313000 453000 407000 42556000 42354000 43136000 42929000 42152000 42041000 42683000 42522000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated fair value of available-for-sale debt securities as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, by contractual maturity, was as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due in one year or less</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,988</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after one year through two years</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,447</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following are the stock-based compensation costs recognized in the Company&#8217;s condensed consolidated statements of comprehensive income (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">903</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">754</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">725</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,705</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,438</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,321</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation costs reflected in net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,526</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,099</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,181</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,768</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities consisted of the following as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gains in Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Losses in Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total noncurrent securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities consisted of the following as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gains in Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Losses in Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,990</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,001</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,998</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,132</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,998</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,992</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,491</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,467</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total noncurrent securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,489</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,459</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,591</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">dition, the unaudited pro forma financial information is not intended to be a projection of future results and does not reflect any operating efficiencies or cost savings that might be achievable.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(unaudited)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212,320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">191,483</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,814</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,060</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,792</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per share, basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.07</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares used in computing net income (loss) per share, basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per share, diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.07</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares used in computing net income (loss) per share, diluted</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,929</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,354</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 2 &#8212; BUSINESS COMBINATIONS</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 30, 2016, the Company completed its acquisition (the Acquisition) of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the outstanding shares of Nanosphere, Inc. (Nanosphere), which was a publicly-held molecular diagnostic company that was founded in 1999 and based in Northbrook, Illinois. On May 15, 2016, the Company, Nanosphere and Commodore Acquisition, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (Purchaser) entered into an Agreement and Plan of Merger (as amended, the Merger Agreement). In accordance with the terms of the Merger Agreement, on June 2, 2016, Purchaser commenced a cash tender offer (the Tender Offer) for all of the outstanding shares of Nanosphere&#8217;s common stock, par value </font><font style="font-family:inherit;font-size:10pt;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> per share (the Shares), for </font><font style="font-family:inherit;font-size:10pt;">$1.70</font><font style="font-family:inherit;font-size:10pt;"> per share, net to the seller in cash, without interest and less any required withholding taxes, upon the terms and conditions set forth in the Offer to Purchase dated June 2, 2016, as amended or supplemented from time to time, and in the related Letter of Transmittal. The Tender Offer expired at 12:00 midnight Eastern Daylight Time, at the end of June 29, 2016, and was not extended.&#160;Upon the completion of the Tender Offer, the Company, through Purchaser, paid </font><font style="font-family:inherit;font-size:10pt;">$1.70</font><font style="font-family:inherit;font-size:10pt;"> for each Share validly tendered and not withdrawn. Following the consummation of the Tender Offer, the Company completed the Acquisition by consummating the merger of Purchaser with and into Nanosphere, pursuant to which, any Shares not purchased in the Tender Offer were automatically converted into the right to receive </font><font style="font-family:inherit;font-size:10pt;">$1.70</font><font style="font-family:inherit;font-size:10pt;"> per Share. The aggregate consideration paid to Nanosphere stockholders required to acquire all outstanding Shares pursuant to the Tender Offer and the merger was approximately </font><font style="font-family:inherit;font-size:10pt;">$88.5 million</font><font style="font-family:inherit;font-size:10pt;">, which was funded from cash on hand. Pursuant to the terms of the Merger Agreement, Nanosphere agreed to cancel all outstanding and exercisable Nanosphere stock options and replace each such stock option with the right to receive a cash payment equal to the number of shares subject to such option multiplied by the difference between </font><font style="font-family:inherit;font-size:10pt;">$1.70</font><font style="font-family:inherit;font-size:10pt;"> and the applicable exercise price of the respective options. Nanosphere also agreed to cancel all of its outstanding restricted stock and convert such restricted stock into the right to receive a cash payment equal to the number of shares of restricted stock multiplied by </font><font style="font-family:inherit;font-size:10pt;">$1.70</font><font style="font-family:inherit;font-size:10pt;">. &#160;The Company paid </font><font style="font-family:inherit;font-size:10pt;">$1.4 million</font><font style="font-family:inherit;font-size:10pt;"> in aggregate consideration of the cancelled Nanosphere options and outstanding restricted stock.&#160;Additionally, for each Nanosphere warrant holder, the Company agreed to issue replacement warrants that are exercisable for an amount in cash equal to the product of the number of shares of stock represented by the replacement warrant and the difference between </font><font style="font-family:inherit;font-size:10pt;">$1.70</font><font style="font-family:inherit;font-size:10pt;"> and the per share price of the replacement warrant.&#160;The Company purchased </font><font style="font-family:inherit;font-size:10pt;">1.5 million</font><font style="font-family:inherit;font-size:10pt;"> Nanosphere warrants outstanding for an additional </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> in consideration to the Nanosphere warrant holders. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Acquisition was undertaken to expand the Company's access to the high-growth molecular microbiology market and to Nanosphere's portfolio of molecular testing solutions. Nanosphere delivers proprietary diagnostic tools that enable detection of respiratory, gastroenteric and bloodstream infections. Nanosphere shares ceased trading on the Nasdaq Capital Market as of the close of business on June 30, 2016. The results of operations for Nanosphere have been included in the Company&#8217;s consolidated financial statements beginning July 1, 2016.&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Immediately subsequent to the Acquisition, on June 30, 2016, the Company retired approximately </font><font style="font-family:inherit;font-size:10pt;">$25.4 million</font><font style="font-family:inherit;font-size:10pt;"> of Nanosphere's debt, including approximately </font><font style="font-family:inherit;font-size:10pt;">$391,000</font><font style="font-family:inherit;font-size:10pt;"> of accrued interest, by using the Company's existing cash reserves, including </font><font style="font-family:inherit;font-size:10pt;">$25.6 million</font><font style="font-family:inherit;font-size:10pt;"> of cash acquired in the Acquisition. As part of this debt retirement, we incurred </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> of related fees which were expensed as part of the Company's second quarter 2016 results. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Acquisition has been accounted for as a business combination in accordance with U.S. GAAP and, as such, the assets acquired and liabilities assumed have been recorded at their respective fair values. The determination of fair value for the identifiable tangible and intangible assets acquired and liabilities assumed requires extensive use of estimates and judgments. Significant estimates and assumptions include, but are not limited to, Level 3 measurements estimating future cash flows and determining the appropriate discount rate. The following table summarizes the estimated fair values of Nanosphere&#8217;s assets acquired and liabilities assumed at June 30, 2016 (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net tangible assets assumed as of June 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,387</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt and accrued interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,391</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets, net of deferred tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,449</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total purchase price</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,409</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less cash and cash equivalents acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash paid for business acquisition</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,098</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is in the process of finalizing third-party valuations of certain intangible assets and finalizing the calculations of the deferred tax liabilities related to Nanosphere; thus the provisional measurement of intangible assets, deferred tax liabilities and goodwill are subject to change.&#160;&#160;If information that existed prior to June 30, 2016 becomes available which would indicate adjustments are required to the purchase price allocation, such adjustments will be included in the purchase price allocations through revisions to the net tangible assets assumed, fair values of the intangible assets, deferred tax assets and liabilities and resulting goodwill recorded.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired finished goods and work-in-process inventory was valued at its estimated selling price less the sum of the costs of sales efforts and a reasonable profit allowance for the Company's selling effort and, with respect to work-in-process inventory, estimated costs to complete. This resulted in a fair value adjustment that increased finished goods inventory by approximately </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, which increased cost of goods sold in the quarter ending September 30, 2016 as these inventory items were sold.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Acquisition contributed </font><font style="font-family:inherit;font-size:10pt;">$7.4 million</font><font style="font-family:inherit;font-size:10pt;"> of revenue and net losses of </font><font style="font-family:inherit;font-size:10pt;">$6.2 million</font><font style="font-family:inherit;font-size:10pt;">, during the three months ended September 30, 2016.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Unaudited Pro forma Financial Information</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nanosphere's results of operations have been included in the Company's financial statements for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, following the Acquisition on June 30, 2016. The unaudited pro forma financial information set forth below assumes that Nanosphere had been acquired at the beginning of January 1, 2015, and includes the effect of estimated amortization of acquired identifiable intangible assets, removal of interest expense on Nanosphere&#8217;s debt extinguished at the date of the Acquisition, and removal of Acquisition costs and the impact of purchase accounting adjustments, tax and inventory valuation adjustments. This unaudited pro forma financial information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have resulted had the Acquisition been in effect at the beginning of the periods presented. In addition, the unaudited pro forma financial information is not intended to be a projection of future results and does not reflect any operating efficiencies or cost savings that might be achievable.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(unaudited)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212,320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">191,483</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,814</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,060</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,792</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per share, basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.07</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares used in computing net income (loss) per share, basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,041</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per share, diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.07</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares used in computing net income (loss) per share, diluted</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,929</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,354</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 12 - COMMITMENTS AND CONTINGENCIES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 30, 2012, Abbott Laboratories, Inc. (Abbott) was named as a defendant in a complaint filed by ENZO Life Sciences, Inc. (ENZO) in U.S. District Court in Delaware for alleged infringement of U.S. Patent 7,064,197 as a result of Abbott's distribution of Luminex's xTAG Respiratory Viral Panel.&#160; Luminex and Abbott entered&#160;into an agreement requiring Luminex to defend and indemnify Abbott for any alleged patent infringement resulting from its distribution of Luminex's xTAG Respiratory Viral Panel.&#160;The complaint sought unspecified monetary damages and injunctive relief.&#160; Abbott filed an answer to the complaint on October 15, 2012.&#160; On November 30, 2012, Luminex intervened in the lawsuit. On January 2, 2013, ENZO filed additional claims against Luminex,&#160;alleging infringement of U.S. Patent 7,064,197 resulting from Luminex's sale of its&#160;xTAG, FlexScript LDA, SelecTAG, and xMAP Salmonella Serotyping Assay&#160;products and alleging infringement of U.S. Patent 8,097,405 resulting from Luminex's&#160;sale of MultiCode</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;products.&#160;Luminex filed an answer to ENZO's additional claims on January 28, 2013.&#160;&#160;On October 2, 2013, ENZO filed additional claims against Luminex, alleging infringement of U.S. Patent 6,992,180 resulting from Luminex&#8217;s sale of MultiCode</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> products.&#160;Luminex filed an answer to ENZO&#8217;s additional claims on October 21, 2013.</font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective July 2, 2015, Luminex agreed to pay ENZO </font><font style="font-family:inherit;font-size:10pt;">$7.1 million</font><font style="font-family:inherit;font-size:10pt;"> to settle the litigation. This settlement resulted in the entry of orders dismissing (i) with prejudice all claims, counterclaims and causes of action asserted by ENZO against Luminex, (ii) without prejudice all claims, counterclaims and causes of action asserted by Luminex against ENZO, (iii) with prejudice all claims, counterclaims and causes of action solely under U.S. Patent 7,064,197 asserted in the litigation by ENZO against Abbott and (iv) without prejudice all claims, counterclaims and causes of action relating solely to U.S. Patent 7,064,197 asserted by Abbott against ENZO; and resulted in the grant to the Company and its affiliates of a fully paid, non-exclusive, worldwide license under the patents asserted in the complaint. In addition, the Company and ENZO released each other from certain claims related to the above-referenced patents, including the claims and counterclaims asserted in the complaint. ENZO further released Abbott from certain claims, including those asserted in the complaint, related solely to U.S. Patent 7,064,197. The settlement was entered into solely by way of compromise and does not constitute an admission or concession by Luminex of any liability or wrongdoing.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because Luminex (i) never paid any royalties to ENZO in the past, (ii) will not be required to pay any future or ongoing royalties to ENZO as a result of the settlement, (iii) has never recorded any revenue or expense related to ENZO in operating revenue or in operating expenses in the past, outside of legal fees, and (iv) believes that it does not infringe on any valid and enforceable claim with respect to the asserted patents, Luminex determined that this settlement of litigation expense was outside of operations. Luminex accordingly recorded the settlement as a separate, non-operating line item in the second quarter of 2015. Luminex made the </font><font style="font-family:inherit;font-size:10pt;">$7.1 million</font><font style="font-family:inherit;font-size:10pt;"> payment to ENZO in July 2015.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When and if it appears probable in management's judgment, and based upon consultation with outside counsel, that we will incur monetary damages or other costs in connection with any claims or proceedings, and such costs can be reasonably estimated, we record the estimated liability in the financial statements. &#160;If only a range of estimated losses can be estimated, we record an amount within the range that, in management's judgment, reflects the most likely outcome; if none of the estimates within that range is a better estimate than any other amount, we record the liability at the low end of the range of estimates. Any such accrual would be charged to expense in the appropriate period.&#160;&#160; We disclose significant contingencies when the loss is not probable and/or the amount of the loss is not estimable, when we believe there is at least a reasonable possibility that a loss has been incurred.&#160; We recognize costs associated with legal proceedings in the period in which the services were provided.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 7 &#8212; OTHER COMPREHENSIVE INCOME (LOSS)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss) represents a measure of all changes in equity that result from recognized transactions and other economic events other than those resulting from investments by and distributions to shareholders. Other comprehensive income (loss) for the Company includes foreign currency translation adjustments and net unrealized holding gains and losses on available-for-sale investments.</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the changes in each component of accumulated other comprehensive income (loss), net of tax (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Available-for-Sale Investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Other Comprehensive Income (Loss) Items</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">330</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net current-period other comprehensive income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of September 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(966</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(966</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the tax (expense) benefit allocated to each component of other comprehensive income (loss) (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Before Tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax Benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net of Tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Before Tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax Benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net of Tax</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized gains on available-for-sale investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">336</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">330</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 9 &#8212; STOCK-BASED COMPENSATION</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s stock option activity for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> was as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Options (shares in thousands)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding as of December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,692</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">886</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(143</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.58</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding as of September 30, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company had </font><font style="font-family:inherit;font-size:10pt;">$11.7 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation costs related to stock options as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, which costs are expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">2.86 years</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s restricted share activity for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> was as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Awards (shares in thousands)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average Grant Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(205</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(53</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.36</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of September 30, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">878</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Units (in thousands)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of September 30, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation costs related to Restricted Stock Awards (RSAs) and Restricted Stock Units (RSUs), respectively. This cost is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">2.36 years</font><font style="font-family:inherit;font-size:10pt;"> years for the RSAs and </font><font style="font-family:inherit;font-size:10pt;">1.95 years</font><font style="font-family:inherit;font-size:10pt;"> years for the RSUs. The Company issues a small number of cash settled RSUs pursuant to the Company's equity incentive plan in certain foreign countries. These grants do not result in the issuance of common stock and are considered immaterial by the Company. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following are the stock-based compensation costs recognized in the Company&#8217;s condensed consolidated statements of comprehensive income (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">903</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">754</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">725</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,705</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,438</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,382</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,321</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation costs reflected in net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,526</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,099</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,181</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,768</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 8 &#8212; EARNINGS PER SHARE</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the denominators used in computing per share net income, or EPS, is as follows (in thousands, except per share amounts):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,751</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,402</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,174</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,484</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator for basic net income per share - weighted average common stock outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,152</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,522</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,041</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities: stock options and awards</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">404</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">407</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator for diluted net income per share - weighted average shares outstanding - diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,136</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,556</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,929</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,354</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net income per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.39</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted net income per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.39</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net income per share is computed by dividing the net income for the period by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed by dividing the net income for the period by the weighted average number of common and common equivalent shares outstanding during the period.&#160;Stock options to acquire approximately </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">0.6 million</font><font style="font-family:inherit;font-size:10pt;"> shares for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">0.6 million</font><font style="font-family:inherit;font-size:10pt;"> shares for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and 2015, respectively, were excluded from the computations of diluted EPS because the effect of including those stock options would have been anti-dilutive.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the Company&#8217;s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;"> (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements as of September 30, 2016 Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money Market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements as of December 31, 2015 Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money Market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,988</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,988</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,459</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,459</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 5 &#8212; FAIR VALUE MEASUREMENT</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Fair Value Measurements and Disclosures Topic of the&#160;Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) defines fair value, establishes a framework for measuring fair value under U.S. GAAP and enhances disclosures about fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The ASC describes a fair value hierarchy based on the following three levels of inputs that may be used to measure fair value, of which the first two are considered observable and the last unobservable:</font></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">Level 1 &#8211;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted prices in active markets for identical assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:84px;text-indent:-60px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">Level 2 &#8211;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:84px;text-indent:-60px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:78px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">Level 3 &#8211;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines the fair value of its investment portfolio assets by obtaining non-binding market prices from its third-party portfolio managers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value.&#160;There were no transfers between Level 1, Level 2, or Level 3 measurements for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> month period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the Company&#8217;s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;"> (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements as of September 30, 2016 Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money Market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements as of December 31, 2015 Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money Market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,988</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,988</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,459</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,459</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 6 &#8212; GOODWILL AND OTHER INTANGIBLE ASSETS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 30, 2016, the Company completed the Acquisition. As a result of the Acquisition, the Company recorded approximately </font><font style="font-family:inherit;font-size:10pt;">$34.3 million</font><font style="font-family:inherit;font-size:10pt;"> of goodwill and </font><font style="font-family:inherit;font-size:10pt;">$41.7 million</font><font style="font-family:inherit;font-size:10pt;"> of other identifiable intangible assets. The goodwill is derived from expected synergies from combining operations of the Company and Nanosphere. The purchase price allocation is preliminary as the Company&#8217;s determination of the fair values of the assets acquired and liabilities assumed is still in process. </font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill is reviewed for impairment at least annually at the beginning of the fourth quarter, or more frequently if impairment indicators arise. The Company's goodwill is not expected to be deductible for tax purposes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in the carrying amount of the Company&#8217;s goodwill during the period are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,619</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,619</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition of Nanosphere</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,279</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,898</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,619</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s intangible assets are reflected in the table below (in thousands, except weighted average lives):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Finite-lived</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Indefinite-lived</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology, trade secrets and know-how</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer lists and contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other identifiable intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IP R&amp;D</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,958</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,890</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,652</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Completion of IP R&amp;D project</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Removal of fully amortized assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(702</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(238</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,101</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,652</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: accumulated amortization:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization balance as of December 31, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19,325</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,085</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(860</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,023</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(743</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(134</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,900</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Removal of fully amortized assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">702</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization balance as of December 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,667</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(756</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,069</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net balance as of December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,456</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,130</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">896</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52,482</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average life (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,652</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions due to acquisition of Nanosphere</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,282</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,409</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,012</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,982</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of September 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,384</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,206</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,664</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,982</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: accumulated amortization:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization balance as of December 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,667</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,069</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,683</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(902</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(212</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,797</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization balance as of September 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,329</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,569</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(968</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31,866</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net balance as of September 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,055</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,637</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,696</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,982</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,370</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average life (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated aggregate amortization expense for the next five fiscal years and thereafter is as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016 (three months)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,482</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,979</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,789</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,789</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,789</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,560</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,388</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IPR&amp;D</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,982</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,370</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OTE 11 &#8212; INCOME TAXES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the end of each interim reporting period, an estimate is made of the effective tax rate expected to be applicable for the full year.&#160;The estimated full year&#8217;s effective tax rate is used to determine the income tax rate for each applicable interim reporting period.&#160;The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period of the enactment date. The effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">21.70%</font><font style="font-family:inherit;font-size:10pt;">, including amounts recorded for discrete events. This differs from the statutory rate of </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> primarily because of the worldwide mix of consolidated earnings and losses before taxes and an assessment regarding the realizability of the Company&#8217;s deferred tax assets.&#160;The Company&#8217;s tax expense reflects the full federal, various state, and foreign blended statutory rates.&#160;The Company is utilizing its net operating losses and tax credits in the U.S., Canada and the Netherlands and currently expects a full year effective tax rate of less than </font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;">. Therefore, cash taxes to be paid are expected to continue to be less than </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> of book tax expense.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, Australia, Canada, China, Hong Kong, Japan, the Netherlands, and various states.&#160;Due to net operating losses, the U.S., Canadian and Australian tax returns dating back to 2011 can still be reviewed by the taxing authorities. No material changes to this liability are expected within the next 12 months.&#160;For the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, there were no material changes to the total amount of unrecognized tax benefits.&#160;The Company recognizes interest and penalties related to uncertain tax positions in the provision for income taxes.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 4 &#8212; INVENTORIES, NET</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of cost or market, with cost determined according to the standard cost method, which approximates the first-in, first-out method.&#160;The Company routinely assesses its on-hand inventory for timely identification and measurement of obsolete, slow-moving or otherwise impaired inventory. Inventories consisted of the following (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Parts and supplies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,792</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-progress</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,797</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,159</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,455</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,252</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 3 &#8212; INVESTMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Marketable Securities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determines the appropriate classification of its investments in debt and equity securities at the time of purchase and re-evaluates such determinations at each balance sheet date.&#160;Marketable securities that are bought and held principally for the purpose of selling them in the near term are classified as trading securities and are reported at fair value, with unrealized gains and losses recognized in earnings.&#160;Debt securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are stated at amortized cost, which approximates the fair value of these investments.&#160;Debt securities for which the Company does not have the intent or ability to hold to maturity are classified as available-for-sale. Debt and marketable equity securities not classified as held-to-maturity or as trading are classified as available-for-sale, and are carried at fair market value, with the unrealized gains and losses included in the determination of comprehensive income and reported in stockholders&#8217; equity.&#160;As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, all of the Company&#8217;s marketable securities were classified as available-for-sale.&#160;Marketable securities are recorded as either short-term or long-term on the balance sheet based on the contractual maturity date.&#160;The fair value of all securities is determined by quoted market prices, market interest rate inputs, or other than quoted prices that are observable either directly or indirectly (as of the end of the reporting period).&#160;Declines in fair value below the Company&#8217;s carrying value deemed to be other than temporary are charged against net earnings. As of </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had no short or long term investments, since those funds were used to pay for the Acquisition.</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities consisted of the following as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gains in Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Losses in Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total noncurrent securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">701</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities consisted of the following as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortized Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gains in Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Losses in Accumulated Other Comprehensive Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,990</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,001</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,998</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,132</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncurrent:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,998</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,992</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-government sponsored debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,491</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,467</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total noncurrent securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,489</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,459</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,591</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from the sales of available-for-sale securities during the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> totaled </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$19.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and these proceeds were used to partially fund the Acquisition. There were no proceeds from the sales of available-for-sale securities for the </font><font style="font-family:inherit;font-size:10pt;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">. Realized gains and losses on sales of investments are determined using the specific identification method.&#160;Realized gains and losses are included in Other income, net in the Consolidated Statements of Comprehensive Income. All of the Company's available-for-sale securities with gross unrealized holding losses as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;"> had been in a loss position for less than 12 months.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated fair value of available-for-sale debt securities as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, by contractual maturity, was as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due in one year or less</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,988</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after one year through two years</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,459</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,447</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Non-Marketable Securities and Other-Than-Temporary Impairment </font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third quarter of 2016, the Company made a </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> minority interest investment in a private company based in the U.S. that is focused on development of next generation technologies. This minority interest is included at cost in other long-term assets on the Company&#8217;s Consolidated Balance Sheets as the Company does not have significant influence over the investee since the Company owns less than </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> of the voting equity in the investee and the investee is not publicly traded. Although we may invest further in this entity over the course of the next several quarters, we do not anticipate our ownership interest to exceed 20% in the short term.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company owns a minority interest in a private company based in the U.S. through its investment of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> in the third quarter of 2012. &#160;This minority interest is included at cost in other long-term assets on the Company&#8217;s Consolidated Balance Sheets as the Company does not have significant influence over the investee since the Company owns less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">20%</font><font style="font-family:inherit;font-size:10pt;"> of the voting equity in the investee and the investee is not publicly traded. </font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's other minority interest in a private company was acquired by a third party in July 2013. The Company realized a gain of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;"> on the sale of this minority interest investment in the third quarter of 2013 and an additional gain of </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> in the first quarter of 2015 related to the settlement of escrowed funds.</font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company regularly evaluates the carrying value of its cost-method investment for impairment and whether any events or circumstances are identified that would significantly harm the fair value of the investment. The primary indicators the Company utilizes to identify these events and circumstances are the investee's ability to remain in business, such as the investee's liquidity and rate of cash use, and&#160;the investee&#8217;s ability to secure additional funding and the value of that additional funding. In the event a decline in fair value is judged to be other-than-temporary, the Company will record an other-than-temporary impairment charge in Other income, net in the Consolidated Statements of Comprehensive Income. As the inputs utilized for the Company's periodic impairment assessment are not based on observable market data, the determination of fair value of this cost-method investment is classified within Level 3 of the fair value hierarchy. See Note 5 - Fair Value Measurement to our condensed consolidated financial statements for further discussion. To determine the fair value of this investment, the Company uses all available financial information related to the entities, including information based on recent or pending third-party equity investments in these entities. In certain instances, a cost-method investment's fair value is not estimated as there are no identified events or changes in the circumstances that may have a significant adverse effect on the fair value of the investment and to do so would be impractical.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 1 &#8212; BASIS OF PRESENTATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared by Luminex Corporation (the Company or Luminex) in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, all adjustments (consisting of normal recurring entries) considered necessary for a fair presentation have been included. Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the year ending </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> (the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> 10-K).</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 10 &#8212; ACCRUED LIABILITIES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation and employee benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,946</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income and other taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">734</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,261</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warranty costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">667</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,199</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,392</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales of certain of the Company's systems are subject to a warranty.&#160;System warranties typically extend for a period of 12 months from the date of installation not to exceed 24 months from the date of shipment.&#160;The Company estimates the amount of warranty claims on sold products that may be incurred based on current and historical data.&#160;The actual warranty expense could differ from the estimates made by the Company based on product performance.&#160;Warranty expenses are evaluated and adjusted periodically.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the changes in the warranty accrual (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued warranty costs as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warranty adjustments/settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(582</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for warranty costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued warranty costs as of September 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">667</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation and employee benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,946</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income and other taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">734</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,261</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warranty costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">667</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,199</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,392</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the changes in each component of accumulated other comprehensive income (loss), net of tax (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency Items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Available-for-Sale Investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Other Comprehensive Income (Loss) Items</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,258</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">330</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net current-period other comprehensive income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of September 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(966</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(966</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the tax (expense) benefit allocated to each component of other comprehensive income (loss) (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Before Tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax Benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net of Tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Before Tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax Benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net of Tax</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized gains on available-for-sale investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">336</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">330</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the denominators used in computing per share net income, or EPS, is as follows (in thousands, except per share amounts):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended September 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nine Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,751</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,402</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,174</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,484</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator for basic net income per share - weighted average common stock outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,152</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,522</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,041</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities: stock options and awards</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">453</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">404</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">407</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator for diluted net income per share - weighted average shares outstanding - diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,136</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,556</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,929</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,354</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net income per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.39</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted net income per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.39</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s intangible assets are reflected in the table below (in thousands, except weighted average lives):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Finite-lived</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Indefinite-lived</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology, trade secrets and know-how</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer lists and contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other identifiable intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IP R&amp;D</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,958</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,890</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,652</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Completion of IP R&amp;D project</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Removal of fully amortized assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(702</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(238</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,101</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,652</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: accumulated amortization:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization balance as of December 31, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19,325</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,085</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(860</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,023</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(743</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(134</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,900</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Removal of fully amortized assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">702</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization balance as of December 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,646</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,667</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(756</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,069</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net balance as of December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,456</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,130</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">896</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52,482</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average life (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,652</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions due to acquisition of Nanosphere</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,282</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,409</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,012</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,982</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of September 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,384</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,206</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,664</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,982</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: accumulated amortization:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization balance as of December 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,667</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,069</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,683</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(902</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(212</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,797</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization balance as of September 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,329</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,569</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(968</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31,866</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net balance as of September 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,055</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,637</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,696</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,982</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,370</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average life (in years)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in the carrying amount of the Company&#8217;s goodwill during the period are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,619</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,619</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition of Nanosphere</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,279</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,898</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,619</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories consisted of the following (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Parts and supplies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,792</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-progress</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,797</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,159</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,455</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,252</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTE 13 &#8212; RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently adopted accounting guidance</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued guidance that simplifies some provisions in stock compensation accounting related to accounting for a stock payment&#8217;s tax consequences. The guidance also amends how excess tax benefits and a company's payments to cover the tax bills for the shares&#8217; recipients should be classified. The amendments allow companies to estimate the number of stock awards they expect to vest, and the amendments also revise the withholding requirements for classifying stock awards as equity. This guidance is effective for annual periods beginning after December 15, 2016. Early adoption is permitted. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This new standard requires that an entity recognize excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement when the awards vest or are settled. Under the previous standard, excess tax benefits and tax deficiencies were recognized in additional paid-in capital. Cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows. In addition, related cash payments made on an employee's behalf for shares withheld are presented as a financing activity on the statement of cash flows.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company early adopted this standard in the quarter ended June 30, 2016. The adoption of this standard resulted in the recognition of </font><font style="font-family:inherit;font-size:10pt;">$6.9 million</font><font style="font-family:inherit;font-size:10pt;"> of previously unrecognized excess tax benefits in deferred income taxes, net and an increase to retained earnings on our Consolidated Balance Sheet and the recognition of </font><font style="font-family:inherit;font-size:10pt;">$211,000</font><font style="font-family:inherit;font-size:10pt;"> of income tax expense in our income tax provision for the nine months ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">. We have elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost to be recognized in each period. </font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2015, the FASB issued additional guidance on business combinations. This guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period with a corresponding adjustment to goodwill in the reporting period in which the adjustment amounts are determined. The effect on earnings from changes in depreciation, amortization or other income effects, if any, as a result of the change to the provisional amounts will be recorded in the same period's financial statements, calculated as if the accounting had been completed at the acquisition date. The Company adopted this standard during the quarter ended June 30, 2016, and its adoption did not have any impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recent accounting guidance not yet adopted</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued specific guidance on eight cash flow classification issues that are not currently addressed by current U.S. GAAP and thereby reduce the current diversity in practice.&#160;&#160;This guidance is effective for annual periods beginning after December 15, 2017. Early adoption is permitted. The Company does not anticipate that this guidance will have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued guidance requiring lessees to recognize a right-of-use asset and a lease liability on the balance sheet for all leases with the exception of short-term leases. The effective date of the new guidance is for the Company's first quarter of fiscal 2019 and early adoption is permitted. The new standard must be adopted using a modified retrospective transition and requires application of the new guidance at the beginning of the earliest comparative period presented. The Company is currently evaluating the impact of the adoption of this requirement on its consolidated financial statements, but does not anticipate that adoption of this guidance will have a material impact on its consolidated financial statements except for the addition of the right-of-use asset and a lease liability to the balance sheet. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued guidance that changes how entities measure equity investments that do not result in consolidation and are not accounted for under the equity method. Entities will be required to measure these investments at fair value at the end of each reporting period and recognize changes in fair value in net income. This guidance also changes certain disclosure requirements and other aspects of current U.S. GAAP. This guidance is effective for annual periods beginning after December 15, 2017. Early adoption is permitted. The Company does not anticipate that adoption of this guidance will have a material impact on its consolidated financial statements as the only potential impact would be related to the Company's one cost-method investment discussed in Note 3 - Investments.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued guidance regarding the measurement of inventory. The new guidance requires inventory to be measured at the lower of cost and net realizable value, which is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. This new guidance is effective for the Company's first quarter of fiscal 2018 and early adoption is permitted. The guidance must be applied prospectively. The Company is currently evaluating the impact of the adoption of this requirement on its consolidated financial statements, but does not anticipate that adoption of this guidance will have a material impact on its consolidated financial statements. </font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued a new standard on revenue recognition which outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the revenue model is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In doing so, companies will need to use their judgment and make estimates more extensively than under current U.S. GAAP. These judgments may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The standard is designed to create greater comparability for financial statement users across industries and jurisdictions and also requires enhanced disclosures. On July 9, 2015, the FASB voted in favor of delaying the effective date of the new standard by one year, with early adoption permitted as of the original effective date. The guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the changes in the warranty accrual (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued warranty costs as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warranty adjustments/settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(582</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for warranty costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued warranty costs as of September 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">667</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the estimated fair values of Nanosphere&#8217;s assets acquired and liabilities assumed at June 30, 2016 (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net tangible assets assumed as of June 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,387</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt and accrued interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,391</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets, net of deferred tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,449</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total purchase price</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,409</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less cash and cash equivalents acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash paid for business acquisition</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,098</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s stock option activity for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> was as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Options (shares in thousands)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding as of December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,692</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">886</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(143</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.58</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding as of September 30, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s restricted share activity for the </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> was as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Awards (shares in thousands)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average Grant Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(205</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(53</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.36</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of September 30, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">878</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Units (in thousands)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cancelled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested as of September 30, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated aggregate amortization expense for the next five fiscal years and thereafter is as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016 (three months)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,482</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,979</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,789</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,789</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,789</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,560</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,388</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IPR&amp;D</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,982</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,370</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> EX-101.SCH 7 lmnx-20160930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2113100 - Disclosure - ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - BASIS OF PRESENTATION (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - BUSINESS COMBINATIONS link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - BUSINESS COMBINATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - BUSINESS COMBINATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2415401 - Disclosure - COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Parenthetical link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - FAIR VALUE MEASUREMENTS (Details 1) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2414401 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - INVENTORY, NET link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - INVENTORY, NET (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - INVENTORY, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - INVESTMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - OTHER COMPREHENSIVE (LOSS) INCOME link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - OTHER COMPREHENSIVE (LOSS) INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - OTHER COMPREHENSIVE (LOSS) INCOME (Details 1) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - OTHER COMPREHENSIVE (LOSS) INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 2416401 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS RECENT ACCOUNTING PRONOUNCEMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - RESTRUCTURING (Details) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - RESTRUCTURING RESTRUCTURING link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - RESTRUCTURING RESTRUCTURING (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - STOCK-BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - STOCK-BASED COMPENSATION (Details 1) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - SUBSEQUENT EVENTS (Notes) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - SUBSEQUENT EVENTS (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 lmnx-20160930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 lmnx-20160930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 lmnx-20160930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Investments [Abstract] INVESTMENTS Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Income Statement Location [Axis] Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain] Income Statement Location [Domain] Cost of revenue Cost of Sales [Member] Research and development Research and Development Expense [Member] Selling, general and administrative General and Administrative Expense [Member] Selling, general and administrative Reflected in Net Income (Loss) [Member] The allocation (or location) of expense to (in) net income (loss). Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Compensation, allocation and classification in income statements [Abstract] Share-based Compensation, allocation and classification in income statements [Abstract] Stock-based compensation costs Allocated Share-based Compensation Expense Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Business Combinations [Abstract] Business Combination Disclosure [Text Block] Business Combination Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Changes in the carrying amount of goodwill Schedule of Goodwill [Table Text Block] Schedule of intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Estimated aggregate amortization expense for the next five years and thereafter Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Statement of Comprehensive Income [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Accumulated Translation Adjustment [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Available-for-sale Securities [Member] Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Statement [Line Items] Statement [Line Items] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Balance as of December 31, 2015 Accumulated Other Comprehensive Income (Loss), Net of Tax Other comprehensive income before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Net current-period other comprehensive income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Balance as of September 30, 2016 Entity [Abstract] Entity [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of Comprehensive Income (Loss) Comprehensive Income (Loss) [Table Text Block] FAIR VALUE MEASUREMENT Fair Value Disclosures [Text Block] Other Comprehensive Income (Loss), Net of Tax [Abstract] Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments, before tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent Foreign currency translation adjustments, tax benefit Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent Foreign currency translation adjustments, net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Unrealized gains on available-for-sale investments, before tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, before Tax Unrealized gains on available-for-sale investments, tax benefit Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax Unrealized gains on available-for-sale investments, net of tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Other comprehensive (loss) income, before tax Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent Other comprehensive (loss) income, tax benefit Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Other comprehensive (loss) income, net of tax Comprehensive Income (Loss) Note Comprehensive Income (Loss) Note [Text Block] Components of available-for-sale securities Available-for-sale Securities [Table Text Block] Estimated fair value of available-for-sale debt securities, by contractual maturity Estimated fair value of available-for-sale debt securities, by contractual maturity [Table Text Block] Tabular disclosure of the contractual maturities of short-term investments designated as available-for-sale. Fair Value of Assets Measured on Recurring Basis [Table] Fair Value of Assets Measured on Recurring Basis [Table] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Non-Current Non-Government Sponsored Debt Securities [Member] Non-Current Non-Government Sponsored Debt Securities [Member] This element represents non-government sponsored debt securities investments that can be investments in debentures, bonds and other debt securities which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Fair Value, Measurements [Domain] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value of Assets Measured on Recurring Basis [Line Items] Fair Value of Assets Measured on Recurring Basis [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Amounts included in asset accounts [Abstract] Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Money Market funds Money Market Funds Fair Value Disclosure This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. This item represents money market funds, a fund that has underlying investments in short-term money-market instruments and pays money market rates of interest. Government sponsored debt securities fair value disclosure Government sponsored debt securities fair value disclosure This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. This element represents government sponsored debt securities investments that can be investments in debentures, bonds and other debt securities issued by GSEs. Non-government sponsored debt securities fair value disclosure Non-government sponsored debt securities fair value disclosure This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. This element represents non-government sponsored debt securities investments that can be investments in debentures, bonds and other debt securities. Accrued Liabilities, Current [Abstract] Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Liabilities [Table Text Block] Changes in warranty accrual Schedule of Product Warranty Liability [Table Text Block] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Business Acquisition, Pro Forma Information [Table Text Block] Business Acquisition, Pro Forma Information [Table Text Block] Income Tax Disclosure [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Intangible Assets [Table] Intangible Assets [Table] Asset Class [Axis] Asset Class [Axis] Asset Class [Domain] Asset Class [Domain] Acquired Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Technology, Trade Secrets, and Know-how [Member] Technology, Trade Secrets, and Know-how [Member] Information related to acquired Technology, Know-How, and Trade Secrets. Technology pertains to right to develop, use, market, sell or offer for sale the product, compounds and intellectual property that has been acquired with respect to products, compounds or processes that have been completed. Trade secrets is, generally, known to only a limited number of the entity's employees, such as a formula, pattern, machine, technology, and production process that may give an entity a competitive advantage. Customer Lists and Contracts [Member] Customer Lists [Member] Other Identifiable Intangible Assets [Member] Other Intangible Assets [Member] Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process Research and Development [Member] In Process Research and Development [Member] Intangible Assets [Line Items] Intangible Assets [Line Items] A table containing detailed characteristics of intangible assets acquired during the period, both finite and indefinite lived intagible assets. Goodwill [Roll Forward] Goodwill [Roll Forward] Balance at beginning of year Goodwill Goodwill Goodwill, Acquired During Period Balance at end of period Finite and Indefinite-lived Intangible Assets [Roll Forward] Finite and Indefinite-lived Intangible Assets [Roll Forward] Finite and Indefinite-lived Intangible Assets [Roll Forward] Balance, beginning Intangible Assets, Gross Sum of the gross carrying amounts before accumulated amortization as of the balance sheet date of all intangible assets. The aggregate gross carrying amount (including any previously recognized impairment charges). A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Completion of In Process Research and Development Project Completion of In Process Research and Development Project Completion of In Process Research and Development Project Removal of fully amortized assets Removal of fully amortized assets Amount of decrease in assets due to the removal of fully amortized intangible assets Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets The amount of acquisition cost of a business combination allocated to an identifiable intangible asset that will be amortized. Balance, ending Less: accumulated amortization [Abstract] Amortization [Abstract] Accumulated amortization, beginning balance Finite-Lived Intangible Assets, Accumulated Amortization Amortization expense Amortization of Intangible Assets Removal of amortization of fully amortized assets Removal of amortization of fully amortized assets Amount of decrease in amortization due to removal of amortization expense of fully amortized assets Accumulated amortization, ending balance Net balance Intangible Assets, Net (Excluding Goodwill) Weighted average life (in years) Finite-Lived Intangible Asset, Useful Life Estimated aggregate amortization expense for the next five years and thereafter [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] 2016 (three months) Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Total Finite-Lived Intangible Assets, Future Amortization Expense, Except In-process Research and Development Finite-Lived Intangible Assets, Future Amortization Expense, Except In-process Research and Development IPR&D Finite-Lived Intangible Assets, Future Amortization Expense, In-process Research and Development The aggregate estimated amortization expense for succeeding fiscal years for In-process Research and Development intangible asset subject to amortization. Total Finite-Lived Intangible Assets, Net RESTRUCTURING [Abstract] RESTRUCTURING [Abstract] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Line Items] Subsequent Event [Line Items] Settlement of litigation Gain (Loss) Related to Litigation Settlement Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Nanosphere [Member] Nanosphere [Member] Nanosphere [Member] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Business Acquisition, Share Price Business Acquisition, Share Price Business Acquisition, Cost of Acquired Entity, Cash Paid Business Acquisition, Cost of Acquired Entity, Cash Paid Amount of cash paid to acquire the entity. Business acquisition, consideration of cancelled options and restricted stock Business acquisition, consideration of cancelled options and restricted stock Business acquisition, consideration of cancelled options and restricted stock Business acquisition, warrants outstanding Business acquisition, warrants outstanding Business acquisition, warrants outstanding Business acquisition, consideration to warrant holders Business acquisition, consideration to warrant holders Business acquisition, consideration to warrant holders Business acquisition, accrued interest on debt Business acquisition, accrued interest on debt Business acquisition, accrued interest on debt Business acquisition, cash acquired during acquisition Cash Business Acquisition, Transaction Costs Business Acquisition, Transaction Costs Net tangible assets assumed as of June 30, 2016 Business acquisition, net tangible assets assumed Business acquisition, net tangible assets assumed Intangible assets subject to amortization Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Long-term debt and accrued interest Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Deferred tax assets, net of deferred tax liabilities Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Business Acquisition, Cost of Acquired Entity, Purchase Price Business Acquisition, Cost of Acquired Entity, Purchase Price The total cost of the acquired entity including the cash paid to shareholders of acquired entities, fair value of debt and equity securities issued to shareholders of acquired entities, the fair value of the liabilities assumed, and direct costs of the acquisition. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Net cash paid for business acquisition Business Acquisition, Net Cash Paid Business Acquisition, Net Cash Paid Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Revenue Revenue, Net Net loss Net Income (Loss) Attributable to Parent Business Acquisition, Pro Forma Revenue Business Acquisition, Pro Forma Revenue Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax Business Acquisition, Pro Forma Net Income (Loss) Business Acquisition, Pro Forma Net Income (Loss) Business Acquisition, Pro Forma Earnings Per Share, Basic Business Acquisition, Pro Forma Earnings Per Share, Basic Denominator for basic net income per share - weighted average common stock outstanding Weighted Average Number of Shares Outstanding, Basic Business Acquisition, Pro Forma Earnings Per Share, Diluted Business Acquisition, Pro Forma Earnings Per Share, Diluted Denominator for diluted net income per share - weighted average shares outstanding - diluted Weighted Average Number of Shares Outstanding, Diluted Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Award Type and Plan Name [Axis] Award Type [Axis] Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Equity Award [Domain] Stock Options [Member] Employee Stock Option [Member] Restricted Stock [Member] Restricted Stock [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock options, outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Options outstanding, beginning balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Cancelled or expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Options outstanding, ending balance (in shares) Stock options, additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted-average price, beginning of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted-average price, granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average price, exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted-average price, cancelled or expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted-average price, end of period (in dollars per share) Total unrecognized compensation costs Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Unrecognized compensation costs, weighted average period of recognition (in years) Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Equity instruments other than options, nonvested [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Non-vested, beginning balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Cancelled or expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Non-vested, ending balance (in shares) Equity instruments other than options, additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Non-vested, beginning balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Cancelled or expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Non-vested, ending balance (in dollars per share) Fair value, financial assets (cash equivalents and investments) measured on a recurring basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Accrued Employee Benefits, Current Accrued Employee Benefits, Current Accrued Income And Other Taxes Accrued Income And Other Taxes Accrued income and other taxes. Other Accrued Liabilities, Current Other Accrued Liabilities, Current Accrued liabilities Accrued Liabilities, Current Accrued warranty costs [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Accrued warranty costs as of December 31, 2015 Standard Product Warranty Accrual Warranty adjustments/settlements Standard Product Warranty Accrual, Decrease for Payments Accrual for warranty costs Standard Product Warranty Accrual, Increase for Warranties Issued Accrued warranty costs as of September 30, 2016 STOCK-BASED COMPENSATION Disclosure of Compensation Related Costs, Share-based Payments [Text Block] CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] Income Statement [Abstract] Income Statement [Abstract] Revenue Cost of revenue Cost of Goods and Services Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Amortization of acquired intangible assets Total operating expenses Operating Expenses Income from operations Operating Income (Loss) Other income (expense), net Other Nonoperating Income (Expense) Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income taxes Income Tax Expense (Benefit) Net income Other comprehensive income: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Unrealized gain on available-for-sale securities, net of tax Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Other comprehensive income (loss) Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Net income per share, basic Earnings Per Share, Basic Shares used in computing net income per share, basic Net income per share, diluted Earnings Per Share, Diluted Shares used in computing net income per share, diluted New Accounting Pronouncements and Changes in Accounting Principles [Abstract] RECENT ACCOUNTING PRONOUNCEMENTS Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Inventory, Net [Abstract] Schedule of Inventory, Current Schedule of Inventory, Current [Table Text Block] Parts and supplies Inventory, Raw Materials and Supplies, Gross Work-in-progress Inventory, Work in Process, Gross Finished goods Inventory, Finished Goods, Gross Inventory, net Inventory, Net COMMITTMENTS AND CONTINGENCIES [Abstract] COMMITTMENTS AND CONTINGENCIES [Abstract] Settlement of litigation Earnings Per Share [Abstract] Numerator: Numerator: [Abstract] Net income Denominator: Denominator: [Abstract] Effect of dilutive securities: stock options and awards Weighted Average Number Diluted Shares Outstanding Adjustment Basic net income per share Diluted net income per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive restricted stock awards, stock options Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Stock options activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Restricted shares activity Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Stock-based compensation costs recognized in consolidated statements of income Stock-based compensation costs recognized in consolidated statements of income [Table Text Block] Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the income statement for the period. This may include the reporting line for the costs and the amount expensed. INVENTORIES, NET Inventory Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] New Accounting Pronouncement, Early Adoption [Table] New Accounting Pronouncement, Early Adoption [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] New Accounting Pronouncement, Early Adoption, Effect [Member] New Accounting Pronouncement, Early Adoption, Effect [Member] New Accounting Pronouncement, Early Adoption [Line Items] New Accounting Pronouncement, Early Adoption [Line Items] Income Tax Expense (Benefit) Retained earnings Retained Earnings (Accumulated Deficit) BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Components of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Investment [Axis] Investment [Axis] Investment [Domain] Investment [Domain] Investment in Private Company 1 [Member] Investment in Private Company 1 [Member] Investment in Private Company 1 [Member] Investment in Private Company 2 [Member] Investment in Private Company 2 [Member] Investment in Private Company 2 [Member] Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis] Money Market Funds [Member] Money Market Funds [Member] Current government-sponsored debt securities [Member] Current government-sponsored debt securities [Member] [Member] Current government-sponsored debt securities [Member] Current Non-Government Sponsored Debt Securities [Member] Current Non-Government Sponsored Debt Securities [Member] This element represents non-government sponsored debt securities investments that can be investments in debentures, bonds and other debt securities which are intended be sold or mature within one year from the balance sheet date or the normal operating cycle, whichever is longer. Total Current Available-for-sale Securities [Member] Total Current Available-for-sale Securities [Member] Total investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities and which are intended be sold or mature within one year from the balance sheet date or the normal operating cycle, whichever is longer. Non-current government sponsored debt securities US Government-sponsored Enterprises Debt Securities [Member] Total Non-Current Available-for-sale Securities [Member] Total Non-Current Available-for-sale Securities [Member] Total Investments in debt and equity securities which are categorized neither as held-to-maturity nor trading and which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Components of Available-for-sale Securities [Line Items] Schedule of Available-for-sale Securities [Line Items] Payments to Acquire Other Investments Payments to Acquire Other Investments Amortized Cost Available-for-sale Securities, Amortized Cost Basis Gains in Accumulated Other Comprehensive Gain Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, before Tax Losses in Accumulated Other Comprehensive Gain Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, before Tax Estimated Fair Value Available-for-sale Securities Available-for-sale Securities [Abstract] Available-for-sale Securities [Abstract] Proceeds from sales of available-for-sale-securities Proceeds from Sale of Available-for-sale Securities Available-for-sale securities, debt maturities [Abstract] Available-for-sale Securities, Debt Maturities [Abstract] Due in one year or less Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value Due after one year through two years Available For Sale Securities Debt Maturities After One Through Two Years Fair Value This item represents the fair value of debt securities which are expected to mature after one year and through two years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities. Total estimated fair value of available-for-sale debt securities Estimated fair value of available-for-sale debt securities fair value disclosure This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. This item represents Available-for-sale Securities which consist of debt investments neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Amount of investments in a private company Amount of investments in a private company The amount of investments in a private company that are intended to be held for an extended period of time (longer than one operating cycle). Ownership percentage in cost method investment Ownership percentage in cost method investment The percentage of ownership of common stock or equity participation in the investee accounted for under the cost method of accounting. The company owns less than the percentage indicated Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Cost-method Investments, Realized Gain (Loss) Schedule of Calculation of Numerator and Denominator in Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Statement of Financial Position [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Short-term Investments Short-term Investments Accounts receivable, net Receivables, Net, Current Inventories, net Prepaids and other Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net Property, Plant and Equipment, Net Intangible assets, net Deferred income taxes Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Long-term investments Long-term Investments Goodwill Other Other Assets, Noncurrent Total assets Assets Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Deferred revenue Deferred Revenue, Current Total current liabilities Liabilities, Current Deferred revenue Deferred Revenue, Noncurrent Other Other Liabilities, Noncurrent Total liabilities Liabilities Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Common stock, $.001 par value, 200,000,000 shares authorized; issued and outstanding: 42,708,733 shares at September 30, 2016; 42,314,581 shares at December 31, 2015 Common Stock, Value, Issued Preferred stock, $.001 par value, 5,000,000 shares authorized; no shares issued and outstanding Preferred Stock, Value, Issued Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated other comprehensive loss Total stockholders' equity Stockholders' Equity Attributable to Parent Total liabilities and stockholders' equity Liabilities and Equity ACCRUED WARRANTY COSTS Product Warranty Disclosure [Text Block] Stockholders' equity: Statement of Stockholders' Equity [Abstract] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, issued (in shares) Common Stock, Shares, Issued Common stock, outstanding (in shares) Common Stock, Shares, Outstanding Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, issued (in shares) Preferred Stock, Shares Issued Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding Statement of Cash Flows [Abstract] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Stock-based compensation Share-based Compensation Deferred income tax expense Deferred Income Tax Expense (Benefit) Excess income tax expense from employee stock-based awards Proceeds and Excess Tax Benefit from Share-based Compensation Loss (gain) on sale or disposal of assets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Other Other Noncash Income (Expense) Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable, net Increase (Decrease) in Receivables Inventories, net Increase (Decrease) in Inventories Other assets Increase (Decrease) in Other Operating Assets Accounts payable Increase (Decrease) in Accounts Payable Accrued liabilities Increase (Decrease) in Accrued Liabilities Deferred revenue Increase (Decrease) in Deferred Revenue Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Sales and maturities of available-for-sale securities Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Proceeds from sale of assets Proceeds from Sale of Productive Assets Business acquisition consideration, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Purchase of cost method investment Acquired technology rights Payments to Acquire Intangible Assets Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Payments on debt Repayments of Long-term Debt Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Shares surrendered for tax withholding Payments Related to Tax Withholding for Share-based Compensation Excess income tax expense from employee stock-based awards Excess Tax Benefit from Share-based Compensation, Financing Activities Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of foreign currency exchange rate on cash Effect of Exchange Rate on Cash and Cash Equivalents Change in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Scenario, Forecast [Member] Scenario, Forecast [Member] Effective tax rate, including amounts recorded for discrete events (in hundredths) Effective Income Tax Rate Reconciliation, Percent Statutory rate (in hundredths) Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Maximum rate for cash taxes expected to be paid (in hundredths) Maximum rate for cash taxes expected to be paid Maximum percentage of cash taxes on pre-tax book income expected to be paid due to the utilization of net operating losses in the U.S. EARNINGS PER SHARE Earnings Per Share [Text Block] EX-101.PRE 11 lmnx-20160930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 lmnxlogoa01a01a02a05.jpg LOGO begin 644 lmnxlogoa01a01a02a05.jpg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end XML 13 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
Document And Entity Information - shares
 9 Months Ended
Sep. 30, 2016
Oct. 31, 2016
Entity [Abstract]    
Entity Registrant Name Luminex Corp  
Entity Central Index Key 0001033905  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   43,584,558
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q3  
Document Type 10-Q  
Document Period End Date Sep. 30, 2016  
Amendment Flag false  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 84,145 $ 128,546
Short-term Investments 0 11,988
Accounts receivable, net 29,962 28,853
Inventories, net 41,455 31,252
Prepaids and other 9,294 8,887
Total current assets 164,856 209,526
Property and equipment, net 55,461 47,796
Intangible assets, net 88,370 52,482
Deferred income taxes 42,208 31,821
Long-term investments 0 7,459
Goodwill 83,898 49,619
Other 6,335 3,853
Total assets 441,128 402,556
Current liabilities:    
Accounts payable 9,881 7,868
Accrued liabilities 16,115 15,152
Deferred revenue 5,601 4,212
Total current liabilities 31,597 27,232
Deferred revenue 1,864 2,064
Other 4,902 4,724
Total liabilities 38,363 34,020
Stockholders' equity:    
Common stock, $.001 par value, 200,000,000 shares authorized; issued and outstanding: 42,708,733 shares at September 30, 2016; 42,314,581 shares at December 31, 2015 43 42
Preferred stock, $.001 par value, 5,000,000 shares authorized; no shares issued and outstanding 0 0
Additional paid-in capital 331,474 321,657
Accumulated other comprehensive loss (966) (1,296)
Retained earnings 72,214 48,133
Total stockholders' equity 402,765 368,536
Total liabilities and stockholders' equity $ 441,128 $ 402,556
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED BALANCE SHEETS Parenthetical - $ / shares
Sep. 30, 2016
Dec. 31, 2015
Stockholders' equity:    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 200,000,000 200,000,000
Common stock, issued (in shares) 42,708,733 42,314,581
Common stock, outstanding (in shares) 42,708,733 42,314,581
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Revenue $ 71,221 $ 60,601 $ 198,368 $ 177,259
Cost of revenue 25,556 18,789 62,976 51,958
Gross profit 45,665 41,812 135,392 125,301
Operating expenses:        
Research and development 12,762 10,093 35,324 31,748
Selling, general and administrative 26,393 21,236 70,942 61,740
Amortization of acquired intangible assets 2,482 777 5,797 2,455
Total operating expenses 41,637 32,106 112,063 95,943
Income from operations 4,028 9,706 23,329 29,358
Other income (expense), net 30 13 (1,395) 964
Settlement of litigation 0 0 0 (7,300)
Income before income taxes 4,058 9,719 21,934 23,022
Income taxes (1,307) (3,317) (4,760) (6,538)
Net income 2,751 6,402 17,174 16,484
Other comprehensive income:        
Foreign currency translation adjustments 113 (20) 292 (375)
Unrealized gain on available-for-sale securities, net of tax 0 2 38 24
Other comprehensive income (loss) 113 (18) 330 (351)
Comprehensive income $ 2,864 $ 6,384 $ 17,504 $ 16,133
Net income per share, basic $ 0.06 $ 0.15 $ 0.40 $ 0.39
Shares used in computing net income per share, basic 42,683 42,152 42,522 42,041
Net income per share, diluted $ 0.06 $ 0.15 $ 0.40 $ 0.39
Shares used in computing net income per share, diluted 43,136 42,556 42,929 42,354
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Net income $ 2,751 $ 6,402 $ 17,174 $ 16,484
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization 5,913 3,411 14,401 9,733
Stock-based compensation 3,526 3,099 8,181 7,768
Deferred income tax expense 1,540 176 4,471 6,207
Excess income tax expense from employee stock-based awards 0 14 0 1,005
Loss (gain) on sale or disposal of assets 87 (62) 128 (743)
Other (799) (25) (870) (128)
Changes in operating assets and liabilities:        
Accounts receivable, net (3,118) (3,985) 3,555 2,101
Inventories, net (2,125) 3,364 (6,165) 7,414
Other assets (902) 764 (230) (1,629)
Accounts payable (1,674) 1,238 1,050 (2,536)
Accrued liabilities (428) (3,452) (6,602) (1,485)
Deferred revenue 112 (36) 733 (212)
Net cash provided by operating activities 4,883 10,908 35,826 43,979
Cash flows from investing activities:        
Sales and maturities of available-for-sale securities 0 0 19,491 0
Purchase of property and equipment (2,675) (2,731) (8,394) (15,299)
Proceeds from sale of assets 42 0 45 893
Business acquisition consideration, net of cash acquired (1,196) 0 (68,098) 0
Purchase of cost method investment (500) 0 (500) 0
Acquired technology rights 0 (650) (200) (852)
Net cash used in investing activities (4,329) (3,381) (57,656) (15,258)
Cash flows from financing activities:        
Payments on debt 0 0 (25,000) 0
Proceeds from issuance of common stock 1,799 977 3,561 1,690
Shares surrendered for tax withholding (13) (14) (1,497) (1,593)
Excess income tax expense from employee stock-based awards 0 (14) 0 (1,005)
Net cash provided by (used in) financing activities 1,786 949 (22,936) (908)
Effect of foreign currency exchange rate on cash 87 13 365 46
Change in cash and cash equivalents 2,427 8,489 (44,401) 27,859
Cash and cash equivalents, beginning of period 81,718 111,064 128,546 91,694
Cash and cash equivalents, end of period $ 84,145 $ 119,553 $ 84,145 $ 119,553
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
BASIS OF PRESENTATION
 9 Months Ended
Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION
NOTE 1 — BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared by Luminex Corporation (the Company or Luminex) in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission (SEC). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, all adjustments (consisting of normal recurring entries) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 (the 2015 10-K).
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
BUSINESS COMBINATIONS
 9 Months Ended
Sep. 30, 2016
Business Combinations [Abstract]  
Business Combination Disclosure [Text Block]
NOTE 2 — BUSINESS COMBINATIONS

On June 30, 2016, the Company completed its acquisition (the Acquisition) of 100% of the outstanding shares of Nanosphere, Inc. (Nanosphere), which was a publicly-held molecular diagnostic company that was founded in 1999 and based in Northbrook, Illinois. On May 15, 2016, the Company, Nanosphere and Commodore Acquisition, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (Purchaser) entered into an Agreement and Plan of Merger (as amended, the Merger Agreement). In accordance with the terms of the Merger Agreement, on June 2, 2016, Purchaser commenced a cash tender offer (the Tender Offer) for all of the outstanding shares of Nanosphere’s common stock, par value $0.01 per share (the Shares), for $1.70 per share, net to the seller in cash, without interest and less any required withholding taxes, upon the terms and conditions set forth in the Offer to Purchase dated June 2, 2016, as amended or supplemented from time to time, and in the related Letter of Transmittal. The Tender Offer expired at 12:00 midnight Eastern Daylight Time, at the end of June 29, 2016, and was not extended. Upon the completion of the Tender Offer, the Company, through Purchaser, paid $1.70 for each Share validly tendered and not withdrawn. Following the consummation of the Tender Offer, the Company completed the Acquisition by consummating the merger of Purchaser with and into Nanosphere, pursuant to which, any Shares not purchased in the Tender Offer were automatically converted into the right to receive $1.70 per Share. The aggregate consideration paid to Nanosphere stockholders required to acquire all outstanding Shares pursuant to the Tender Offer and the merger was approximately $88.5 million, which was funded from cash on hand. Pursuant to the terms of the Merger Agreement, Nanosphere agreed to cancel all outstanding and exercisable Nanosphere stock options and replace each such stock option with the right to receive a cash payment equal to the number of shares subject to such option multiplied by the difference between $1.70 and the applicable exercise price of the respective options. Nanosphere also agreed to cancel all of its outstanding restricted stock and convert such restricted stock into the right to receive a cash payment equal to the number of shares of restricted stock multiplied by $1.70.  The Company paid $1.4 million in aggregate consideration of the cancelled Nanosphere options and outstanding restricted stock. Additionally, for each Nanosphere warrant holder, the Company agreed to issue replacement warrants that are exercisable for an amount in cash equal to the product of the number of shares of stock represented by the replacement warrant and the difference between $1.70 and the per share price of the replacement warrant. The Company purchased 1.5 million Nanosphere warrants outstanding for an additional $2.5 million in consideration to the Nanosphere warrant holders.

The Acquisition was undertaken to expand the Company's access to the high-growth molecular microbiology market and to Nanosphere's portfolio of molecular testing solutions. Nanosphere delivers proprietary diagnostic tools that enable detection of respiratory, gastroenteric and bloodstream infections. Nanosphere shares ceased trading on the Nasdaq Capital Market as of the close of business on June 30, 2016. The results of operations for Nanosphere have been included in the Company’s consolidated financial statements beginning July 1, 2016.  

Immediately subsequent to the Acquisition, on June 30, 2016, the Company retired approximately $25.4 million of Nanosphere's debt, including approximately $391,000 of accrued interest, by using the Company's existing cash reserves, including $25.6 million of cash acquired in the Acquisition. As part of this debt retirement, we incurred $1.5 million of related fees which were expensed as part of the Company's second quarter 2016 results.

The Acquisition has been accounted for as a business combination in accordance with U.S. GAAP and, as such, the assets acquired and liabilities assumed have been recorded at their respective fair values. The determination of fair value for the identifiable tangible and intangible assets acquired and liabilities assumed requires extensive use of estimates and judgments. Significant estimates and assumptions include, but are not limited to, Level 3 measurements estimating future cash flows and determining the appropriate discount rate. The following table summarizes the estimated fair values of Nanosphere’s assets acquired and liabilities assumed at June 30, 2016 (in thousands):
 
 
Net tangible assets assumed as of June 30, 2016
$
34,387

Intangible assets subject to amortization
41,685

Long-term debt and accrued interest
(25,391
)
Deferred tax assets, net of deferred tax liabilities
7,449

Goodwill
34,279

Total purchase price
92,409

Less cash and cash equivalents acquired
(24,311
)
Net cash paid for business acquisition
$
68,098



The Company is in the process of finalizing third-party valuations of certain intangible assets and finalizing the calculations of the deferred tax liabilities related to Nanosphere; thus the provisional measurement of intangible assets, deferred tax liabilities and goodwill are subject to change.  If information that existed prior to June 30, 2016 becomes available which would indicate adjustments are required to the purchase price allocation, such adjustments will be included in the purchase price allocations through revisions to the net tangible assets assumed, fair values of the intangible assets, deferred tax assets and liabilities and resulting goodwill recorded.

Acquired finished goods and work-in-process inventory was valued at its estimated selling price less the sum of the costs of sales efforts and a reasonable profit allowance for the Company's selling effort and, with respect to work-in-process inventory, estimated costs to complete. This resulted in a fair value adjustment that increased finished goods inventory by approximately $0.5 million, which increased cost of goods sold in the quarter ending September 30, 2016 as these inventory items were sold.

The Acquisition contributed $7.4 million of revenue and net losses of $6.2 million, during the three months ended September 30, 2016.

Unaudited Pro forma Financial Information
Nanosphere's results of operations have been included in the Company's financial statements for the three months ended September 30, 2016, following the Acquisition on June 30, 2016. The unaudited pro forma financial information set forth below assumes that Nanosphere had been acquired at the beginning of January 1, 2015, and includes the effect of estimated amortization of acquired identifiable intangible assets, removal of interest expense on Nanosphere’s debt extinguished at the date of the Acquisition, and removal of Acquisition costs and the impact of purchase accounting adjustments, tax and inventory valuation adjustments. This unaudited pro forma financial information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have resulted had the Acquisition been in effect at the beginning of the periods presented. In addition, the unaudited pro forma financial information is not intended to be a projection of future results and does not reflect any operating efficiencies or cost savings that might be achievable.

 
Nine Months Ended September 30,
 
2016
 
2015
 
(unaudited)
(in thousands)
Revenue
$
212,320

 
$
191,483

Income from operations
12,814

 
4,060

Net income (loss)
10,557

 
(2,792
)
Net income (loss) per share, basic
0.25

 
(0.07
)
Shares used in computing net income (loss) per share, basic
42,522

 
42,041

Net income (loss) per share, diluted
0.25

 
(0.07
)
Shares used in computing net income (loss) per share, diluted
42,929

 
42,354
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
INVESTMENTS
 9 Months Ended
Sep. 30, 2016
Investments [Abstract]  
INVESTMENTS
NOTE 3 — INVESTMENTS

Marketable Securities

The Company determines the appropriate classification of its investments in debt and equity securities at the time of purchase and re-evaluates such determinations at each balance sheet date. Marketable securities that are bought and held principally for the purpose of selling them in the near term are classified as trading securities and are reported at fair value, with unrealized gains and losses recognized in earnings. Debt securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are stated at amortized cost, which approximates the fair value of these investments. Debt securities for which the Company does not have the intent or ability to hold to maturity are classified as available-for-sale. Debt and marketable equity securities not classified as held-to-maturity or as trading are classified as available-for-sale, and are carried at fair market value, with the unrealized gains and losses included in the determination of comprehensive income and reported in stockholders’ equity. As of September 30, 2016 and December 31, 2015, all of the Company’s marketable securities were classified as available-for-sale. Marketable securities are recorded as either short-term or long-term on the balance sheet based on the contractual maturity date. The fair value of all securities is determined by quoted market prices, market interest rate inputs, or other than quoted prices that are observable either directly or indirectly (as of the end of the reporting period). Declines in fair value below the Company’s carrying value deemed to be other than temporary are charged against net earnings. As of September 30, 2016, the Company had no short or long term investments, since those funds were used to pay for the Acquisition.

Available-for-sale securities consisted of the following as of September 30, 2016 (in thousands):
 
Amortized Cost
 
Gains in Accumulated Other Comprehensive Income
 
Losses in Accumulated Other Comprehensive Income
 
Estimated Fair Value
Current:
 
 
 
 
 
 
 
Cash equivalents
$
701

 


 
$
—

 
$
701

Government sponsored debt securities
—

 
—

 
—

 
—

Non-government sponsored debt securities
—

 
—

 
—

 
—

Total current securities
701

 
—

 
—

 
701

Noncurrent:
 

 
 

 
 

 
 

Government sponsored debt securities
—

 
—

 
—

 
—

Non-government sponsored debt securities
—

 
—

 
—

 
—

Total noncurrent securities
—

 
—

 
—

 
—

Total available-for-sale securities
$
701

 
$
—

 
$
—

 
$
701

 
Available-for-sale securities consisted of the following as of December 31, 2015 (in thousands):
 
Amortized Cost
 
Gains in Accumulated Other Comprehensive Income
 
Losses in Accumulated Other Comprehensive Income
 
Estimated Fair Value
Current:
 
 
 
 
 
 
 
Cash equivalents
$
144

 
$
—

 
$
—

 
$
144

Government sponsored debt securities
10,000

 
—

 
(10
)
 
9,990

Non-government sponsored debt securities
2,001

 
—

 
(3
)
 
1,998

Total current securities
12,145

 
—

 
(13
)
 
12,132

Noncurrent:
 

 
 

 
 

 
 

Government sponsored debt securities
1,998

 
—

 
(6
)
 
1,992

Non-government sponsored debt securities
5,491

 
—

 
(24
)
 
5,467

Total noncurrent securities
7,489

 
—

 
(30
)
 
7,459

Total available-for-sale securities
$
19,634

 
$
—

 
$
(43
)
 
$
19,591


Proceeds from the sales of available-for-sale securities during the three and nine months ended September 30, 2016 totaled zero and $19.5 million, respectively, and these proceeds were used to partially fund the Acquisition. There were no proceeds from the sales of available-for-sale securities for the three and nine ended September 30, 2015. Realized gains and losses on sales of investments are determined using the specific identification method. Realized gains and losses are included in Other income, net in the Consolidated Statements of Comprehensive Income. All of the Company's available-for-sale securities with gross unrealized holding losses as of September 30, 2016 and December 31, 2015 had been in a loss position for less than 12 months.

The estimated fair value of available-for-sale debt securities as of September 30, 2016 and December 31, 2015, by contractual maturity, was as follows (in thousands):
 
Estimated Fair Value
 
September 30, 2016
 
December 31, 2015
Due in one year or less
$
—

 
$
11,988

Due after one year through two years
—

 
7,459

 
$
—

 
$
19,447



Expected maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.

Non-Marketable Securities and Other-Than-Temporary Impairment

In the third quarter of 2016, the Company made a $0.5 million minority interest investment in a private company based in the U.S. that is focused on development of next generation technologies. This minority interest is included at cost in other long-term assets on the Company’s Consolidated Balance Sheets as the Company does not have significant influence over the investee since the Company owns less than 20% of the voting equity in the investee and the investee is not publicly traded. Although we may invest further in this entity over the course of the next several quarters, we do not anticipate our ownership interest to exceed 20% in the short term.

The Company owns a minority interest in a private company based in the U.S. through its investment of $1.0 million in the third quarter of 2012.  This minority interest is included at cost in other long-term assets on the Company’s Consolidated Balance Sheets as the Company does not have significant influence over the investee since the Company owns less than 20% of the voting equity in the investee and the investee is not publicly traded.

The Company's other minority interest in a private company was acquired by a third party in July 2013. The Company realized a gain of $5.4 million on the sale of this minority interest investment in the third quarter of 2013 and an additional gain of $0.9 million in the first quarter of 2015 related to the settlement of escrowed funds.

The Company regularly evaluates the carrying value of its cost-method investment for impairment and whether any events or circumstances are identified that would significantly harm the fair value of the investment. The primary indicators the Company utilizes to identify these events and circumstances are the investee's ability to remain in business, such as the investee's liquidity and rate of cash use, and the investee’s ability to secure additional funding and the value of that additional funding. In the event a decline in fair value is judged to be other-than-temporary, the Company will record an other-than-temporary impairment charge in Other income, net in the Consolidated Statements of Comprehensive Income. As the inputs utilized for the Company's periodic impairment assessment are not based on observable market data, the determination of fair value of this cost-method investment is classified within Level 3 of the fair value hierarchy. See Note 5 - Fair Value Measurement to our condensed consolidated financial statements for further discussion. To determine the fair value of this investment, the Company uses all available financial information related to the entities, including information based on recent or pending third-party equity investments in these entities. In certain instances, a cost-method investment's fair value is not estimated as there are no identified events or changes in the circumstances that may have a significant adverse effect on the fair value of the investment and to do so would be impractical.
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
INVENTORY, NET
 9 Months Ended
Sep. 30, 2016
Inventory, Net [Abstract]  
INVENTORIES, NET
NOTE 4 — INVENTORIES, NET

Inventories are stated at the lower of cost or market, with cost determined according to the standard cost method, which approximates the first-in, first-out method. The Company routinely assesses its on-hand inventory for timely identification and measurement of obsolete, slow-moving or otherwise impaired inventory. Inventories consisted of the following (in thousands):
 
September 30, 2016
 
December 31, 2015
Parts and supplies
$
23,792

 
$
15,296

Work-in-progress
6,704

 
8,797

Finished goods
10,959

 
7,159

 
$
41,455

 
$
31,252
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
FAIR VALUE MEASUREMENTS
 9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENT
NOTE 5 — FAIR VALUE MEASUREMENT

The Fair Value Measurements and Disclosures Topic of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) defines fair value, establishes a framework for measuring fair value under U.S. GAAP and enhances disclosures about fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The ASC describes a fair value hierarchy based on the following three levels of inputs that may be used to measure fair value, of which the first two are considered observable and the last unobservable:
 
Level 1 –
Quoted prices in active markets for identical assets or liabilities.
 
Level 2 –
Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
 
Level 3 –
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company determines the fair value of its investment portfolio assets by obtaining non-binding market prices from its third-party portfolio managers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. There were no transfers between Level 1, Level 2, or Level 3 measurements for the three month period ended September 30, 2016.

The following table represents the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2016 and December 31, 2015 (in thousands):
 
Fair Value Measurements as of September 30, 2016 Using
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Money Market funds
$
701

 
$
—

 
$
—

 
$
701

Government sponsored debt securities
—

 
—

 
—

 
—

Non-government sponsored debt securities
—

 
—

 
—

 
—


 
Fair Value Measurements as of December 31, 2015 Using
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Money Market funds
$
144

 
$
—

 
$
—

 
$
144

Government sponsored debt securities
—

 
11,988

 
—

 
$
11,988

Non-government sponsored debt securities
—

 
7,459

 
—

 
$
7,459
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
GOODWILL AND OTHER INTANGIBLE ASSETS
 9 Months Ended
Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS
NOTE 6 — GOODWILL AND OTHER INTANGIBLE ASSETS

On June 30, 2016, the Company completed the Acquisition. As a result of the Acquisition, the Company recorded approximately $34.3 million of goodwill and $41.7 million of other identifiable intangible assets. The goodwill is derived from expected synergies from combining operations of the Company and Nanosphere. The purchase price allocation is preliminary as the Company’s determination of the fair values of the assets acquired and liabilities assumed is still in process.

Goodwill is reviewed for impairment at least annually at the beginning of the fourth quarter, or more frequently if impairment indicators arise. The Company's goodwill is not expected to be deductible for tax purposes.

The changes in the carrying amount of the Company’s goodwill during the period are as follows (in thousands):
 
September 30, 2016
 
December 31, 2015
Balance at beginning of year
$
49,619

 
$
49,619

Acquisition of Nanosphere
34,279

 
—

Balance at end of period
$
83,898

 
$
49,619



The Company’s intangible assets are reflected in the table below (in thousands, except weighted average lives):
 
Finite-lived
 
Indefinite-lived
 
 
 
Technology, trade secrets and know-how
 
Customer lists and contracts
 
Other identifiable intangible assets
 
IP R&D
 
Total
2015
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2014
$
29,704

 
$
7,958

 
$
1,890

 
$
40,100

 
$
79,652

Completion of IP R&D project
40,100

 
—

 
—

 
(40,100
)
 
—

Removal of fully amortized assets
(702
)
 
(161
)
 
(238
)
 
—

 
(1,101
)
Balance as of December 31, 2015
69,102

 
7,797

 
1,652

 
—

 
78,551

Less: accumulated amortization:
 

 
 

 
 

 
 

 
 

Accumulated amortization balance as of December 31, 2014
(19,325
)
 
(3,085
)
 
(860
)
 
—

 
(23,270
)
Amortization expense
(3,023
)
 
(743
)
 
(134
)
 
—

 
(3,900
)
Removal of fully amortized assets
702

 
161

 
238

 
—

 
1,101

Accumulated amortization balance as of December 31, 2015
(21,646
)
 
(3,667
)
 
(756
)
 
—

 
(26,069
)
Net balance as of December 31, 2015
$
47,456

 
$
4,130

 
$
896

 
$
—

 
$
52,482

Weighted average life (in years)
10

 
11

 
11

 
 

 
 

 
 
 
 
 
 
 
 
 
 
2016
 

 
 

 
 

 
 

 
 

Balance as of December 31, 2015
$
69,102

 
$
7,797

 
$
1,652

 
$
—

 
$
78,551

Additions due to acquisition of Nanosphere
12,282

 
12,409

 
4,012

 
12,982

 
41,685

Balance as of September 30, 2016
81,384

 
20,206

 
5,664

 
12,982

 
120,236

Less: accumulated amortization:
 

 
 

 
 

 
 

 
 

Accumulated amortization balance as of December 31, 2015
(21,646
)
 
(3,667
)
 
(756
)
 
—

 
(26,069
)
Amortization expense
(4,683
)
 
(902
)
 
(212
)
 
—

 
(5,797
)
Accumulated amortization balance as of September 30, 2016
(26,329
)
 
(4,569
)
 
(968
)
 
—

 
(31,866
)
Net balance as of September 30, 2016
$
55,055

 
$
15,637

 
$
4,696

 
$
12,982

 
$
88,370

Weighted average life (in years)
10

 
10

 
10

 
 

 
 



The estimated aggregate amortization expense for the next five fiscal years and thereafter is as follows (in thousands):
2016 (three months)
$
2,482

2017
8,979

2018
8,789

2019
8,789

2020
8,789

Thereafter
37,560

 
$
75,388

IPR&D
12,982

 
$
88,370
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
OTHER COMPREHENSIVE (LOSS) INCOME
 9 Months Ended
Sep. 30, 2016
Statement of Comprehensive Income [Abstract]  
Comprehensive Income (Loss) Note
NOTE 7 — OTHER COMPREHENSIVE INCOME (LOSS)

Other comprehensive income (loss) represents a measure of all changes in equity that result from recognized transactions and other economic events other than those resulting from investments by and distributions to shareholders. Other comprehensive income (loss) for the Company includes foreign currency translation adjustments and net unrealized holding gains and losses on available-for-sale investments.

The following table presents the changes in each component of accumulated other comprehensive income (loss), net of tax (in thousands):
 
Foreign Currency Items
 
Available-for-Sale Investments
 
Accumulated Other Comprehensive Income (Loss) Items
Balance as of December 31, 2015
$
(1,258
)
 
$
(38
)
 
$
(1,296
)
Other comprehensive income before reclassifications
292

 
38

 
330

Net current-period other comprehensive income
292

 
38

 
330

Balance as of September 30, 2016
$
(966
)
 
$
—

 
$
(966
)


The following table presents the tax (expense) benefit allocated to each component of other comprehensive income (loss) (in thousands):
 
Three Months Ended September 30, 2016
 
Nine Months Ended September 30, 2016
 
Before Tax
 
Tax Benefit
 
Net of Tax
 
Before Tax
 
Tax Benefit
 
Net of Tax
Foreign currency translation adjustments
$
113

 
$
—

 
$
113

 
$
292

 
$
—

 
$
292

Unrealized gains on available-for-sale investments
—

 
—

 
—

 
44

 
(6
)
 
38

Other comprehensive income (loss)
$
113

 
$
—

 
$
113

 
$
336

 
$
(6
)
 
$
330
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
EARNINGS PER SHARE
 9 Months Ended
Sep. 30, 2016
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
NOTE 8 — EARNINGS PER SHARE

A reconciliation of the denominators used in computing per share net income, or EPS, is as follows (in thousands, except per share amounts):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Numerator:
 
 
 
 
 
 
 
Net income
$
2,751

 
$
6,402

 
$
17,174

 
$
16,484

Denominator:
 

 
 

 
 

 
 

Denominator for basic net income per share - weighted average common stock outstanding
42,683

 
42,152

 
42,522

 
42,041

Effect of dilutive securities: stock options and awards
453

 
404

 
407

 
313

Denominator for diluted net income per share - weighted average shares outstanding - diluted
43,136

 
42,556

 
42,929

 
42,354

Basic net income per share
$
0.06

 
$
0.15

 
$
0.40

 
$
0.39

Diluted net income per share
$
0.06

 
$
0.15

 
$
0.40

 
$
0.39


 

Basic net income per share is computed by dividing the net income for the period by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed by dividing the net income for the period by the weighted average number of common and common equivalent shares outstanding during the period. Stock options to acquire approximately zero and 0.6 million shares for the three months ended September 30, 2016 and 2015, and zero and 0.6 million shares for the nine months ended September 30, 2016 and 2015, respectively, were excluded from the computations of diluted EPS because the effect of including those stock options would have been anti-dilutive.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
STOCK-BASED COMPENSATION
 9 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION
NOTE 9 — STOCK-BASED COMPENSATION

The Company’s stock option activity for the nine months ended September 30, 2016 was as follows:
Stock Options (shares in thousands)
Shares
 
Weighted Average Exercise Price
Outstanding as of December 31, 2015
1,692

 
$
17.47

Granted
886

 
19.21

Exercised
(143
)
 
17.51

Cancelled or expired
(92
)
 
18.58

Outstanding as of September 30, 2016
2,343

 
$
18.08


 
The Company had $11.7 million of total unrecognized compensation costs related to stock options as of September 30, 2016, which costs are expected to be recognized over a weighted average period of 2.86 years years.

The Company’s restricted share activity for the nine months ended September 30, 2016 was as follows:
Restricted Stock Awards (shares in thousands)
Shares
 
Weighted Average Grant Price
Non-vested as of December 31, 2015
836

 
$
18.66

Granted
300

 
19.74

Vested
(205
)
 
19.59

Cancelled or expired
(53
)
 
18.36

Non-vested as of September 30, 2016
878

 
$
18.83

 
 
 
 
Restricted Stock Units (in thousands)
Shares
 
 

Non-vested as of December 31, 2015
501

 
 

Granted
99

 
 

Vested
(83
)
 
 

Cancelled or expired
(46
)
 
 

Non-vested as of September 30, 2016
471

 
 


 
As of September 30, 2016, there was $15.0 million and $3.3 million of total unrecognized compensation costs related to Restricted Stock Awards (RSAs) and Restricted Stock Units (RSUs), respectively. This cost is expected to be recognized over a weighted average period of 2.36 years years for the RSAs and 1.95 years years for the RSUs. The Company issues a small number of cash settled RSUs pursuant to the Company's equity incentive plan in certain foreign countries. These grants do not result in the issuance of common stock and are considered immaterial by the Company.

The following are the stock-based compensation costs recognized in the Company’s condensed consolidated statements of comprehensive income (in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Cost of revenue
$
334

 
$
238

 
$
903

 
$
742

Research and development
754

 
725

 
1,896

 
1,705

Selling, general and administrative
2,438

 
2,136

 
5,382

 
5,321

Stock-based compensation costs reflected in net income
$
3,526

 
$
3,099

 
$
8,181

 
$
7,768
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
ACCRUED LIABILITIES
 9 Months Ended
Sep. 30, 2016
Accrued Liabilities, Current [Abstract]  
ACCRUED WARRANTY COSTS
NOTE 10 — ACCRUED LIABILITIES

Accrued liabilities consisted of the following (in thousands):
 
September 30, 2016
 
December 31, 2015
Compensation and employee benefits
$
11,515

 
$
10,946

Income and other taxes
734

 
1,261

Warranty costs
667

 
553

Other
3,199

 
2,392

 
$
16,115

 
$
15,152


Sales of certain of the Company's systems are subject to a warranty. System warranties typically extend for a period of 12 months from the date of installation not to exceed 24 months from the date of shipment. The Company estimates the amount of warranty claims on sold products that may be incurred based on current and historical data. The actual warranty expense could differ from the estimates made by the Company based on product performance. Warranty expenses are evaluated and adjusted periodically.

The following table summarizes the changes in the warranty accrual (in thousands):
Accrued warranty costs as of December 31, 2015
$
553

Warranty adjustments/settlements
(582
)
Accrual for warranty costs
696

Accrued warranty costs as of September 30, 2016
$
667
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
INCOME TAXES
 9 Months Ended
Sep. 30, 2016
Income Tax Disclosure [Abstract]  
INCOME TAXES
OTE 11 — INCOME TAXES
 
At the end of each interim reporting period, an estimate is made of the effective tax rate expected to be applicable for the full year. The estimated full year’s effective tax rate is used to determine the income tax rate for each applicable interim reporting period. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period of the enactment date. The effective tax rate for the nine months ended September 30, 2016 was 21.70%, including amounts recorded for discrete events. This differs from the statutory rate of 35% primarily because of the worldwide mix of consolidated earnings and losses before taxes and an assessment regarding the realizability of the Company’s deferred tax assets. The Company’s tax expense reflects the full federal, various state, and foreign blended statutory rates. The Company is utilizing its net operating losses and tax credits in the U.S., Canada and the Netherlands and currently expects a full year effective tax rate of less than 30%. Therefore, cash taxes to be paid are expected to continue to be less than 15% of book tax expense.
 
The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, Australia, Canada, China, Hong Kong, Japan, the Netherlands, and various states. Due to net operating losses, the U.S., Canadian and Australian tax returns dating back to 2011 can still be reviewed by the taxing authorities. No material changes to this liability are expected within the next 12 months. For the nine months ended September 30, 2016, there were no material changes to the total amount of unrecognized tax benefits. The Company recognizes interest and penalties related to uncertain tax positions in the provision for income taxes.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE 12 - COMMITMENTS AND CONTINGENCIES

On August 30, 2012, Abbott Laboratories, Inc. (Abbott) was named as a defendant in a complaint filed by ENZO Life Sciences, Inc. (ENZO) in U.S. District Court in Delaware for alleged infringement of U.S. Patent 7,064,197 as a result of Abbott's distribution of Luminex's xTAG Respiratory Viral Panel.  Luminex and Abbott entered into an agreement requiring Luminex to defend and indemnify Abbott for any alleged patent infringement resulting from its distribution of Luminex's xTAG Respiratory Viral Panel. The complaint sought unspecified monetary damages and injunctive relief.  Abbott filed an answer to the complaint on October 15, 2012.  On November 30, 2012, Luminex intervened in the lawsuit. On January 2, 2013, ENZO filed additional claims against Luminex, alleging infringement of U.S. Patent 7,064,197 resulting from Luminex's sale of its xTAG, FlexScript LDA, SelecTAG, and xMAP Salmonella Serotyping Assay products and alleging infringement of U.S. Patent 8,097,405 resulting from Luminex's sale of MultiCode® products. Luminex filed an answer to ENZO's additional claims on January 28, 2013.  On October 2, 2013, ENZO filed additional claims against Luminex, alleging infringement of U.S. Patent 6,992,180 resulting from Luminex’s sale of MultiCode® products. Luminex filed an answer to ENZO’s additional claims on October 21, 2013.

Effective July 2, 2015, Luminex agreed to pay ENZO $7.1 million to settle the litigation. This settlement resulted in the entry of orders dismissing (i) with prejudice all claims, counterclaims and causes of action asserted by ENZO against Luminex, (ii) without prejudice all claims, counterclaims and causes of action asserted by Luminex against ENZO, (iii) with prejudice all claims, counterclaims and causes of action solely under U.S. Patent 7,064,197 asserted in the litigation by ENZO against Abbott and (iv) without prejudice all claims, counterclaims and causes of action relating solely to U.S. Patent 7,064,197 asserted by Abbott against ENZO; and resulted in the grant to the Company and its affiliates of a fully paid, non-exclusive, worldwide license under the patents asserted in the complaint. In addition, the Company and ENZO released each other from certain claims related to the above-referenced patents, including the claims and counterclaims asserted in the complaint. ENZO further released Abbott from certain claims, including those asserted in the complaint, related solely to U.S. Patent 7,064,197. The settlement was entered into solely by way of compromise and does not constitute an admission or concession by Luminex of any liability or wrongdoing.

Because Luminex (i) never paid any royalties to ENZO in the past, (ii) will not be required to pay any future or ongoing royalties to ENZO as a result of the settlement, (iii) has never recorded any revenue or expense related to ENZO in operating revenue or in operating expenses in the past, outside of legal fees, and (iv) believes that it does not infringe on any valid and enforceable claim with respect to the asserted patents, Luminex determined that this settlement of litigation expense was outside of operations. Luminex accordingly recorded the settlement as a separate, non-operating line item in the second quarter of 2015. Luminex made the $7.1 million payment to ENZO in July 2015.

When and if it appears probable in management's judgment, and based upon consultation with outside counsel, that we will incur monetary damages or other costs in connection with any claims or proceedings, and such costs can be reasonably estimated, we record the estimated liability in the financial statements.  If only a range of estimated losses can be estimated, we record an amount within the range that, in management's judgment, reflects the most likely outcome; if none of the estimates within that range is a better estimate than any other amount, we record the liability at the low end of the range of estimates. Any such accrual would be charged to expense in the appropriate period.   We disclose significant contingencies when the loss is not probable and/or the amount of the loss is not estimable, when we believe there is at least a reasonable possibility that a loss has been incurred.  We recognize costs associated with legal proceedings in the period in which the services were provided.
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
RECENT ACCOUNTING PRONOUNCEMENTS
 9 Months Ended
Sep. 30, 2016
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
RECENT ACCOUNTING PRONOUNCEMENTS
NOTE 13 — RECENT ACCOUNTING PRONOUNCEMENTS

Recently adopted accounting guidance

In March 2016, the FASB issued guidance that simplifies some provisions in stock compensation accounting related to accounting for a stock payment’s tax consequences. The guidance also amends how excess tax benefits and a company's payments to cover the tax bills for the shares’ recipients should be classified. The amendments allow companies to estimate the number of stock awards they expect to vest, and the amendments also revise the withholding requirements for classifying stock awards as equity. This guidance is effective for annual periods beginning after December 15, 2016. Early adoption is permitted.

This new standard requires that an entity recognize excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement when the awards vest or are settled. Under the previous standard, excess tax benefits and tax deficiencies were recognized in additional paid-in capital. Cash flows related to excess tax benefits will no longer be separately classified as a financing activity apart from other income tax cash flows. In addition, related cash payments made on an employee's behalf for shares withheld are presented as a financing activity on the statement of cash flows.

The Company early adopted this standard in the quarter ended June 30, 2016. The adoption of this standard resulted in the recognition of $6.9 million of previously unrecognized excess tax benefits in deferred income taxes, net and an increase to retained earnings on our Consolidated Balance Sheet and the recognition of $211,000 of income tax expense in our income tax provision for the nine months ended September 30, 2016. We have elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost to be recognized in each period.

In September 2015, the FASB issued additional guidance on business combinations. This guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period with a corresponding adjustment to goodwill in the reporting period in which the adjustment amounts are determined. The effect on earnings from changes in depreciation, amortization or other income effects, if any, as a result of the change to the provisional amounts will be recorded in the same period's financial statements, calculated as if the accounting had been completed at the acquisition date. The Company adopted this standard during the quarter ended June 30, 2016, and its adoption did not have any impact on its consolidated financial statements.

Recent accounting guidance not yet adopted

In August 2016, the FASB issued specific guidance on eight cash flow classification issues that are not currently addressed by current U.S. GAAP and thereby reduce the current diversity in practice.  This guidance is effective for annual periods beginning after December 15, 2017. Early adoption is permitted. The Company does not anticipate that this guidance will have a material impact on its consolidated financial statements.

In February 2016, the FASB issued guidance requiring lessees to recognize a right-of-use asset and a lease liability on the balance sheet for all leases with the exception of short-term leases. The effective date of the new guidance is for the Company's first quarter of fiscal 2019 and early adoption is permitted. The new standard must be adopted using a modified retrospective transition and requires application of the new guidance at the beginning of the earliest comparative period presented. The Company is currently evaluating the impact of the adoption of this requirement on its consolidated financial statements, but does not anticipate that adoption of this guidance will have a material impact on its consolidated financial statements except for the addition of the right-of-use asset and a lease liability to the balance sheet.

In January 2016, the FASB issued guidance that changes how entities measure equity investments that do not result in consolidation and are not accounted for under the equity method. Entities will be required to measure these investments at fair value at the end of each reporting period and recognize changes in fair value in net income. This guidance also changes certain disclosure requirements and other aspects of current U.S. GAAP. This guidance is effective for annual periods beginning after December 15, 2017. Early adoption is permitted. The Company does not anticipate that adoption of this guidance will have a material impact on its consolidated financial statements as the only potential impact would be related to the Company's one cost-method investment discussed in Note 3 - Investments.

In July 2015, the FASB issued guidance regarding the measurement of inventory. The new guidance requires inventory to be measured at the lower of cost and net realizable value, which is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. This new guidance is effective for the Company's first quarter of fiscal 2018 and early adoption is permitted. The guidance must be applied prospectively. The Company is currently evaluating the impact of the adoption of this requirement on its consolidated financial statements, but does not anticipate that adoption of this guidance will have a material impact on its consolidated financial statements.

In May 2014, the FASB issued a new standard on revenue recognition which outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the revenue model is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In doing so, companies will need to use their judgment and make estimates more extensively than under current U.S. GAAP. These judgments may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The standard is designed to create greater comparability for financial statement users across industries and jurisdictions and also requires enhanced disclosures. On July 9, 2015, the FASB voted in favor of delaying the effective date of the new standard by one year, with early adoption permitted as of the original effective date. The guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
BUSINESS COMBINATIONS (Tables)
 9 Months Ended
Sep. 30, 2016
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
The following table summarizes the estimated fair values of Nanosphere’s assets acquired and liabilities assumed at June 30, 2016 (in thousands):
 
 
Net tangible assets assumed as of June 30, 2016
$
34,387

Intangible assets subject to amortization
41,685

Long-term debt and accrued interest
(25,391
)
Deferred tax assets, net of deferred tax liabilities
7,449

Goodwill
34,279

Total purchase price
92,409

Less cash and cash equivalents acquired
(24,311
)
Net cash paid for business acquisition
$
68,098
Business Acquisition, Pro Forma Information [Table Text Block]
dition, the unaudited pro forma financial information is not intended to be a projection of future results and does not reflect any operating efficiencies or cost savings that might be achievable.

 
Nine Months Ended September 30,
 
2016
 
2015
 
(unaudited)
(in thousands)
Revenue
$
212,320

 
$
191,483

Income from operations
12,814

 
4,060

Net income (loss)
10,557

 
(2,792
)
Net income (loss) per share, basic
0.25

 
(0.07
)
Shares used in computing net income (loss) per share, basic
42,522

 
42,041

Net income (loss) per share, diluted
0.25

 
(0.07
)
Shares used in computing net income (loss) per share, diluted
42,929

 
42,354
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
INVESTMENTS (Tables)
 9 Months Ended
Sep. 30, 2016
Investments [Abstract]  
Components of available-for-sale securities
Available-for-sale securities consisted of the following as of September 30, 2016 (in thousands):
 
Amortized Cost
 
Gains in Accumulated Other Comprehensive Income
 
Losses in Accumulated Other Comprehensive Income
 
Estimated Fair Value
Current:
 
 
 
 
 
 
 
Cash equivalents
$
701

 


 
$
—

 
$
701

Government sponsored debt securities
—

 
—

 
—

 
—

Non-government sponsored debt securities
—

 
—

 
—

 
—

Total current securities
701

 
—

 
—

 
701

Noncurrent:
 

 
 

 
 

 
 

Government sponsored debt securities
—

 
—

 
—

 
—

Non-government sponsored debt securities
—

 
—

 
—

 
—

Total noncurrent securities
—

 
—

 
—

 
—

Total available-for-sale securities
$
701

 
$
—

 
$
—

 
$
701

 
Available-for-sale securities consisted of the following as of December 31, 2015 (in thousands):
 
Amortized Cost
 
Gains in Accumulated Other Comprehensive Income
 
Losses in Accumulated Other Comprehensive Income
 
Estimated Fair Value
Current:
 
 
 
 
 
 
 
Cash equivalents
$
144

 
$
—

 
$
—

 
$
144

Government sponsored debt securities
10,000

 
—

 
(10
)
 
9,990

Non-government sponsored debt securities
2,001

 
—

 
(3
)
 
1,998

Total current securities
12,145

 
—

 
(13
)
 
12,132

Noncurrent:
 

 
 

 
 

 
 

Government sponsored debt securities
1,998

 
—

 
(6
)
 
1,992

Non-government sponsored debt securities
5,491

 
—

 
(24
)
 
5,467

Total noncurrent securities
7,489

 
—

 
(30
)
 
7,459

Total available-for-sale securities
$
19,634

 
$
—

 
$
(43
)
 
$
19,591
Estimated fair value of available-for-sale debt securities, by contractual maturity
The estimated fair value of available-for-sale debt securities as of September 30, 2016 and December 31, 2015, by contractual maturity, was as follows (in thousands):
 
Estimated Fair Value
 
September 30, 2016
 
December 31, 2015
Due in one year or less
$
—

 
$
11,988

Due after one year through two years
—

 
7,459

 
$
—

 
$
19,447
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
INVENTORY, NET (Tables)
 9 Months Ended
Sep. 30, 2016
Inventory, Net [Abstract]  
Schedule of Inventory, Current
Inventories consisted of the following (in thousands):
 
September 30, 2016
 
December 31, 2015
Parts and supplies
$
23,792

 
$
15,296

Work-in-progress
6,704

 
8,797

Finished goods
10,959

 
7,159

 
$
41,455

 
$
31,252
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
FAIR VALUE MEASUREMENTS (Tables)
 9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
Fair value, financial assets (cash equivalents and investments) measured on a recurring basis
The following table represents the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2016 and December 31, 2015 (in thousands):
 
Fair Value Measurements as of September 30, 2016 Using
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Money Market funds
$
701

 
$
—

 
$
—

 
$
701

Government sponsored debt securities
—

 
—

 
—

 
—

Non-government sponsored debt securities
—

 
—

 
—

 
—


 
Fair Value Measurements as of December 31, 2015 Using
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Money Market funds
$
144

 
$
—

 
$
—

 
$
144

Government sponsored debt securities
—

 
11,988

 
—

 
$
11,988

Non-government sponsored debt securities
—

 
7,459

 
—

 
$
7,459
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 9 Months Ended
Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes in the carrying amount of goodwill
The changes in the carrying amount of the Company’s goodwill during the period are as follows (in thousands):
 
September 30, 2016
 
December 31, 2015
Balance at beginning of year
$
49,619

 
$
49,619

Acquisition of Nanosphere
34,279

 
—

Balance at end of period
$
83,898

 
$
49,619
Schedule of intangible assets
The Company’s intangible assets are reflected in the table below (in thousands, except weighted average lives):
 
Finite-lived
 
Indefinite-lived
 
 
 
Technology, trade secrets and know-how
 
Customer lists and contracts
 
Other identifiable intangible assets
 
IP R&D
 
Total
2015
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2014
$
29,704

 
$
7,958

 
$
1,890

 
$
40,100

 
$
79,652

Completion of IP R&D project
40,100

 
—

 
—

 
(40,100
)
 
—

Removal of fully amortized assets
(702
)
 
(161
)
 
(238
)
 
—

 
(1,101
)
Balance as of December 31, 2015
69,102

 
7,797

 
1,652

 
—

 
78,551

Less: accumulated amortization:
 

 
 

 
 

 
 

 
 

Accumulated amortization balance as of December 31, 2014
(19,325
)
 
(3,085
)
 
(860
)
 
—

 
(23,270
)
Amortization expense
(3,023
)
 
(743
)
 
(134
)
 
—

 
(3,900
)
Removal of fully amortized assets
702

 
161

 
238

 
—

 
1,101

Accumulated amortization balance as of December 31, 2015
(21,646
)
 
(3,667
)
 
(756
)
 
—

 
(26,069
)
Net balance as of December 31, 2015
$
47,456

 
$
4,130

 
$
896

 
$
—

 
$
52,482

Weighted average life (in years)
10

 
11

 
11

 
 

 
 

 
 
 
 
 
 
 
 
 
 
2016
 

 
 

 
 

 
 

 
 

Balance as of December 31, 2015
$
69,102

 
$
7,797

 
$
1,652

 
$
—

 
$
78,551

Additions due to acquisition of Nanosphere
12,282

 
12,409

 
4,012

 
12,982

 
41,685

Balance as of September 30, 2016
81,384

 
20,206

 
5,664

 
12,982

 
120,236

Less: accumulated amortization:
 

 
 

 
 

 
 

 
 

Accumulated amortization balance as of December 31, 2015
(21,646
)
 
(3,667
)
 
(756
)
 
—

 
(26,069
)
Amortization expense
(4,683
)
 
(902
)
 
(212
)
 
—

 
(5,797
)
Accumulated amortization balance as of September 30, 2016
(26,329
)
 
(4,569
)
 
(968
)
 
—

 
(31,866
)
Net balance as of September 30, 2016
$
55,055

 
$
15,637

 
$
4,696

 
$
12,982

 
$
88,370

Weighted average life (in years)
10

 
10

 
10

 
 

 
 
Estimated aggregate amortization expense for the next five years and thereafter
The estimated aggregate amortization expense for the next five fiscal years and thereafter is as follows (in thousands):
2016 (three months)
$
2,482

2017
8,979

2018
8,789

2019
8,789

2020
8,789

Thereafter
37,560

 
$
75,388

IPR&D
12,982

 
$
88,370
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
OTHER COMPREHENSIVE (LOSS) INCOME (Tables)
 9 Months Ended
Sep. 30, 2016
Statement of Comprehensive Income [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The following table presents the changes in each component of accumulated other comprehensive income (loss), net of tax (in thousands):
 
Foreign Currency Items
 
Available-for-Sale Investments
 
Accumulated Other Comprehensive Income (Loss) Items
Balance as of December 31, 2015
$
(1,258
)
 
$
(38
)
 
$
(1,296
)
Other comprehensive income before reclassifications
292

 
38

 
330

Net current-period other comprehensive income
292

 
38

 
330

Balance as of September 30, 2016
$
(966
)
 
$
—

 
$
(966
)
Schedule of Comprehensive Income (Loss)
The following table presents the tax (expense) benefit allocated to each component of other comprehensive income (loss) (in thousands):
 
Three Months Ended September 30, 2016
 
Nine Months Ended September 30, 2016
 
Before Tax
 
Tax Benefit
 
Net of Tax
 
Before Tax
 
Tax Benefit
 
Net of Tax
Foreign currency translation adjustments
$
113

 
$
—

 
$
113

 
$
292

 
$
—

 
$
292

Unrealized gains on available-for-sale investments
—

 
—

 
—

 
44

 
(6
)
 
38

Other comprehensive income (loss)
$
113

 
$
—

 
$
113

 
$
336

 
$
(6
)
 
$
330
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
EARNINGS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2016
Earnings Per Share [Abstract]  
Schedule of Calculation of Numerator and Denominator in Earnings Per Share
A reconciliation of the denominators used in computing per share net income, or EPS, is as follows (in thousands, except per share amounts):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Numerator:
 
 
 
 
 
 
 
Net income
$
2,751

 
$
6,402

 
$
17,174

 
$
16,484

Denominator:
 

 
 

 
 

 
 

Denominator for basic net income per share - weighted average common stock outstanding
42,683

 
42,152

 
42,522

 
42,041

Effect of dilutive securities: stock options and awards
453

 
404

 
407

 
313

Denominator for diluted net income per share - weighted average shares outstanding - diluted
43,136

 
42,556

 
42,929

 
42,354

Basic net income per share
$
0.06

 
$
0.15

 
$
0.40

 
$
0.39

Diluted net income per share
$
0.06

 
$
0.15

 
$
0.40

 
$
0.39
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock options activity
The Company’s stock option activity for the nine months ended September 30, 2016 was as follows:
Stock Options (shares in thousands)
Shares
 
Weighted Average Exercise Price
Outstanding as of December 31, 2015
1,692

 
$
17.47

Granted
886

 
19.21

Exercised
(143
)
 
17.51

Cancelled or expired
(92
)
 
18.58

Outstanding as of September 30, 2016
2,343

 
$
18.08
Restricted shares activity
The Company’s restricted share activity for the nine months ended September 30, 2016 was as follows:
Restricted Stock Awards (shares in thousands)
Shares
 
Weighted Average Grant Price
Non-vested as of December 31, 2015
836

 
$
18.66

Granted
300

 
19.74

Vested
(205
)
 
19.59

Cancelled or expired
(53
)
 
18.36

Non-vested as of September 30, 2016
878

 
$
18.83

 
 
 
 
Restricted Stock Units (in thousands)
Shares
 
 

Non-vested as of December 31, 2015
501

 
 

Granted
99

 
 

Vested
(83
)
 
 

Cancelled or expired
(46
)
 
 

Non-vested as of September 30, 2016
471

 
 
Stock-based compensation costs recognized in consolidated statements of income
The following are the stock-based compensation costs recognized in the Company’s condensed consolidated statements of comprehensive income (in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Cost of revenue
$
334

 
$
238

 
$
903

 
$
742

Research and development
754

 
725

 
1,896

 
1,705

Selling, general and administrative
2,438

 
2,136

 
5,382

 
5,321

Stock-based compensation costs reflected in net income
$
3,526

 
$
3,099

 
$
8,181

 
$
7,768
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
ACCRUED LIABILITIES (Tables)
 9 Months Ended
Sep. 30, 2016
Accrued Liabilities, Current [Abstract]  
Schedule of Accrued Liabilities [Table Text Block]
Accrued liabilities consisted of the following (in thousands):
 
September 30, 2016
 
December 31, 2015
Compensation and employee benefits
$
11,515

 
$
10,946

Income and other taxes
734

 
1,261

Warranty costs
667

 
553

Other
3,199

 
2,392

 
$
16,115

 
$
15,152
Changes in warranty accrual
The following table summarizes the changes in the warranty accrual (in thousands):
Accrued warranty costs as of December 31, 2015
$
553

Warranty adjustments/settlements
(582
)
Accrual for warranty costs
696

Accrued warranty costs as of September 30, 2016
$
667
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
BUSINESS COMBINATIONS (Details) - USD ($)
$ / shares in Units, shares in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Jun. 30, 2016
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Business Acquisition [Line Items]            
Common stock, par value (in dollars per share) $ 0.001     $ 0.001   $ 0.001
Goodwill       $ 34,279,000   $ 0
Revenue $ 71,221,000 $ 60,601,000   198,368,000 $ 177,259,000  
Net loss $ 2,751,000 $ 6,402,000   $ 17,174,000 $ 16,484,000  
Denominator for basic net income per share - weighted average common stock outstanding 42,683 42,152   42,522 42,041  
Denominator for diluted net income per share - weighted average shares outstanding - diluted 43,136 42,556   42,929 42,354  
Nanosphere [Member]            
Business Acquisition [Line Items]            
Business Acquisition, Percentage of Voting Interests Acquired     100.00%      
Common stock, par value (in dollars per share)     $ 0.01      
Business Acquisition, Share Price     $ 1.70      
Business Acquisition, Cost of Acquired Entity, Cash Paid     $ 88,500,000      
Business acquisition, consideration of cancelled options and restricted stock     $ 1,400,000      
Business acquisition, warrants outstanding     1,500      
Business acquisition, consideration to warrant holders     $ 2,500,000      
Business acquisition, accrued interest on debt     391,000      
Business acquisition, cash acquired during acquisition     25,600,000      
Business Acquisition, Transaction Costs     1,500,000      
Net tangible assets assumed as of June 30, 2016     34,387,000      
Intangible assets subject to amortization     41,685,000      
Long-term debt and accrued interest     (25,391,000)      
Deferred tax assets, net of deferred tax liabilities     7,449,000      
Goodwill     34,279,000      
Business Acquisition, Cost of Acquired Entity, Purchase Price     92,409,000      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents     24,311,000      
Net cash paid for business acquisition     $ 68,098,000      
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory $ 500,000          
Revenue 7,400,000          
Net loss $ 6,200,000          
Business Acquisition, Pro Forma Revenue       $ 212,320,000 $ 191,483,000  
Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax       12,814,000 4,060,000  
Business Acquisition, Pro Forma Net Income (Loss)       $ 10,557,000 $ (2,792,000)  
Business Acquisition, Pro Forma Earnings Per Share, Basic       $ 0.25 $ (0.07)  
Business Acquisition, Pro Forma Earnings Per Share, Diluted       $ 0.25 $ (0.07)  
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
INVESTMENTS (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2013
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Components of Available-for-sale Securities [Line Items]            
Payments to Acquire Other Investments $ 500 $ 0   $ 500 $ 0  
Amortized Cost 701     701   $ 19,634
Gains in Accumulated Other Comprehensive Gain 0     0   0
Losses in Accumulated Other Comprehensive Gain 0     0   (43)
Non-government sponsored debt securities fair value disclosure 0     0   7,459
Government sponsored debt securities fair value disclosure 0     0   11,988
Estimated Fair Value 701     701   19,591
Available-for-sale Securities [Abstract]            
Proceeds from sales of available-for-sale-securities 0 $ 0   19,500 $ 0  
Available-for-sale securities, debt maturities [Abstract]            
Due in one year or less 0     0   11,988
Due after one year through two years 0     0   7,459
Total estimated fair value of available-for-sale debt securities $ 0     $ 0   19,447
Ownership percentage in cost method investment 20.00%     20.00%    
Money Market Funds [Member]            
Components of Available-for-sale Securities [Line Items]            
Amortized Cost $ 701     $ 701   144
Gains in Accumulated Other Comprehensive Gain       0
Losses in Accumulated Other Comprehensive Gain 0     0   0
Estimated Fair Value 701     701   144
Current government-sponsored debt securities [Member]            
Components of Available-for-sale Securities [Line Items]            
Amortized Cost 0     0   10,000
Gains in Accumulated Other Comprehensive Gain 0     0   0
Losses in Accumulated Other Comprehensive Gain 0     0   (10)
Estimated Fair Value 0     0   9,990
Current Non-Government Sponsored Debt Securities [Member]            
Components of Available-for-sale Securities [Line Items]            
Amortized Cost 0     0   2,001
Gains in Accumulated Other Comprehensive Gain 0     0   0
Losses in Accumulated Other Comprehensive Gain 0     0   (3)
Estimated Fair Value 0     0   1,998
Total Current Available-for-sale Securities [Member]            
Components of Available-for-sale Securities [Line Items]            
Amortized Cost 701     701   12,145
Gains in Accumulated Other Comprehensive Gain 0     0   0
Losses in Accumulated Other Comprehensive Gain 0     0   (13)
Estimated Fair Value 701     701   12,132
Non-current government sponsored debt securities            
Components of Available-for-sale Securities [Line Items]            
Amortized Cost 0     0   1,998
Gains in Accumulated Other Comprehensive Gain 0     0   0
Losses in Accumulated Other Comprehensive Gain 0     0   (6)
Government sponsored debt securities fair value disclosure 0     0    
Estimated Fair Value           1,992
Non-Current Non-Government Sponsored Debt Securities [Member]            
Components of Available-for-sale Securities [Line Items]            
Amortized Cost 0     0   5,491
Gains in Accumulated Other Comprehensive Gain 0     0   0
Losses in Accumulated Other Comprehensive Gain 0     0   (24)
Non-government sponsored debt securities fair value disclosure 0     0    
Estimated Fair Value           5,467
Total Non-Current Available-for-sale Securities [Member]            
Components of Available-for-sale Securities [Line Items]            
Amortized Cost 0     0   7,489
Gains in Accumulated Other Comprehensive Gain 0     0   0
Losses in Accumulated Other Comprehensive Gain 0     0   (30)
Estimated Fair Value 0     0   $ 7,459
Investment in Private Company 1 [Member]            
Available-for-sale securities, debt maturities [Abstract]            
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 900   $ 5,400      
Investment in Private Company 2 [Member]            
Available-for-sale securities, debt maturities [Abstract]            
Amount of investments in a private company $ 1,000     $ 1,000    
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
INVENTORY, NET (Details) - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Inventory, Net [Abstract]    
Parts and supplies $ 23,792 $ 15,296
Work-in-progress 6,704 8,797
Finished goods 10,959 7,159
Inventory, net $ 41,455 $ 31,252
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
FAIR VALUE MEASUREMENTS (Details) - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Amounts included in asset accounts [Abstract]    
Money Market funds $ 701 $ 144
Government sponsored debt securities fair value disclosure 0 11,988
Non-government sponsored debt securities fair value disclosure 0 7,459
Fair Value, Inputs, Level 1 [Member]    
Amounts included in asset accounts [Abstract]    
Money Market funds 701 144
Government sponsored debt securities fair value disclosure 0 0
Non-government sponsored debt securities fair value disclosure 0 0
Fair Value, Inputs, Level 2 [Member]    
Amounts included in asset accounts [Abstract]    
Money Market funds 0 0
Government sponsored debt securities fair value disclosure 0 11,988
Non-government sponsored debt securities fair value disclosure 0 7,459
Fair Value, Inputs, Level 3 [Member]    
Amounts included in asset accounts [Abstract]    
Money Market funds 0 0
Government sponsored debt securities fair value disclosure 0 0
Non-government sponsored debt securities fair value disclosure 0 $ 0
Non-Current Non-Government Sponsored Debt Securities [Member]    
Amounts included in asset accounts [Abstract]    
Non-government sponsored debt securities fair value disclosure $ 0  
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
GOODWILL AND OTHER INTANGIBLE ASSETS (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Goodwill [Roll Forward]          
Balance at beginning of year     $ 49,619 $ 49,619 $ 49,619
Goodwill     34,279   0
Balance at end of period $ 83,898   83,898   49,619
Finite and Indefinite-lived Intangible Assets [Roll Forward]          
Balance, beginning     78,551 79,652 79,652
Completion of In Process Research and Development Project         0
Removal of fully amortized assets         (1,101)
Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets 41,685   41,685    
Balance, ending 120,236   120,236   78,551
Less: accumulated amortization [Abstract]          
Accumulated amortization, beginning balance     (26,069) (23,270) (23,270)
Amortization expense (2,482) $ (777) (5,797) (2,455) (3,900)
Removal of amortization of fully amortized assets         1,101
Accumulated amortization, ending balance (31,866)   (31,866)   (26,069)
Net balance 88,370   88,370   52,482
Estimated aggregate amortization expense for the next five years and thereafter [Abstract]          
2016 (three months) 2,482   2,482    
2017 8,979   8,979    
2018 8,789   8,789    
2019 8,789   8,789    
2020 8,789   8,789    
Thereafter 37,560   37,560    
Total 75,388   75,388    
IPR&D 12,982   12,982    
Total 88,370   88,370    
In-process Research and Development [Member]          
Finite and Indefinite-lived Intangible Assets [Roll Forward]          
Balance, beginning     0 40,100 40,100
Completion of In Process Research and Development Project         (40,100)
Removal of fully amortized assets         0
Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets 12,982   12,982    
Balance, ending 12,982   12,982   0
Less: accumulated amortization [Abstract]          
Accumulated amortization, beginning balance     0 0 0
Amortization expense     0   0
Removal of amortization of fully amortized assets         0
Accumulated amortization, ending balance 0   0   0
Net balance 12,982   12,982   0
Technology, Trade Secrets, and Know-how [Member]          
Finite and Indefinite-lived Intangible Assets [Roll Forward]          
Balance, beginning     69,102 29,704 29,704
Completion of In Process Research and Development Project         (40,100)
Removal of fully amortized assets         (702)
Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets 12,282   12,282    
Balance, ending 81,384   81,384   69,102
Less: accumulated amortization [Abstract]          
Accumulated amortization, beginning balance     (21,646) (19,325) (19,325)
Amortization expense     (4,683)   (3,023)
Removal of amortization of fully amortized assets         702
Accumulated amortization, ending balance (26,329)   (26,329)   (21,646)
Net balance 55,055   $ 55,055   $ 47,456
Weighted average life (in years)     10 years   10 years
Customer Lists and Contracts [Member]          
Finite and Indefinite-lived Intangible Assets [Roll Forward]          
Balance, beginning     $ 7,797 7,958 $ 7,958
Completion of In Process Research and Development Project         0
Removal of fully amortized assets         (161)
Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets 12,409   12,409    
Balance, ending 20,206   20,206   7,797
Less: accumulated amortization [Abstract]          
Accumulated amortization, beginning balance     (3,667) (3,085) (3,085)
Amortization expense     (902)   (743)
Removal of amortization of fully amortized assets         161
Accumulated amortization, ending balance (4,569)   (4,569)   (3,667)
Net balance 15,637   $ 15,637   $ 4,130
Weighted average life (in years)     10 years   11 years
Other Identifiable Intangible Assets [Member]          
Finite and Indefinite-lived Intangible Assets [Roll Forward]          
Balance, beginning     $ 1,652 1,890 $ 1,890
Completion of In Process Research and Development Project         0
Removal of fully amortized assets         (238)
Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets 4,012   4,012    
Balance, ending 5,664   5,664   1,652
Less: accumulated amortization [Abstract]          
Accumulated amortization, beginning balance     (756) $ (860) (860)
Amortization expense     (212)   (134)
Removal of amortization of fully amortized assets         238
Accumulated amortization, ending balance (968)   (968)   (756)
Net balance $ 4,696   $ 4,696   $ 896
Weighted average life (in years)     10 years   11 years
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2
OTHER COMPREHENSIVE (LOSS) INCOME (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]        
Balance as of December 31, 2015     $ (1,296)  
Other comprehensive income before reclassifications     330  
Net current-period other comprehensive income $ 113 $ (18) 330 $ (351)
Balance as of September 30, 2016 (966)   (966)  
Accumulated Translation Adjustment [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]        
Balance as of December 31, 2015     (1,258)  
Other comprehensive income before reclassifications     292  
Net current-period other comprehensive income     292  
Balance as of September 30, 2016 (966)   (966)  
Available-for-sale Securities [Member]        
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]        
Balance as of December 31, 2015     (38)  
Other comprehensive income before reclassifications     38  
Net current-period other comprehensive income     38  
Balance as of September 30, 2016 $ 0   $ 0  
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.5.0.2
OTHER COMPREHENSIVE (LOSS) INCOME (Details 1) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Other Comprehensive Income (Loss), Net of Tax [Abstract]        
Foreign currency translation adjustments, before tax $ 113   $ 292  
Foreign currency translation adjustments, tax benefit 0   0  
Foreign currency translation adjustments, net of tax 113   292  
Unrealized gains on available-for-sale investments, before tax 0   44  
Unrealized gains on available-for-sale investments, tax benefit 0   (6)  
Unrealized gains on available-for-sale investments, net of tax 0   38  
Other comprehensive (loss) income, before tax 113   336  
Other comprehensive (loss) income, tax benefit 0   (6)  
Other comprehensive (loss) income, net of tax $ 113 $ (18) $ 330 $ (351)
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Numerator:        
Net income $ 2,751 $ 6,402 $ 17,174 $ 16,484
Denominator:        
Denominator for basic net income per share - weighted average common stock outstanding 42,683,000 42,152,000 42,522,000 42,041,000
Effect of dilutive securities: stock options and awards 453,000 404,000 407,000 313,000
Denominator for diluted net income per share - weighted average shares outstanding - diluted 43,136,000 42,556,000 42,929,000 42,354,000
Basic net income per share $ 0.06 $ 0.15 $ 0.40 $ 0.39
Diluted net income per share $ 0.06 $ 0.15 $ 0.40 $ 0.39
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive restricted stock awards, stock options 0 579,256 0 579,256
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.5.0.2
STOCK-BASED COMPENSATION (Details)
$ / shares in Units, shares in Thousands, $ in Millions
 9 Months Ended
Sep. 30, 2016
USD ($)
$ / shares
shares
Stock options, additional Disclosures [Abstract]  
Total unrecognized compensation costs | $ $ 11.7
Unrecognized compensation costs, weighted average period of recognition (in years) 2 years 10 months 10 days
Stock Options [Member]  
Stock options, outstanding [Roll Forward]  
Options outstanding, beginning balance (in shares) 1,692
Granted (in shares) 886
Exercised (in shares) (143)
Cancelled or expired (in shares) (92)
Options outstanding, ending balance (in shares) 2,343
Stock options, additional Disclosures [Abstract]  
Weighted-average price, beginning of period (in dollars per share) | $ / shares $ 17.47
Weighted-average price, granted (in dollars per share) | $ / shares 19.21
Weighted average price, exercised (in dollars per share) | $ / shares 17.51
Weighted-average price, cancelled or expired (in dollars per share) | $ / shares 18.58
Weighted-average price, end of period (in dollars per share) | $ / shares $ 18.08
Restricted Stock [Member]  
Stock options, additional Disclosures [Abstract]  
Total unrecognized compensation costs | $ $ 15.0
Unrecognized compensation costs, weighted average period of recognition (in years) 2 years 4 months 10 days
Equity instruments other than options, nonvested [Roll Forward]  
Non-vested, beginning balance (in shares) 836
Granted (in shares) 300
Vested (in shares) (205)
Cancelled or expired (in shares) (53)
Non-vested, ending balance (in shares) 878
Equity instruments other than options, additional Disclosures [Abstract]  
Non-vested, beginning balance (in dollars per share) | $ / shares $ 18.66
Granted (in dollars per share) | $ / shares 19.74
Vested (in dollars per share) | $ / shares 19.59
Cancelled or expired (in dollars per share) | $ / shares 18.36
Non-vested, ending balance (in dollars per share) | $ / shares $ 18.83
Restricted Stock Units (RSUs) [Member]  
Stock options, additional Disclosures [Abstract]  
Total unrecognized compensation costs | $ $ 3.3
Unrecognized compensation costs, weighted average period of recognition (in years) 1 year 11 months 12 days
Equity instruments other than options, nonvested [Roll Forward]  
Non-vested, beginning balance (in shares) 501
Granted (in shares) 99
Vested (in shares) (83)
Cancelled or expired (in shares) (46)
Non-vested, ending balance (in shares) 471
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2
STOCK-BASED COMPENSATION (Details 1) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Cost of revenue        
Share-based Compensation, allocation and classification in income statements [Abstract]        
Stock-based compensation costs $ 334 $ 238 $ 903 $ 742
Research and development        
Share-based Compensation, allocation and classification in income statements [Abstract]        
Stock-based compensation costs 754 725 1,896 1,705
Selling, general and administrative        
Share-based Compensation, allocation and classification in income statements [Abstract]        
Stock-based compensation costs 2,438 2,136 5,382 5,321
Selling, general and administrative        
Share-based Compensation, allocation and classification in income statements [Abstract]        
Stock-based compensation costs $ 3,526 $ 3,099 $ 8,181 $ 7,768
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.5.0.2
ACCRUED LIABILITIES (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Dec. 31, 2015
Accrued Liabilities, Current [Abstract]    
Accrued Employee Benefits, Current $ 11,515 $ 10,946
Accrued Income And Other Taxes 734 1,261
Other Accrued Liabilities, Current 3,199 2,392
Accrued liabilities 16,115 $ 15,152
Accrued warranty costs [Roll Forward]    
Accrued warranty costs as of December 31, 2015 553  
Warranty adjustments/settlements (582)  
Accrual for warranty costs 696  
Accrued warranty costs as of September 30, 2016 $ 667  
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
INCOME TAXES (Details)
 9 Months Ended 12 Months Ended
Sep. 30, 2016
Dec. 31, 2016
Effective tax rate, including amounts recorded for discrete events (in hundredths) 21.70%  
Statutory rate (in hundredths) 35.00%  
Maximum rate for cash taxes expected to be paid (in hundredths) 15.00%  
Scenario, Forecast [Member]    
Effective tax rate, including amounts recorded for discrete events (in hundredths)   30.00%
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Jun. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
COMMITTMENTS AND CONTINGENCIES [Abstract]          
Settlement of litigation $ 0 $ 0 $ 7,100 $ 0 $ 7,300
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.5.0.2
RECENT ACCOUNTING PRONOUNCEMENTS RECENT ACCOUNTING PRONOUNCEMENTS (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
New Accounting Pronouncement, Early Adoption [Line Items]          
Income Tax Expense (Benefit) $ 1,307,000 $ 3,317,000 $ 4,760,000 $ 6,538,000  
Retained earnings 72,214,000   72,214,000   $ 48,133,000
New Accounting Pronouncement, Early Adoption, Effect [Member]          
New Accounting Pronouncement, Early Adoption [Line Items]          
Income Tax Expense (Benefit)     211,000    
Retained earnings $ 6,900,000   $ 6,900,000    
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.5.0.2
SUBSEQUENT EVENTS (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Jun. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Subsequent Event [Line Items]          
Settlement of litigation $ 0 $ 0 $ (7,100) $ 0 $ (7,300)
EXCEL 55 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 56 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 57 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 95 218 1 false 28 0 false 4 false false R1.htm 0001000 - Document - Document And Entity Information Sheet http://www.luminexcorp.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.luminexcorp.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Parenthetical Sheet http://www.luminexcorp.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS Parenthetical Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.luminexcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.luminexcorp.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 2101100 - Disclosure - BASIS OF PRESENTATION Sheet http://www.luminexcorp.com/role/BasisOfPresentation BASIS OF PRESENTATION Notes 6 false false R7.htm 2104100 - Disclosure - BUSINESS COMBINATIONS Sheet http://www.luminexcorp.com/role/BusinessCombinations BUSINESS COMBINATIONS Notes 7 false false R8.htm 2105100 - Disclosure - INVESTMENTS Sheet http://www.luminexcorp.com/role/Investments INVESTMENTS Notes 8 false false R9.htm 2106100 - Disclosure - INVENTORY, NET Sheet http://www.luminexcorp.com/role/InventoryNet INVENTORY, NET Notes 9 false false R10.htm 2107100 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.luminexcorp.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 10 false false R11.htm 2108100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Sheet http://www.luminexcorp.com/role/GoodwillAndOtherIntangibleAssets GOODWILL AND OTHER INTANGIBLE ASSETS Notes 11 false false R12.htm 2109100 - Disclosure - OTHER COMPREHENSIVE (LOSS) INCOME Sheet http://www.luminexcorp.com/role/OtherComprehensiveLossIncome OTHER COMPREHENSIVE (LOSS) INCOME Notes 12 false false R13.htm 2110100 - Disclosure - EARNINGS PER SHARE Sheet http://www.luminexcorp.com/role/EarningsPerShare EARNINGS PER SHARE Notes 13 false false R14.htm 2111100 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.luminexcorp.com/role/StockBasedCompensation STOCK-BASED COMPENSATION Notes 14 false false R15.htm 2113100 - Disclosure - ACCRUED LIABILITIES Sheet http://www.luminexcorp.com/role/AccruedLiabilities ACCRUED LIABILITIES Notes 15 false false R16.htm 2114100 - Disclosure - INCOME TAXES Sheet http://www.luminexcorp.com/role/IncomeTaxes INCOME TAXES Notes 16 false false R17.htm 2115100 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.luminexcorp.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 17 false false R18.htm 2116100 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS Sheet http://www.luminexcorp.com/role/RecentAccountingPronouncements RECENT ACCOUNTING PRONOUNCEMENTS Notes 18 false false R19.htm 2304301 - Disclosure - BUSINESS COMBINATIONS (Tables) Sheet http://www.luminexcorp.com/role/BusinessCombinationsTables BUSINESS COMBINATIONS (Tables) Tables http://www.luminexcorp.com/role/BusinessCombinations 19 false false R20.htm 2305301 - Disclosure - INVESTMENTS (Tables) Sheet http://www.luminexcorp.com/role/InvestmentsTables INVESTMENTS (Tables) Tables http://www.luminexcorp.com/role/Investments 20 false false R21.htm 2306301 - Disclosure - INVENTORY, NET (Tables) Sheet http://www.luminexcorp.com/role/InventoryNetTables INVENTORY, NET (Tables) Tables http://www.luminexcorp.com/role/InventoryNet 21 false false R22.htm 2307301 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.luminexcorp.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.luminexcorp.com/role/FairValueMeasurements 22 false false R23.htm 2308301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Sheet http://www.luminexcorp.com/role/GoodwillAndOtherIntangibleAssetsTables GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Tables http://www.luminexcorp.com/role/GoodwillAndOtherIntangibleAssets 23 false false R24.htm 2309301 - Disclosure - OTHER COMPREHENSIVE (LOSS) INCOME (Tables) Sheet http://www.luminexcorp.com/role/OtherComprehensiveLossIncomeTables OTHER COMPREHENSIVE (LOSS) INCOME (Tables) Tables http://www.luminexcorp.com/role/OtherComprehensiveLossIncome 24 false false R25.htm 2310301 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://www.luminexcorp.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://www.luminexcorp.com/role/EarningsPerShare 25 false false R26.htm 2311301 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.luminexcorp.com/role/StockBasedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://www.luminexcorp.com/role/StockBasedCompensation 26 false false R27.htm 2313301 - Disclosure - ACCRUED LIABILITIES (Tables) Sheet http://www.luminexcorp.com/role/AccruedLiabilitiesTables ACCRUED LIABILITIES (Tables) Tables http://www.luminexcorp.com/role/AccruedLiabilities 27 false false R28.htm 2404402 - Disclosure - BUSINESS COMBINATIONS (Details) Sheet http://www.luminexcorp.com/role/BusinessCombinationsDetails BUSINESS COMBINATIONS (Details) Details http://www.luminexcorp.com/role/BusinessCombinationsTables 28 false false R29.htm 2405402 - Disclosure - INVESTMENTS (Details) Sheet http://www.luminexcorp.com/role/InvestmentsDetails INVESTMENTS (Details) Details http://www.luminexcorp.com/role/InvestmentsTables 29 false false R30.htm 2406402 - Disclosure - INVENTORY, NET (Details) Sheet http://www.luminexcorp.com/role/InventoryNetDetails INVENTORY, NET (Details) Details http://www.luminexcorp.com/role/InventoryNetTables 30 false false R31.htm 2407402 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://www.luminexcorp.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://www.luminexcorp.com/role/FairValueMeasurementsTables 31 false false R32.htm 2408402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details) Sheet http://www.luminexcorp.com/role/GoodwillAndOtherIntangibleAssetsDetails GOODWILL AND OTHER INTANGIBLE ASSETS (Details) Details http://www.luminexcorp.com/role/GoodwillAndOtherIntangibleAssetsTables 32 false false R33.htm 2409402 - Disclosure - OTHER COMPREHENSIVE (LOSS) INCOME (Details) Sheet http://www.luminexcorp.com/role/OtherComprehensiveLossIncomeDetails OTHER COMPREHENSIVE (LOSS) INCOME (Details) Details http://www.luminexcorp.com/role/OtherComprehensiveLossIncomeTables 33 false false R34.htm 2409403 - Disclosure - OTHER COMPREHENSIVE (LOSS) INCOME (Details 1) Sheet http://www.luminexcorp.com/role/OtherComprehensiveLossIncomeDetails1 OTHER COMPREHENSIVE (LOSS) INCOME (Details 1) Details http://www.luminexcorp.com/role/OtherComprehensiveLossIncomeTables 34 false false R35.htm 2410402 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://www.luminexcorp.com/role/EarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://www.luminexcorp.com/role/EarningsPerShareTables 35 false false R36.htm 2411402 - Disclosure - STOCK-BASED COMPENSATION (Details) Sheet http://www.luminexcorp.com/role/StockBasedCompensationDetails STOCK-BASED COMPENSATION (Details) Details http://www.luminexcorp.com/role/StockBasedCompensationTables 36 false false R37.htm 2411403 - Disclosure - STOCK-BASED COMPENSATION (Details 1) Sheet http://www.luminexcorp.com/role/StockBasedCompensationDetails1 STOCK-BASED COMPENSATION (Details 1) Details http://www.luminexcorp.com/role/StockBasedCompensationTables 37 false false R38.htm 2413402 - Disclosure - ACCRUED LIABILITIES (Details) Sheet http://www.luminexcorp.com/role/AccruedLiabilitiesDetails ACCRUED LIABILITIES (Details) Details http://www.luminexcorp.com/role/AccruedLiabilitiesTables 38 false false R39.htm 2414401 - Disclosure - INCOME TAXES (Details) Sheet http://www.luminexcorp.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://www.luminexcorp.com/role/IncomeTaxes 39 false false R40.htm 2415401 - Disclosure - COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.luminexcorp.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES (Details) Details 40 false false R41.htm 2416401 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS RECENT ACCOUNTING PRONOUNCEMENTS (Details) Sheet http://www.luminexcorp.com/role/RecentAccountingPronouncementsRecentAccountingPronouncementsDetails RECENT ACCOUNTING PRONOUNCEMENTS RECENT ACCOUNTING PRONOUNCEMENTS (Details) Details 41 false false R42.htm 2417402 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.luminexcorp.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details 42 false false All Reports Book All Reports lmnx-20160930.xml lmnx-20160930.xsd lmnx-20160930_cal.xml lmnx-20160930_def.xml lmnx-20160930_lab.xml lmnx-20160930_pre.xml true true ZIP 61 0001033905-16-000192-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001033905-16-000192-xbrl.zip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end